{"source": "EMA documents JSON (filtered)", "days": 30, "cutoff_utc": "2025-12-02T06:31:20.011313+00:00", "count": 855, "debug_skipped_str": 0, "debug_skipped_other": 0, "items": [{"id": "71445", "name": "Agenda of the COMP meeting 2-3 December 2025", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-12-02T09:47:53Z", "last_update_date": "2025-12-02T09:47:53Z", "reference_number": "EMA/COMP/360557/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-comp-meeting-2-3-december-2025_en.xlsx"}, {"id": "55801", "name": "Upstaza : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-08-09T11:00:00Z", "last_update_date": "2025-12-02T14:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/upstaza-epar-product-information_en.pdf"}, {"id": "56137", "name": "Upstaza : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-20T09:20:00Z", "last_update_date": "2025-12-02T14:31:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/upstaza-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71446", "name": "Upstaza : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T10:00:40Z", "last_update_date": "2025-12-02T10:00:40Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/upstaza-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "62590", "name": "Krazati : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-22T11:22:29Z", "last_update_date": "2025-12-02T10:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/krazati-epar-product-information_en.pdf"}, {"id": "63299", "name": "Krazati : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-22T12:06:00Z", "last_update_date": "2025-12-02T10:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/krazati-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71447", "name": "Union Product Database (UPD) - Questions & answers: Network use", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T10:32:11Z", "last_update_date": "2025-12-02T10:32:11Z", "reference_number": "EMA/379949/2025", "url": "https://www.ema.europa.eu/en/documents/other/union-product-database-upd-questions-answers-network-use_en.pdf"}, {"id": "53698", "name": "Union Product Database (UPD) registration guide for UI and API users", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-12T11:06:00Z", "last_update_date": "2025-12-02T10:30:00Z", "reference_number": "EMA/362250/2023", "url": "https://www.ema.europa.eu/en/documents/other/upd-registration-guide-ui-api-users_en.pdf"}, {"id": "62589", "name": "Krazati : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2024-03-13T11:20:53Z", "last_update_date": "2025-12-02T10:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/krazati-epar-risk-management-plan_en.pdf"}, {"id": "69632", "name": "Declaration of interests: Stefanie Prilla", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-01T15:58:39Z", "last_update_date": "2025-12-02T10:37:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/declaration-interests-stefanie-prilla_en.pdf"}, {"id": "3347", "name": "IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2018-07-04T14:00:00Z", "last_update_date": "2025-12-02T11:15:00Z", "reference_number": "EMA/444925/2018 Version 3.10", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/iris-guide-applicants-how-create-submit-scientific-applications-industry-individual-applicants_en.pdf"}, {"id": "45767", "name": "Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2019-10-22T14:37:00Z", "last_update_date": "2025-12-02T11:25:00Z", "reference_number": "EMA/37991/2019 Rev.6", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/questions-answers-implementation-medical-devices-vitro-diagnostic-medical-devices-regulations-eu-2017-745-eu-2017-746-tracked-changes_en.pdf"}, {"id": "71448", "name": "Gilenya-PAM-0000295236 : EPAR - Assessment report", "type": "variation-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T11:24:31Z", "last_update_date": "2025-12-02T11:24:31Z", "reference_number": "EMADOC-1700519818-2443340", "url": "https://www.ema.europa.eu/en/documents/variation-report/gilenya-pam-0000295236-epar-assessment-report_en.pdf"}, {"id": "43928", "name": "Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2019-02-28T12:00:00Z", "last_update_date": "2025-12-02T11:25:00Z", "reference_number": "EMA/37991/2019 Rev.6", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/questions-answers-implementation-medical-devices-vitro-diagnostic-medical-devices-regulations-eu-2017-745-eu-2017-746_en.pdf"}, {"id": "26644", "name": "Mysildecard : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2016-12-08T01:00:00Z", "last_update_date": "2025-12-02T16:17:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mysildecard-epar-product-information_en.pdf"}, {"id": "63284", "name": "Mysildecard : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-21T14:21:19Z", "last_update_date": "2025-12-02T16:40:06Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/mysildecard-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71449", "name": "Agenda of the CVMP meeting 2-4 December 2025", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-12-02T11:31:29Z", "last_update_date": "2025-12-02T11:31:29Z", "reference_number": "EMA/CVMP/366230/2025 – draft 3", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-cvmp-meeting-2-4-december-2025_en.pdf"}, {"id": "70649", "name": "Izamby : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-17T15:30:01Z", "last_update_date": "2025-12-02T15:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/izamby-epar-product-information-tracked-changes_en.docx"}, {"id": "71450", "name": "EMA/PE/0000232315: EMA decision of 19 March 2025 on the acceptance of a modification of an agreed paediatric investigation plan for spesolimab (Spevigo)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-02T11:44:17Z", "last_update_date": "2025-12-02T11:44:17Z", "reference_number": "EMADOC-1700519818-1976710", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000232315-ema-decision-19-march-2025-acceptance-modification-agreed-paediatric-investigation-plan-spesolimab-spevigo_en.pdf"}, {"id": "71451", "name": "P/0388/2024: EMA decision of 8 November 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for tildrakizumab (Ilumetri), (EMEA-001451-PIP02-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-02T11:50:11Z", "last_update_date": "2025-12-02T11:50:11Z", "reference_number": "EMA/513587/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0388-2024-ema-decision-8-november-2024-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-tildrakizumab-ilumetri-emea-001451-pip02-24_en.pdf"}, {"id": "71452", "name": "P/0387/2024: EMA decision of 8 November 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for ravulizumab (Ultomiris), (EMEA-001943-PIP07-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-02T11:51:24Z", "last_update_date": "2025-12-02T11:51:24Z", "reference_number": "EMA/506319/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0387-2024-ema-decision-8-november-2024-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-ravulizumab-ultomiris-emea-001943-pip07-24_en.pdf"}, {"id": "49491", "name": "Aybintio : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2020-12-09T15:43:00Z", "last_update_date": "2025-12-02T11:38:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/aybintio-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "63227", "name": "Pregabalin Sandoz : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-16T11:00:00Z", "last_update_date": "2025-12-02T10:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pregabalin-sandoz-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "9482", "name": "Pregabalin Sandoz : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-16T02:00:00Z", "last_update_date": "2025-12-02T15:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pregabalin-sandoz-epar-product-information_en.pdf"}, {"id": "60228", "name": "Tevimbra : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-10-02T15:34:00Z", "last_update_date": "2025-12-02T10:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/tevimbra-epar-risk-management-plan_en.pdf"}, {"id": "71455", "name": "Propylthiouracil : List of nationally authorised medicinal products - PSUSA/00002558/202501", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T15:31:41Z", "last_update_date": "2025-12-02T15:31:41Z", "reference_number": "EMADOC-1700519818-2688635", "url": "https://www.ema.europa.eu/en/documents/psusa/propylthiouracil-list-nationally-authorised-medicinal-products-psusa-00002558-202501_en.pdf"}, {"id": "34335", "name": "Kaletra : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-23T02:00:00Z", "last_update_date": "2025-12-02T16:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/kaletra-epar-product-information_en.pdf"}, {"id": "67725", "name": "Kaletra : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-10T11:49:05Z", "last_update_date": "2025-12-02T15:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/kaletra-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "51731", "name": "Aluvia : Product information", "type": "outside-EU-product-information", "status": "unknown", "consultation_date": "", "publish_date": "2010-01-29T16:35:00Z", "last_update_date": "2025-12-02T11:44:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/outside-eu-product-information/aluvia-product-information_en.pdf"}, {"id": "67754", "name": "Aluvia : Procedural steps taken and scientific information after opinion", "type": "outside-EU-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-11T13:26:00Z", "last_update_date": "2025-12-02T15:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/outside-eu-steps-after/aluvia-procedural-steps-taken-scientific-information-after-opinion_en.pdf"}, {"id": "71453", "name": "Methylphenidate hydrochloride : List of nationally authorised medicinal products - EMA/PASS/0000248031", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T16:08:00Z", "last_update_date": "2025-12-02T16:08:00Z", "reference_number": "EMADOC-1700519818-2688035", "url": "https://www.ema.europa.eu/en/documents/psusa/methylphenidate-hydrochloride-list-nationally-authorised-medicinal-products-ema-pass-0000248031_en.pdf"}, {"id": "71458", "name": "SPOR & XEVMPD status update webinar – Questions and Answers", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T16:33:44Z", "last_update_date": "2025-12-02T16:33:44Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/spor-xevmpd-status-update-webinar-questions-answers_en.pdf"}, {"id": "71460", "name": "CAT quarterly highlights and approved ATMPs - December 2025", "type": "committee-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T16:39:46Z", "last_update_date": "2025-12-02T16:39:46Z", "reference_number": "EMA/CAT/380337/2025", "url": "https://www.ema.europa.eu/en/documents/committee-report/cat-quarterly-highlights-approved-atmps-december-2025_en.pdf"}, {"id": "12438", "name": "Protopic : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-06T02:00:00Z", "last_update_date": "2025-12-03T09:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/protopic-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71457", "name": "Protopic : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T16:24:23Z", "last_update_date": "2025-12-03T16:24:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/protopic-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71464", "name": "Aybintio : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T08:15:41Z", "last_update_date": "2025-12-03T08:15:41Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aybintio-epar-product-information-tracked-changes_en.docx"}, {"id": "71463", "name": "Agenda of the CAT meeting 3-5 December 2025", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-12-03T09:00:00Z", "last_update_date": "2025-12-03T09:00:00Z", "reference_number": "EMA/CAT/380010/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-cat-meeting-3-5-december-2025_en.pdf"}, {"id": "50808", "name": "Ontozry : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-13T15:40:00Z", "last_update_date": "2025-12-03T14:34:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ontozry-epar-product-information_en.pdf"}, {"id": "67688", "name": "Ontozry : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-08T12:15:57Z", "last_update_date": "2025-12-03T08:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ontozry-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71465", "name": "HMA-EMA joint Network Data Steering Group meeting - 6 October 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-03T09:32:00Z", "last_update_date": "2025-12-03T09:32:00Z", "reference_number": "EMA/323786/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/hma-ema-joint-network-data-steering-group-meeting-6-october-2025_en.pdf"}, {"id": "71466", "name": "Tibolone : List of nationally authorised medicinal products - PSUSA/00002947/202412", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T10:21:31Z", "last_update_date": "2025-12-03T10:21:31Z", "reference_number": "EMADOC-1700519818-1987499", "url": "https://www.ema.europa.eu/en/documents/psusa/tibolone-list-nationally-authorised-medicinal-products-psusa-00002947-202412_en.pdf"}, {"id": "69107", "name": "Oczyesa : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-04T13:22:41Z", "last_update_date": "2025-12-03T10:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/oczyesa-epar-product-information_en.pdf"}, {"id": "71467", "name": "Oczyesa : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T10:31:05Z", "last_update_date": "2025-12-03T10:31:05Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/oczyesa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "27520", "name": "Keytruda : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-30T02:00:00Z", "last_update_date": "2025-12-03T10:43:00Z", "reference_number": "EMA/99022/2025", "url": "https://www.ema.europa.eu/en/documents/overview/keytruda-epar-medicine-overview_en.pdf"}, {"id": "28260", "name": "Keytruda : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-30T02:00:00Z", "last_update_date": "2025-12-03T10:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/keytruda-epar-risk-management-plan_en.pdf"}, {"id": "37007", "name": "Keytruda : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-30T02:00:00Z", "last_update_date": "2025-12-03T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/keytruda-epar-all-authorised-presentations_en.pdf"}, {"id": "63196", "name": "Keytruda : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-30T10:14:51Z", "last_update_date": "2025-12-03T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/keytruda-epar-product-information_en.pdf"}, {"id": "69751", "name": "Keytruda : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-14T17:43:58Z", "last_update_date": "2025-12-03T16:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/keytruda-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71468", "name": "Keytruda-X-0000248795 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-03T10:51:03Z", "last_update_date": "2025-12-03T10:51:03Z", "reference_number": "EMADOC-1700519818-2228659", "url": "https://www.ema.europa.eu/en/documents/variation-report/keytruda-x-0000248795-epar-assessment-report-variation_en.pdf"}, {"id": "18684", "name": "Febuxostat Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-10-19T02:00:00Z", "last_update_date": "2025-12-03T11:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/febuxostat-viatris-epar-product-information_en.pdf"}, {"id": "34747", "name": "HMPC: overview of assessment work - priority list", "type": "other", "status": "Adopted", "consultation_date": "", "publish_date": "2009-10-26T00:09:00Z", "last_update_date": "2025-12-03T14:08:00Z", "reference_number": "EMA/HMPC/561868/2021", "url": "https://www.ema.europa.eu/en/documents/other/hmpc-overview-assessment-work-priority-list_en.pdf"}, {"id": "5878", "name": "Adempas : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2014-04-10T02:00:00Z", "last_update_date": "2025-12-03T01:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/adempas-epar-product-information_en.pdf"}, {"id": "71471", "name": "Keeping medicines safe: What actions can EMA take?", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T12:00:00Z", "last_update_date": "2025-12-03T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/keeping-medicines-safe-what-actions-can-ema-take_en.pdf"}, {"id": "71469", "name": "Keeping medicines safe: Reporting side effects can make medicines safer for everyone", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T12:00:00Z", "last_update_date": "2025-12-03T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/keeping-medicines-safe-reporting-side-effects-can-make-medicines-safer-everyone_en.pdf"}, {"id": "70546", "name": "Vaxelis : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2016-02-26T14:39:47Z", "last_update_date": "2025-12-03T12:22:22Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/vaxelis-epar-product-information_en.pdf"}, {"id": "71473", "name": "Protopic : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T13:38:15Z", "last_update_date": "2025-12-03T13:38:15Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx"}, {"id": "50105", "name": "Enhertu : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-02-08T17:14:00Z", "last_update_date": "2025-12-03T16:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/enhertu-epar-product-information_en.pdf"}, {"id": "51253", "name": "Enhertu : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2021-05-25T13:30:00Z", "last_update_date": "2025-12-03T16:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/enhertu-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "50108", "name": "Enhertu : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2021-02-08T17:23:00Z", "last_update_date": "2025-12-03T16:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/enhertu-epar-risk-management-plan_en.pdf"}, {"id": "9020", "name": "NexoBrid : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-01-07T01:00:00Z", "last_update_date": "2025-12-03T16:44:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/nexobrid-epar-product-information_en.pdf"}, {"id": "11944", "name": "NexoBrid : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2013-09-30T17:15:00Z", "last_update_date": "2025-12-03T16:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/nexobrid-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "37248", "name": "NexoBrid : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2013-01-07T01:00:00Z", "last_update_date": "2025-12-03T01:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/nexobrid-epar-all-authorised-presentations_en.pdf"}, {"id": "71475", "name": "NexoBrid : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T14:19:34Z", "last_update_date": "2025-12-03T14:19:34Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/nexobrid-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71474", "name": "EMA decision on adoption by analogy of Commission decision C (2025) 2495", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T13:54:42Z", "last_update_date": "2025-12-03T13:54:42Z", "reference_number": "EMA/MB/283584/2025", "url": "https://www.ema.europa.eu/en/documents/other/ema-decision-adoption-analogy-commission-decision-c-2025-2495_en.pdf"}, {"id": "71476", "name": "Compliance notifications explanation and Q&A", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T15:00:00Z", "last_update_date": "2025-12-03T15:00:00Z", "reference_number": "EMA/362031/2025", "url": "https://www.ema.europa.eu/en/documents/other/compliance-notifications-explanation-qa_en.pdf"}, {"id": "71477", "name": "Guidelines for real-time co-authoring in SharePoint online", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T15:06:58Z", "last_update_date": "2025-12-03T15:06:58Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/guidelines-real-time-co-authoring-sharepoint-online_en.pdf"}, {"id": "63142", "name": "Incellipan : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-02T14:08:00Z", "last_update_date": "2025-12-03T15:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/incellipan-epar-product-information_en.pdf"}, {"id": "71478", "name": "Incellipan : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T15:15:40Z", "last_update_date": "2025-12-03T15:15:40Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/incellipan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71479", "name": "Enhertu : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T15:32:58Z", "last_update_date": "2025-12-03T15:32:58Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/enhertu-epar-product-information-tracked-changes_en.docx"}, {"id": "5294", "name": "Cancidas : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-05T02:09:00Z", "last_update_date": "2025-12-03T16:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/cancidas-epar-product-information_en.pdf"}, {"id": "67962", "name": "\tCancidas : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-24T16:42:49Z", "last_update_date": "2025-12-03T15:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cancidas-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71480", "name": "Cancidas-PSUSA-00000576-202412 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T15:39:39Z", "last_update_date": "2025-12-03T15:39:39Z", "reference_number": "EMADOC-1700519818-2694156", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/cancidas-psusa-00000576-202412-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "43303", "name": "Delstrigo : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2019-01-10T15:59:00Z", "last_update_date": "2025-12-03T17:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/delstrigo-epar-product-information_en.pdf"}, {"id": "69604", "name": "Delstrigo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-31T16:42:15Z", "last_update_date": "2025-12-03T15:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/delstrigo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71481", "name": "Caspofungin : List of nationally authorised medicinal products - PSUSA/00000576/202412", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T16:11:48Z", "last_update_date": "2025-12-03T16:11:48Z", "reference_number": "EMADOC-1700519818-2694579", "url": "https://www.ema.europa.eu/en/documents/psusa/caspofungin-list-nationally-authorised-medicinal-products-psusa-00000576-202412_en.pdf"}, {"id": "71482", "name": "Caspofungin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000576/202412", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T16:13:06Z", "last_update_date": "2025-12-03T16:13:06Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/caspofungin-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00000576-202412_en.pdf"}, {"id": "18365", "name": "Baraclude : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-10-13T03:00:00Z", "last_update_date": "2025-12-03T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/baraclude-epar-product-information_en.pdf"}, {"id": "39445", "name": "Baraclude : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-10-13T03:00:00Z", "last_update_date": "2025-12-03T16:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/baraclude-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71483", "name": "Baraclude : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T16:24:06Z", "last_update_date": "2025-12-03T16:24:06Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/baraclude-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71484", "name": "Baraclude : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T16:25:45Z", "last_update_date": "2025-12-03T16:25:45Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx"}, {"id": "70652", "name": "Tryngolza : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-17T15:44:56Z", "last_update_date": "2025-12-03T16:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tryngolza-epar-product-information_en.pdf"}, {"id": "71485", "name": "Tryngolza : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-03T16:30:55Z", "last_update_date": "2025-12-03T16:30:55Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tryngolza-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "24631", "name": "Abbreviations used in EMA scientific committees and Coordination Group for Mutual Recognition and Decentralised Procedures (CMD) documents, and in relation to EMA’s regulatory activities", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2012-10-05T13:59:00Z", "last_update_date": "2025-12-03T16:36:00Z", "reference_number": "EMA/899164/2022 Rev.4", "url": "https://www.ema.europa.eu/en/documents/other/abbreviations-used-ema-scientific-committees-coordination-group-mutual-recognition-decentralised-procedures-cmd-documents-relation-emas-regulatory-activities_en.pdf"}, {"id": "36207", "name": "Tagrisso : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2016-04-12T02:00:00Z", "last_update_date": "2025-12-04T17:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tagrisso-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "39868", "name": "Tagrisso : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2016-02-17T11:00:00Z", "last_update_date": "2025-12-04T17:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tagrisso-epar-product-information_en.pdf"}, {"id": "71490", "name": "Tagrisso : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T08:39:45Z", "last_update_date": "2025-12-04T08:39:45Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tagrisso-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71491", "name": "Tagrisso : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T08:41:43Z", "last_update_date": "2025-12-04T08:41:43Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/tagrisso-epar-product-information-tracked-changes_en.docx"}, {"id": "50764", "name": "Sunitinib Accord : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-06T17:32:00Z", "last_update_date": "2025-12-04T14:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"}, {"id": "68116", "name": "Sunitinib Accord : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-06T15:07:23Z", "last_update_date": "2025-12-04T09:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/sunitinib-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "33734", "name": "Lynparza : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-01-09T01:00:00Z", "last_update_date": "2025-12-04T13:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/lynparza-epar-product-information_en.pdf"}, {"id": "69384", "name": "Lynparza : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-18T15:17:05Z", "last_update_date": "2025-12-04T12:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lynparza-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71492", "name": "Lynparza-VR-0000287658 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T09:12:05Z", "last_update_date": "2025-12-04T09:12:05Z", "reference_number": "EMADOC-1700519818-2335536", "url": "https://www.ema.europa.eu/en/documents/variation-report/lynparza-vr-0000287658-epar-assessment-report-variation_en.pdf"}, {"id": "70898", "name": "Lynparza : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-29T12:51:37Z", "last_update_date": "2025-12-04T09:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lynparza-epar-product-information-tracked-changes_en.docx"}, {"id": "71493", "name": "Withdrawal assessment report for Tuzodi", "type": "withdrawal-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T09:25:28Z", "last_update_date": "2025-12-04T09:25:28Z", "reference_number": "EMADOC-1829012207-24310", "url": "https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-tuzodi_en.pdf"}, {"id": "70178", "name": "Questions and answers on the withdrawal of application for the marketing authorisation of Tuzodi (midazolam)", "type": "medicine-qa", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-19T08:48:57Z", "last_update_date": "2025-12-04T09:27:00Z", "reference_number": "EMA/301698/2025", "url": "https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-withdrawal-application-marketing-authorisation-tuzodi-midazolam_en.pdf"}, {"id": "54011", "name": "Paxlovid : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-28T13:58:00Z", "last_update_date": "2025-12-04T16:26:00Z", "reference_number": "EMA/342276/2025", "url": "https://www.ema.europa.eu/en/documents/overview/paxlovid-epar-medicine-overview_en.pdf"}, {"id": "53960", "name": "Paxlovid : EPAR - Risk-management-plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-27T16:37:00Z", "last_update_date": "2025-12-04T11:04:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/paxlovid-epar-risk-management-plan_en.pdf"}, {"id": "54012", "name": "Paxlovid : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-28T14:03:00Z", "last_update_date": "2025-12-04T13:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/paxlovid-epar-all-authorised-presentations_en.pdf"}, {"id": "54863", "name": "Paxlovid : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-29T11:00:00Z", "last_update_date": "2025-12-04T11:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/paxlovid-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "61038", "name": "Paxlovid : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-28T13:27:08Z", "last_update_date": "2025-12-04T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/paxlovid-epar-product-information_en.pdf"}, {"id": "71494", "name": "Paxlovid-H-C-005973-II-0061-G : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T09:39:06Z", "last_update_date": "2025-12-04T09:39:06Z", "reference_number": "EMA/CHMP/308349/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/paxlovid-h-c-005973-ii-0061-g-epar-assessment-report-variation_en.pdf"}, {"id": "71495", "name": "Paxlovid : EPAR - Scientific conclusions on the request for one-year marketing protection presented by the European Medicines Agency", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T09:44:16Z", "last_update_date": "2025-12-04T09:44:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/paxlovid-epar-scientific-conclusions-request-one-year-marketing-protection-presented-european-medicines-agency_en.pdf"}, {"id": "71496", "name": "Declaration of Interests: Anna-Sofia Joro", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T10:32:17Z", "last_update_date": "2025-12-04T10:32:17Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/declaration-interests-anna-sofia-joro_en.pdf"}, {"id": "53006", "name": "Veterinary Scientific Advice procedure – timelines 2026 - information for applicants", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2021-11-05T15:41:00Z", "last_update_date": "2025-12-04T10:45:00Z", "reference_number": "EMA/CVMP/SAWP/357647/2025", "url": "https://www.ema.europa.eu/en/documents/other/veterinary-scientific-advice-procedure-timelines-2026-information-applicants_en.pdf"}, {"id": "71497", "name": "Adcetris-H-C-002455-II-0111 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T11:38:37Z", "last_update_date": "2025-12-04T11:38:37Z", "reference_number": "EMA/324858/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/adcetris-h-c-002455-ii-0111-epar-assessment-report-variation_en.pdf"}, {"id": "71177", "name": "Questions and answers on the refusal of a change to the marketing authorisation for Hetlioz (tasimelteon) (II-40)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-11-14T11:50:47Z", "last_update_date": "2025-12-04T11:50:00Z", "reference_number": "EMEA/H/C/003870/II/0040", "url": "https://www.ema.europa.eu/en/documents/smop/questions-answers-refusal-change-marketing-authorisation-hetlioz-tasimelteon-ii-40_en.pdf"}, {"id": "43144", "name": "Dengvaxia : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2018-12-18T17:36:00Z", "last_update_date": "2025-12-04T15:12:00Z", "reference_number": "EMA/688282/2021 ", "url": "https://www.ema.europa.eu/en/documents/overview/dengvaxia-epar-medicine-overview_en.pdf"}, {"id": "53921", "name": "Dengvaxia : EPAR - Risk management plan summary", "type": "rmp-summary", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-26T15:14:00Z", "last_update_date": "2025-12-04T15:01:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp-summary/dengvaxia-epar-risk-management-plan-summary_en.pdf"}, {"id": "43145", "name": "Dengvaxia : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-12-18T17:38:00Z", "last_update_date": "2025-12-04T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/dengvaxia-epar-product-information_en.pdf"}, {"id": "43146", "name": "Dengvaxia : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2018-12-18T17:39:00Z", "last_update_date": "2025-12-04T10:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/dengvaxia-epar-all-authorised-presentations_en.pdf"}, {"id": "43147", "name": "Dengvaxia : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2018-12-18T17:40:00Z", "last_update_date": "2025-12-04T12:00:00Z", "reference_number": "EMA/791273/2018", "url": "https://www.ema.europa.eu/en/documents/assessment-report/dengvaxia-epar-public-assessment-report_en.pdf"}, {"id": "42355", "name": "CHMP summary of positive opinion for Dengvaxia", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2018-10-19T15:03:00Z", "last_update_date": "2025-12-04T12:00:00Z", "reference_number": "EMA/CHMP/666423/2018", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-dengvaxia_en.pdf"}, {"id": "45778", "name": "Dengvaxia-H-C-4171-II-0003-G : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2019-10-23T16:53:00Z", "last_update_date": "2025-12-04T12:00:00Z", "reference_number": "EMA/553606/2019", "url": "https://www.ema.europa.eu/en/documents/variation-report/dengvaxia-h-c-4171-ii-0003-g-epar-assessment-report-variation_en.pdf"}, {"id": "45779", "name": "Dengvaxia : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2019-10-23T16:56:00Z", "last_update_date": "2025-12-04T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/dengvaxia-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "53922", "name": "Dengvaxia-H-C-4171-II-11 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2022-01-26T15:16:00Z", "last_update_date": "2025-12-04T12:00:00Z", "reference_number": "EMA/754271/2021", "url": "https://www.ema.europa.eu/en/documents/variation-report/dengvaxia-h-c-4171-ii-11-epar-assessment-report-variation_en.pdf"}, {"id": "53924", "name": "Dengvaxia-H-C-4171-II-12 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2022-01-26T15:20:00Z", "last_update_date": "2025-12-04T12:00:00Z", "reference_number": "EMA/754269/2021", "url": "https://www.ema.europa.eu/en/documents/variation-report/dengvaxia-h-c-4171-ii-12-epar-assessment-report-variation_en.pdf"}, {"id": "53075", "name": "CHMP post-authorisation summary of positive opinion for Dengvaxia (II-11;II-12)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2021-11-12T14:48:00Z", "last_update_date": "2025-12-04T12:00:00Z", "reference_number": "EMA/CHMP/618604/2021", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-dengvaxia-ii-11ii-12_en.pdf"}, {"id": "47978", "name": "P/0065/2020: EMA decision of 21 February 2020 on the acceptance of a modification of an agreed PIP for live, attenuated, chimeric dengue virus, serotype 1 / live, attenuated, chimeric dengue virus, serotype 2 / live, attenuated, chimeric dengue virus...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2020-06-12T14:00:00Z", "last_update_date": "2025-12-04T12:12:00Z", "reference_number": "EMA/85734/2020", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0065-2020-ema-decision-21-february-2020-acceptance-modification-agreed-pip-live-attenuated-chimeric-dengue-virus-serotype-1-live-attenuated-chimeric-dengue-virus-serotype-2-live-attenuated-chimeric_en.pdf"}, {"id": "71454", "name": "Methylphenidate hydrochloride : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - EMA/PASS/0000248031", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T16:09:00Z", "last_update_date": "2025-12-02T16:01:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/methylphenidate-hydrochloride-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-ema-pass-0000248031_en.pdf"}, {"id": "71499", "name": "Brinsupri : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T12:36:07Z", "last_update_date": "2025-12-04T12:36:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/brinsupri-epar-risk-management-plan_en.pdf"}, {"id": "71498", "name": "Brinsupri : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T12:34:13Z", "last_update_date": "2025-12-04T12:34:13Z", "reference_number": "EMA/341492/2025", "url": "https://www.ema.europa.eu/en/documents/overview/brinsupri-epar-medicine-overview_en.pdf"}, {"id": "71500", "name": "Brinsupri : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T12:37:19Z", "last_update_date": "2025-12-04T12:37:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/brinsupri-epar-product-information_en.pdf"}, {"id": "71501", "name": "Brinsupri : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T12:38:36Z", "last_update_date": "2025-12-04T12:38:36Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/brinsupri-epar-all-authorised-presentations_en.pdf"}, {"id": "71502", "name": "Brinsupri : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T12:39:35Z", "last_update_date": "2025-12-04T12:39:35Z", "reference_number": "EMA/345552/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/brinsupri-epar-public-assessment-report_en.pdf"}, {"id": "3770", "name": "Nucala : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2016-04-15T02:00:00Z", "last_update_date": "2025-12-04T16:03:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/nucala-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "37307", "name": "Nucala : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-12-03T01:00:00Z", "last_update_date": "2025-12-04T16:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/nucala-epar-product-information_en.pdf"}, {"id": "71503", "name": "Denosumab Intas : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T13:57:19Z", "last_update_date": "2025-12-04T13:57:19Z", "reference_number": "EMA/329167/2025", "url": "https://www.ema.europa.eu/en/documents/overview/denosumab-intas-epar-medicine-overview_en.pdf"}, {"id": "71504", "name": "Denosumab Intas : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T13:58:56Z", "last_update_date": "2025-12-04T13:58:56Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/denosumab-intas-epar-risk-management-plan_en.pdf"}, {"id": "71505", "name": "Denosumab Intas : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T14:05:46Z", "last_update_date": "2025-12-04T14:05:46Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/denosumab-intas-epar-product-information_en.pdf"}, {"id": "71506", "name": "Denosumab Intas : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T14:06:48Z", "last_update_date": "2025-12-04T14:06:48Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/denosumab-intas-epar-all-authorised-presentations_en.pdf"}, {"id": "71507", "name": "Denosumab Intas : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T14:07:46Z", "last_update_date": "2025-12-04T14:07:46Z", "reference_number": "EMA/CHMP/311939/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/denosumab-intas-epar-public-assessment-report_en.pdf"}, {"id": "61105", "name": "Veterinary Union Pharmacovigilance Database - Best Practice Guide ", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2023-11-30T19:06:12Z", "last_update_date": "2025-12-04T14:30:00Z", "reference_number": "EMA/371192/2021 Rev.13", "url": "https://www.ema.europa.eu/en/documents/other/veterinary-union-pharmacovigilance-database-best-practice-guide_en.pdf"}, {"id": "54602", "name": "Veterinary signal assessment report for marketing authorisation holders", "type": "template-form", "status": "unknown", "consultation_date": "", "publish_date": "2022-03-29T10:00:00Z", "last_update_date": "2025-12-04T14:29:55Z", "reference_number": "EMA/464566/2021 Rev.2", "url": "https://www.ema.europa.eu/en/documents/template-form/veterinary-signal-assessment-report-marketing-authorisation-holders_en.docx"}, {"id": "66799", "name": "\tPaxlovid : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-14T16:22:10Z", "last_update_date": "2025-12-04T16:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/paxlovid-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71508", "name": "Paxlovid-VR-0000262540 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T14:52:01Z", "last_update_date": "2025-12-04T14:52:01Z", "reference_number": "EMADOC-1700519818-2050861", "url": "https://www.ema.europa.eu/en/documents/variation-report/paxlovid-vr-0000262540-epar-assessment-report-variation_en.pdf"}, {"id": "16845", "name": "Opdivo : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-16T12:00:00Z", "last_update_date": "2025-12-04T11:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/opdivo-epar-product-information_en.pdf"}, {"id": "71284", "name": "Opdivo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-21T12:30:50Z", "last_update_date": "2025-12-04T15:18:08Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/opdivo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "50861", "name": "Sogroya : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-15T14:12:00Z", "last_update_date": "2025-12-04T11:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/sogroya-epar-product-information_en.pdf"}, {"id": "55469", "name": "Sogroya : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2022-07-06T11:01:00Z", "last_update_date": "2025-12-04T13:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/sogroya-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71509", "name": "Sogroya : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T15:25:11Z", "last_update_date": "2025-12-04T15:25:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/sogroya-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71510", "name": "Jivi-PAM-0000267496 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T15:27:57Z", "last_update_date": "2025-12-04T15:27:57Z", "reference_number": "EMADOC-1700519818-2339670", "url": "https://www.ema.europa.eu/en/documents/variation-report/jivi-pam-0000267496-epar-assessment-report_en.pdf"}, {"id": "49253", "name": "Consideration on core requirements for RMPs of COVID-19 vaccines", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2020-11-13T14:30:00Z", "last_update_date": "2025-12-04T16:27:00Z", "reference_number": "EMA/PRAC/709308/2022", "url": "https://www.ema.europa.eu/en/documents/other/consideration-core-requirements-rmps-covid-19-vaccines_en.pdf"}, {"id": "71512", "name": "Consultation on an ancillary medicinal substance incorporated in a medical device - Gynemed GmbH & Co. KG HSA-containing ART media", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-04T16:40:00Z", "last_update_date": "2025-12-04T16:40:00Z", "reference_number": "EMA/CHMP/258625/2025", "url": "https://www.ema.europa.eu/en/documents/other/consultation-ancillary-medicinal-substance-incorporated-medical-device-gynemed-gmbh-co-kg-hsa-containing-art-media_en.pdf"}, {"id": "71511", "name": "Explanatory note on the withdrawal of the interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU", "type": "scientific-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-04T17:00:54Z", "last_update_date": "2025-12-04T17:00:54Z", "reference_number": "EMA/175359/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/explanatory-note-withdrawal-interim-guidance-enhanced-safety-surveillance-seasonal-influenza-vaccines-eu_en.pdf"}, {"id": "71513", "name": "EMA/PE/0000254020: EMA decision of 27 June 2025 on the acceptance of a modification of an agreed paediatric investigation plan for risankizumab (Skyrizi)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T08:56:57Z", "last_update_date": "2025-12-05T08:56:57Z", "reference_number": "EMADOC-1700519818-2223385", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000254020-ema-decision-27-june-2025-acceptance-modification-agreed-paediatric-investigation-plan-risankizumab-skyrizi_en.pdf"}, {"id": "71514", "name": "EMA/PE/0000274326: EMA decision of 31 October 2025 on the acceptance of a modification of an agreed paediatric investigation plan for risankizumab (Skyrizi)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T08:58:02Z", "last_update_date": "2025-12-05T08:58:02Z", "reference_number": "EMADOC-1700519818-2525361", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000274326-ema-decision-31-october-2025-acceptance-modification-agreed-paediatric-investigation-plan-risankizumab-skyrizi_en.pdf"}, {"id": "71515", "name": "EMA/PE/0000221709: EMA decision of 7 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for apitegromab", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:26:27Z", "last_update_date": "2025-12-05T09:26:27Z", "reference_number": "EMADOC-1700519818-1736438", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221709-ema-decision-7-november-2024-acceptance-modification-agreed-paediatric-investigation-plan-apitegromab_en.pdf"}, {"id": "71516", "name": "EMA/PE/0000182362: EMA decision of 14 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for tildrakizumab (Ilumetri)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:33:55Z", "last_update_date": "2025-12-05T09:33:55Z", "reference_number": "EMADOC-1700519818-1760793", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182362-ema-decision-14-november-2024-acceptance-modification-agreed-paediatric-investigation-plan-tildrakizumab-ilumetri_en.pdf"}, {"id": "71517", "name": "EMA/PE/0000183059: EMA decision of 13 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for abrocitinib (Cibinqo)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:40:48Z", "last_update_date": "2025-12-05T09:40:48Z", "reference_number": "EMADOC-1700519818-1759464", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183059-ema-decision-13-november-2024-acceptance-modification-agreed-paediatric-investigation-plan-abrocitinib-cibinqo_en.pdf"}, {"id": "71518", "name": "EMA/PE/0000221076: EMA decision of 8 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for adrenaline (epinephrine) (EURneffy)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:42:04Z", "last_update_date": "2025-12-05T09:42:04Z", "reference_number": "EMADOC-1700519818-1738916", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221076-ema-decision-8-november-2024-acceptance-modification-agreed-paediatric-investigation-plan-adrenaline-epinephrine-eurneffy_en.pdf"}, {"id": "71519", "name": "EMA/PE/0000183220: EMA decision of 22 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for iclepertin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:43:01Z", "last_update_date": "2025-12-05T09:43:01Z", "reference_number": "EMADOC-1700519818-1766863", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183220-ema-decision-22-november-2024-acceptance-modification-agreed-paediatric-investigation-plan-iclepertin_en.pdf"}, {"id": "71520", "name": "EMA/PE/0000221589: EMA decision of 25 Nov 2024 on the acceptance of a modification of an agreed PIP for split influenza virus, inactivated containing antigens equivalent to the A/H1N1 and A/H3N2-like strain, B-like strain (Victoria / Yamagata lineage)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:43:53Z", "last_update_date": "2025-12-05T09:43:53Z", "reference_number": "EMADOC-1700519818-1773555", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221589-ema-decision-25-nov-2024-acceptance-modification-agreed-pip-split-influenza-virus-inactivated-containing-antigens-equivalent-h1n1-h3n2-strain-b-strain-victoria-yamagata-lineage_en.pdf"}, {"id": "71521", "name": "EMA/PE/0000238005: EMA decision of 27 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for inebilizumab (Uplinza)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:54:25Z", "last_update_date": "2025-12-05T09:54:25Z", "reference_number": "EMADOC-1700519818-1776292", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000238005-ema-decision-27-november-2024-acceptance-modification-agreed-paediatric-investigation-plan-inebilizumab-uplinza_en.pdf"}, {"id": "71522", "name": "EMA/PE/0000238074: EMA decision of 27 November 2024 on the acceptance of a modification of an agreed paediatric investigation plan for mitapivat (Pryrukind)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T09:55:17Z", "last_update_date": "2025-12-05T09:55:17Z", "reference_number": "EMADOC-1700519818-1789262", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000238074-ema-decision-27-november-2024-acceptance-modification-agreed-paediatric-investigation-plan-mitapivat-pryrukind_en.pdf"}, {"id": "71523", "name": "Presentation - Patient and HCP engagement highlights 2025 (M. Carr)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T11:32:27Z", "last_update_date": "2025-12-05T11:32:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-patient-hcp-engagement-highlights-2025-m-carr_en.pdf"}, {"id": "71525", "name": "Presentation - Overview of evolution of patient and healthcare professional engagement in EMA activities (M. Mavris)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T11:34:53Z", "last_update_date": "2025-12-05T11:34:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-overview-evolution-patient-healthcare-professional-engagement-ema-activities-m-mavris_en.pdf"}, {"id": "71526", "name": "Presentation - EMA-led RWE generation (D. Morales)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T11:36:47Z", "last_update_date": "2025-12-05T11:36:47Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-ema-led-rwe-generation-d-morales_en.pdf"}, {"id": "71527", "name": "Applications for new human medicines under evaluation: December 2025", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T11:45:00Z", "last_update_date": "2025-12-05T11:45:00Z", "reference_number": "EMA/352289/2025", "url": "https://www.ema.europa.eu/en/documents/report/applications-new-human-medicines-under-evaluation-december-2025_en.xlsx"}, {"id": "71524", "name": "All languages - Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668) - Revision 5", "type": "scientific-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T11:39:00Z", "last_update_date": "2025-12-05T11:39:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/all-languages-annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human-use-sante-2017-11668-revision-5_en.xlsx"}, {"id": "71528", "name": "Presentation - Updates on Cancer Medicines Forum (C. Voltz-Girolt)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T11:38:37Z", "last_update_date": "2025-12-05T11:38:37Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-updates-cancer-medicines-forum-c-voltz-girolt_en.pdf"}, {"id": "71529", "name": "Imnovid : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T11:54:02Z", "last_update_date": "2025-12-05T11:54:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/imnovid-epar-product-information-tracked-changes_en.docx"}, {"id": "71456", "name": "Propylthiouracil : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002558/202501", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-02T15:33:06Z", "last_update_date": "2025-12-05T13:35:00Z", "reference_number": "EMADOC-1700519818-2688635", "url": "https://www.ema.europa.eu/en/documents/psusa/propylthiouracil-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002558-202501_en.pdf"}, {"id": "53840", "name": "Voraxaze : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-20T09:28:00Z", "last_update_date": "2025-12-05T13:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/voraxaze-epar-product-information_en.pdf"}, {"id": "62072", "name": "Voraxaze : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-02-12T13:05:48Z", "last_update_date": "2025-12-05T14:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/voraxaze-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71534", "name": "Voraxaze : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T14:05:37Z", "last_update_date": "2025-12-05T14:05:37Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/voraxaze-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "68332", "name": "Lidocaine (Porcine) - Summary opinion of the CVMP on the modification of maximum residue limits", "type": "mrl-summary", "status": "Adopted", "consultation_date": "", "publish_date": "2025-05-16T15:02:04Z", "last_update_date": "2025-12-05T14:21:49Z", "reference_number": "EMA/CVMP/380363/2025", "url": "https://www.ema.europa.eu/en/documents/mrl-summary/lidocaine-porcine-summary-opinion-cvmp-modification-maximum-residue-limits_en.pdf"}, {"id": "13396", "name": "Zomarist : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-21T03:09:00Z", "last_update_date": "2025-12-05T17:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/zomarist-epar-product-information_en.pdf"}, {"id": "41412", "name": "Zomarist : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2009-01-12T00:09:00Z", "last_update_date": "2025-12-05T00:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/zomarist-epar-all-authorised-presentations_en.pdf"}, {"id": "66567", "name": "Zomarist : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-03T11:23:22Z", "last_update_date": "2025-12-05T16:43:34Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/zomarist-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71530", "name": "CVMP summary of positive opinion for Epizootic haemorrhagic disease vaccine (recombinant protein) Laboratorios Syva S.A.", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T14:00:00Z", "last_update_date": "2025-12-05T14:00:00Z", "reference_number": "EMA/CVMP/368551/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/cvmp-summary-positive-opinion-epizootic-haemorrhagic-disease-vaccine-recombinant-protein-laboratorios-syva-sa_en.pdf"}, {"id": "71531", "name": "CVMP summary of positive opinion for Firocoxib CP-Pharma", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T14:00:00Z", "last_update_date": "2025-12-05T14:00:00Z", "reference_number": "EMA/CVMP/367445/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/cvmp-summary-positive-opinion-firocoxib-cp-pharma_en.pdf"}, {"id": "71532", "name": "CVMP summary of positive opinion for Varenzin", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T14:00:00Z", "last_update_date": "2025-12-05T14:00:00Z", "reference_number": "EMA/CVMP/367341/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/cvmp-summary-positive-opinion-varenzin_en.pdf"}, {"id": "71533", "name": "CVMP post-authorisation summary of positive opinion for Dexdomitor (EMA/VRA/0000257740)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-05T14:00:00Z", "last_update_date": "2025-12-05T14:00:00Z", "reference_number": "EMADOC-1700519818-2668331", "url": "https://www.ema.europa.eu/en/documents/smop/cvmp-post-authorisation-summary-positive-opinion-dexdomitor-ema-vra-0000257740_en.pdf"}, {"id": "4887", "name": "Icandra : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2009-03-03T01:00:00Z", "last_update_date": "2025-12-05T11:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/icandra-epar-all-authorised-presentations_en.pdf"}, {"id": "5380", "name": "Icandra : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-21T02:00:00Z", "last_update_date": "2025-12-05T09:49:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/icandra-epar-product-information_en.pdf"}, {"id": "7905", "name": "Icandra : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-01-29T02:00:00Z", "last_update_date": "2025-12-05T16:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/icandra-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71536", "name": "Presentation - Multi-stakeholder platform 2025 activity (D. Lacombe, F. Houÿez, A. Zanoletty)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:02:47Z", "last_update_date": "2025-12-05T15:02:47Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-multi-stakeholder-platform-2025-activity-d-lacombe-f-houyez-zanoletty_en.pdf"}, {"id": "71537", "name": "Presentation - Accelerating Clinical Trials in the EU (ACT EU) (L. Pioppo)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:05:20Z", "last_update_date": "2025-12-05T15:05:20Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-accelerating-clinical-trials-eu-act-eu-l-pioppo_en.pdf"}, {"id": "71538", "name": "Presentation - A Patient’s quest to the Magical Land of Clinical Trials: Is there a Yellow Brick Road? (I. Psalti)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:06:37Z", "last_update_date": "2025-12-05T15:06:37Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-patients-quest-magical-land-clinical-trials-there-yellow-brick-road-i-psalti_en.pdf"}, {"id": "71539", "name": "Presentation - Annual training 2026 (K. Immonen)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:08:18Z", "last_update_date": "2025-12-05T15:08:18Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-annual-training-2026-k-immonen_en.pdf"}, {"id": "71540", "name": "Presentation - Training on Scientific Advice (L. Barbier)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:09:28Z", "last_update_date": "2025-12-05T15:09:28Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-training-scientific-advice-l-barbier_en.pdf"}, {"id": "71541", "name": "Presentation - EMA international engagement and activities (M. Harvey)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:10:35Z", "last_update_date": "2025-12-05T15:10:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-ema-international-engagement-activities-m-harvey_en.pdf"}, {"id": "71542", "name": "Presentation - Updates from the Cardiovascular Space (M. Holler)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:12:19Z", "last_update_date": "2025-12-05T15:12:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-updates-cardiovascular-space-m-holler_en.pdf"}, {"id": "71543", "name": "Presentation - Aligning policies with real-world medical needs (M. Romano)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:13:43Z", "last_update_date": "2025-12-05T15:13:43Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-aligning-policies-real-world-medical-needs-m-romano_en.pdf"}, {"id": "71343", "name": "Agenda - 15th Industry Standing Group (ISG) meeting", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-26T11:05:39Z", "last_update_date": "2025-12-05T15:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-15th-industry-standing-group-isg-meeting_en.pdf"}, {"id": "71544", "name": "Presentation - Proposed Critical Medicines Act (V. Bennett)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:14:57Z", "last_update_date": "2025-12-05T15:14:57Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-proposed-critical-medicines-act-v-bennett_en.pdf"}, {"id": "71545", "name": "Presentation - Introducing to shortages topic (M. Dias)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:16:21Z", "last_update_date": "2025-12-05T15:16:21Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-introducing-shortages-topic-m-dias_en.pdf"}, {"id": "71546", "name": "Presentation - Union list of critical medicines - first annual update (S. McMahon)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:17:36Z", "last_update_date": "2025-12-05T15:17:36Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-union-list-critical-medicines-first-annual-update-s-mcmahon_en.pdf"}, {"id": "71547", "name": "Presentation - Shortage Prevention Plan and Shortage Mitigation Plan pilot (M. Alcaraz)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:19:52Z", "last_update_date": "2025-12-05T15:19:52Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-shortage-prevention-plan-shortage-mitigation-plan-pilot-m-alcaraz_en.pdf"}, {"id": "71548", "name": "Presentation - Ongoing critical shortages and activities (K. Kruttwig)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:21:42Z", "last_update_date": "2025-12-05T15:21:42Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-ongoing-critical-shortages-activities-k-kruttwig_en.pdf"}, {"id": "71549", "name": "Presentation - EAHP Survey on the shortages of medicines and  medical devices (D. Makridaki)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:22:52Z", "last_update_date": "2025-12-05T15:22:52Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-eahp-survey-shortages-medicines-medical-devices-d-makridaki_en.pdf"}, {"id": "65253", "name": "Enzalutamide Viatris : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-10-09T14:14:00Z", "last_update_date": "2025-12-05T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/enzalutamide-viatris-epar-product-information_en.pdf"}, {"id": "65258", "name": "Enzalutamide Viatris : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-10-09T15:13:00Z", "last_update_date": "2025-12-05T19:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/enzalutamide-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71550", "name": "Presentation - EMA-HMA repurposing pilot report (C. Bouygues)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:24:05Z", "last_update_date": "2025-12-05T15:24:05Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-ema-hma-repurposing-pilot-report-c-bouygues_en.pdf"}, {"id": "71551", "name": "Presentation - Social media campaigns (G. Gabrielli)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:25:10Z", "last_update_date": "2025-12-05T15:25:10Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-social-media-campaigns-g-gabrielli_en.pdf"}, {"id": "71552", "name": "Presentation - Gender equality in women’s health - the forgotten priority (C. de Vries)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:26:41Z", "last_update_date": "2025-12-05T15:26:41Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-gender-equality-womens-health-forgotten-priority-c-de-vries_en.pdf"}, {"id": "71553", "name": "Presentation - Communications on safety monitoring of medicines in the EU (V. Pashova, S. Cohen)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:28:08Z", "last_update_date": "2025-12-05T15:28:08Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-communications-safety-monitoring-medicines-eu-v-pashova-s-cohen_en.pdf"}, {"id": "71554", "name": "Presentation - Medicine overviews - Feedback from patient and healthcare professional survey (C. Ester)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:29:27Z", "last_update_date": "2025-12-05T15:29:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-medicine-overviews-feedback-patient-healthcare-professional-survey-c-ester_en.pdf"}, {"id": "71555", "name": "Presentation - Update on Human Medicines Highlights (K. Immonen)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T15:31:26Z", "last_update_date": "2025-12-05T15:31:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-update-human-medicines-highlights-k-immonen_en.pdf"}, {"id": "3528", "name": "Adynovi : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2018-04-09T02:00:00Z", "last_update_date": "2025-12-05T17:38:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/adynovi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "38487", "name": "Ravicti : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-12-18T01:00:00Z", "last_update_date": "2025-12-05T13:53:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ravicti-epar-product-information_en.pdf"}, {"id": "41438", "name": "Ravicti : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2016-03-31T15:39:00Z", "last_update_date": "2025-12-05T16:34:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ravicti-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71557", "name": "Ravicti : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-05T16:12:45Z", "last_update_date": "2025-12-05T16:12:45Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ravicti-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71560", "name": "Direct healthcare professional communication (DHPC) : Remsima (infliximab): New IV formulation (100 mg and 350 mg concentrate for solution for infusion) contains sorbitol and is therefore contraindicated in patients with hereditary fructose intolerance", "type": "dhpc", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T09:12:39Z", "last_update_date": "2025-12-08T09:12:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/dhpc/direct-healthcare-professional-communication-dhpc-remsima-infliximab-new-iv-formulation-100-mg-350-mg-concentrate-solution-infusion-contains-sorbitol-therefore-contraindicated-patients-hereditary_en.pdf"}, {"id": "16890", "name": "Eucreas : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-21T02:00:00Z", "last_update_date": "2025-12-08T16:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/eucreas-epar-product-information_en.pdf"}, {"id": "66565", "name": "Eucreas : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-03T10:55:10Z", "last_update_date": "2025-12-08T16:42:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/eucreas-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "19687", "name": "Eucreas : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2007-12-03T01:00:00Z", "last_update_date": "2025-12-08T01:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/eucreas-epar-all-authorised-presentations_en.pdf"}, {"id": "71535", "name": "Eucreas : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T14:15:42Z", "last_update_date": "2025-12-08T14:15:42Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/eucreas-epar-product-information-tracked-changes_en.docx"}, {"id": "60215", "name": "Lyfnua : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2023-09-29T15:12:00Z", "last_update_date": "2025-12-08T14:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/lyfnua-epar-product-information_en.pdf"}, {"id": "68281", "name": "Lyfnua : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-14T14:02:22Z", "last_update_date": "2025-12-08T09:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lyfnua-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71562", "name": "Lyfnua : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T09:41:31Z", "last_update_date": "2025-12-08T09:41:31Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lyfnua-epar-product-information-tracked-changes_en.docx-0"}, {"id": "60926", "name": "Ebglyss : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2023-11-21T16:29:43Z", "last_update_date": "2025-12-08T14:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ebglyss-epar-product-information_en.pdf"}, {"id": "67671", "name": "\tEbglyss : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-07T16:12:21Z", "last_update_date": "2025-12-08T15:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ebglyss-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "63347", "name": "Filspari : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-28T15:29:00Z", "last_update_date": "2025-12-08T11:51:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/filspari-epar-product-information_en.pdf"}, {"id": "63842", "name": "Filspari : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-07-02T11:54:00Z", "last_update_date": "2025-12-08T10:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/filspari-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71564", "name": "Filspari : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T09:57:17Z", "last_update_date": "2025-12-08T09:57:17Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/filspari-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "56003", "name": "Scemblix : EPAR - Medicine Overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-07T11:34:00Z", "last_update_date": "2025-12-08T10:45:00Z", "reference_number": "EMADOC-1829012207-33715", "url": "https://www.ema.europa.eu/en/documents/overview/scemblix-epar-medicine-overview_en.pdf"}, {"id": "56008", "name": "Scemblix : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-07T11:57:00Z", "last_update_date": "2025-12-08T16:33:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/scemblix-epar-risk-management-plan_en.pdf"}, {"id": "71565", "name": "EMA/PE/0000225184: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for nirmatrelvir, nirmatrelvir / ritonavir ( Paxlovid)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:47:39Z", "last_update_date": "2025-12-08T10:47:39Z", "reference_number": "EMADOC-1700519818-1788035", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000225184-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-nirmatrelvir-nirmatrelvir-ritonavir-paxlovid_en.pdf"}, {"id": "71566", "name": "EMA/PE/0000224486: EMA decision of 5 December 2024 on the granting of a product specific waiver for amlodipine, ramipril, rosuvastatin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:48:39Z", "last_update_date": "2025-12-08T10:48:39Z", "reference_number": "EMADOC-1700519818-1792333", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000224486-ema-decision-5-december-2024-granting-product-specific-waiver-amlodipine-ramipril-rosuvastatin_en.pdf"}, {"id": "71567", "name": "EMA/PE/0000224202: EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for dengue tetravalent vaccine (live, attenuated) (Qdenga)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:49:35Z", "last_update_date": "2025-12-08T10:49:35Z", "reference_number": "EMADOC-1700519818-1793045", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000224202-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-dengue-tetravalent-vaccine-live-attenuated-qdenga_en.pdf"}, {"id": "71568", "name": "EMA/PE/0000221803: EMA decision of 6 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for betula pendula pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:50:20Z", "last_update_date": "2025-12-08T10:50:20Z", "reference_number": "EMADOC-1700519818-1793589", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221803-ema-decision-6-december-2024-refusal-paediatric-investigation-plan-granting-waiver-betula-pendula-pollen-extract_en.pdf"}, {"id": "56004", "name": "Scemblix : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-07T11:40:00Z", "last_update_date": "2025-12-08T15:31:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/scemblix-epar-product-information_en.pdf"}, {"id": "57031", "name": "Scemblix : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2022-12-15T12:25:00Z", "last_update_date": "2025-12-08T17:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/scemblix-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "67920", "name": "Scemblix : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-22T09:18:23Z", "last_update_date": "2025-12-08T15:44:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/scemblix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71571", "name": "Scemblix-VR-0000265010 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:51:23Z", "last_update_date": "2025-12-08T10:51:23Z", "reference_number": "EMADOC-1700519818-2475374", "url": "https://www.ema.europa.eu/en/documents/variation-report/scemblix-vr-0000265010-epar-assessment-report-variation_en.pdf"}, {"id": "71572", "name": "Scemblix : Orphan maintenance assessment report (post authorisation)", "type": "orphan-maintenance-report-post", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T10:53:19Z", "last_update_date": "2025-12-08T10:53:19Z", "reference_number": "EMADOC-360526170-2697193", "url": "https://www.ema.europa.eu/en/documents/orphan-maintenance-report-post/scemblix-orphan-maintenance-assessment-report-post-authorisation_en.pdf"}, {"id": "71573", "name": "P/0393/2024: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for tulisokibart (EMEA-003556-PIP02-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:54:33Z", "last_update_date": "2025-12-08T10:54:33Z", "reference_number": "EMA/554343/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0393-2024-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-tulisokibart-emea-003556-pip02-24_en.pdf"}, {"id": "71575", "name": "P/0397/2024: EMA decision of 5 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral for trastuzumab deruxtecan (Enhertu), (EMEA-002978-PIP02-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:57:05Z", "last_update_date": "2025-12-08T10:57:05Z", "reference_number": "EMA/556006/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0397-2024-ema-decision-5-december-2024-agreement-paediatric-investigation-plan-granting-deferral-trastuzumab-deruxtecan-enhertu-emea-002978-pip02-24_en.pdf"}, {"id": "71576", "name": "P/0394/2024: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan for 7-ethyl-10-hydroxy-camptothecin (SN-38) (EMEA-003588-PIP01-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T10:58:01Z", "last_update_date": "2025-12-08T10:58:01Z", "reference_number": "EMA/554382/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0394-2024-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-7-ethyl-10-hydroxy-camptothecin-sn-38-emea-003588-pip01-24_en.pdf"}, {"id": "71578", "name": "P/0391/2024: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for doruxapapogenum ralaplasmidum, (EMEA-003506-PIP01-23)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T11:06:18Z", "last_update_date": "2025-12-08T11:06:18Z", "reference_number": "EMA/552735/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0391-2024-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-doruxapapogenum-ralaplasmidum-emea-003506-pip01-23_en.pdf"}, {"id": "71579", "name": "P/0390/2024: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for tulisokibart, (EMEA-003556-PIP01-23)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-08T11:10:55Z", "last_update_date": "2025-12-08T11:10:55Z", "reference_number": "EMA/552717/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0390-2024-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-tulisokibart-emea-003556-pip01-23_en.pdf"}, {"id": "64717", "name": "Eurneffy : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-09-05T13:23:32Z", "last_update_date": "2025-12-08T09:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/eurneffy-epar-product-information_en.pdf"}, {"id": "66447", "name": "Product Management Service (PMS) roadmap", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-01-24T13:27:43Z", "last_update_date": "2025-12-08T11:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/product-management-service-pms-roadmap_en.pdf"}, {"id": "27431", "name": "Xermelo : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-10-20T02:00:00Z", "last_update_date": "2025-12-08T15:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/xermelo-epar-product-information_en.pdf"}, {"id": "67750", "name": "Xermelo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-11T13:10:52Z", "last_update_date": "2025-12-08T09:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/xermelo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "42736", "name": "Symkevi : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-11-22T09:58:00Z", "last_update_date": "2025-12-08T13:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/symkevi-epar-product-information_en.pdf"}, {"id": "44109", "name": "Symkevi : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2019-03-26T15:33:00Z", "last_update_date": "2025-12-08T13:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/symkevi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71581", "name": "Symkevi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T11:44:07Z", "last_update_date": "2025-12-08T11:44:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/symkevi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71582", "name": "Symkevi-PSUSA-00010730-202502 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T11:45:41Z", "last_update_date": "2025-12-08T11:45:41Z", "reference_number": "EMADOC-1700519818-2694378", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/symkevi-psusa-00010730-202502-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "40814", "name": "Zubsolv : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-01-12T01:00:00Z", "last_update_date": "2025-12-08T09:49:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/zubsolv-epar-product-information_en.pdf"}, {"id": "67575", "name": "Zubsolv : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-01T13:13:37Z", "last_update_date": "2025-12-08T11:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/zubsolv-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "70021", "name": "Programme - Joint HMA/EMA multi-stakeholder workshop on Patient Registries December 2025", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-09-09T14:54:27Z", "last_update_date": "2025-12-08T16:22:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/programme-joint-hma-ema-multi-stakeholder-workshop-patient-registries-december-2025_en.pdf"}, {"id": "71586", "name": "Release notes - production release version 1.7.2544 - 5 December 2025 - Veterinary Medicinal Products Regulation: Union Product Database", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T13:30:37Z", "last_update_date": "2025-12-08T13:30:37Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/release-notes-production-release-version-172544-5-december-2025-veterinary-medicinal-products-regulation-union-product-database_en.pdf"}, {"id": "71073", "name": "Agenda - Quarterly System Demo Q4 2025", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-10T16:00:42Z", "last_update_date": "2025-12-08T15:03:03Z", "reference_number": "EMA/356849/2025 Rev.3", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-quarterly-system-demo-q4-2025_en.pdf"}, {"id": "71249", "name": "Classification of changes", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-19T14:19:47Z", "last_update_date": "2025-12-08T14:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/classification-changes_en.pdf"}, {"id": "71250", "name": "Classification of changes (tracked changes)", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-19T14:20:57Z", "last_update_date": "2025-12-08T14:01:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/classification-changes-tracked-changes_en.pdf"}, {"id": "71590", "name": "Agenda of the CHMP meeting 8-11 December 2025", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-12-08T15:01:38Z", "last_update_date": "2025-12-08T15:01:38Z", "reference_number": "EMA/CHMP/347361/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-8-11-december-2025_en.pdf"}, {"id": "71591", "name": "Annex to agenda of the CHMP meeting 8-11 December 2025", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-12-08T15:03:38Z", "last_update_date": "2025-12-08T15:03:38Z", "reference_number": "EMA/CHMP/362409/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/annex-agenda-chmp-meeting-8-11-december-2025_en.xlsx"}, {"id": "44169", "name": "Neulasta : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2019-04-03T16:33:00Z", "last_update_date": "2025-12-08T13:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/neulasta-epar-risk-management-plan_en.pdf"}, {"id": "65009", "name": "Anzupgo : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-09-24T12:29:00Z", "last_update_date": "2025-12-08T11:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/anzupgo-epar-product-information_en.pdf"}, {"id": "24752", "name": "Neulasta : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-11-09T01:00:00Z", "last_update_date": "2025-12-08T13:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/neulasta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71592", "name": "Neulasta : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T15:56:25Z", "last_update_date": "2025-12-08T15:56:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/neulasta-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "70542", "name": "Agenda - HMA/EMA Annual Data Forum 2025", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-10-14T11:32:10Z", "last_update_date": "2025-12-08T15:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-hma-ema-annual-data-forum-2025_en.pdf"}, {"id": "13814", "name": "Caprelsa : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2012-03-02T16:15:00Z", "last_update_date": "2025-12-08T15:46:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/caprelsa-epar-product-information_en.pdf"}, {"id": "64992", "name": "Caprelsa : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-09-23T23:00:00Z", "last_update_date": "2025-12-08T12:08:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/caprelsa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71593", "name": "Medicinal products for human use: monthly figures - November 2025", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T16:21:54Z", "last_update_date": "2025-12-08T16:21:54Z", "reference_number": "EMA/382460/2025", "url": "https://www.ema.europa.eu/en/documents/report/medicinal-products-human-use-monthly-figures-november-2025_en.pdf"}, {"id": "6837", "name": "Yescarta : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-09-10T02:00:00Z", "last_update_date": "2025-12-08T14:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/yescarta-epar-product-information_en.pdf"}, {"id": "69803", "name": "Yescarta : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-20T16:12:11Z", "last_update_date": "2025-12-08T16:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/yescarta-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "49934", "name": "Tecartus : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-01-25T15:49:00Z", "last_update_date": "2025-12-08T14:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tecartus-epar-product-information_en.pdf"}, {"id": "68540", "name": "Tecartus : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-02T19:53:51Z", "last_update_date": "2025-12-08T16:39:45Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tecartus-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "49664", "name": "Palforzia : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2020-12-21T12:36:00Z", "last_update_date": "2025-12-08T17:18:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/palforzia-epar-product-information_en.pdf"}, {"id": "66333", "name": "Palforzia : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-01-16T15:37:27Z", "last_update_date": "2025-12-08T17:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/palforzia-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71594", "name": "Addendum to Assessment report on Althaea officinalis L., radix", "type": "herbal-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T16:42:02Z", "last_update_date": "2025-12-08T16:42:02Z", "reference_number": "EMA/HMPC/301260/2025", "url": "https://www.ema.europa.eu/en/documents/herbal-report/addendum-assessment-report-althaea-officinalis-l-radix_en.pdf"}, {"id": "71595", "name": "Medicine shortage communication (MSC): Insulin lispro Sanofi (insulin lispro 100 units/ml solution for injection in cartridge and pre-filled pen)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T16:50:51Z", "last_update_date": "2025-12-08T16:50:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/medicine-shortage-communication-msc-insulin-lispro-sanofi-insulin-lispro-100-units-ml-solution-injection-cartridge-pre-filled-pen_en.pdf"}, {"id": "71596", "name": "Addendum to Assessment report on Carum carvi L., aetheroleum", "type": "herbal-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T16:45:36Z", "last_update_date": "2025-12-08T16:45:36Z", "reference_number": "EMA/HMPC/296779/2025", "url": "https://www.ema.europa.eu/en/documents/herbal-report/addendum-assessment-report-carum-carvi-l-aetheroleum_en.pdf"}, {"id": "71597", "name": "Addendum to Assessment report on Carum carvi L., fructus", "type": "herbal-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-08T16:48:26Z", "last_update_date": "2025-12-08T16:48:26Z", "reference_number": "EMA/HMPC/296784/2025", "url": "https://www.ema.europa.eu/en/documents/herbal-report/addendum-assessment-report-carum-carvi-l-fructus_en.pdf"}, {"id": "71598", "name": "Agenda - PDCO agenda of the 9-12 December 2025 meeting", "type": "agenda", "status": "Draft", "consultation_date": "", "publish_date": "2025-12-08T18:16:23Z", "last_update_date": "2025-12-08T18:16:23Z", "reference_number": "EMA/PDCO/372844/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-pdco-agenda-9-12-december-2025-meeting_en.xlsx"}, {"id": "71577", "name": "P/0392/2024: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral for linaprazan glurate (EMEA-003558-PIP01-23)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T10:59:32Z", "last_update_date": "2025-12-09T10:59:32Z", "reference_number": "EMA/554255/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0392-2024-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-deferral-linaprazan-glurate-emea-003558-pip01-23_en.pdf"}, {"id": "71574", "name": "P/0398/2024: EMA decision of 17 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for olorofim, (EMEA-003564-PIP01-23) in", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T10:55:52Z", "last_update_date": "2025-12-09T10:55:52Z", "reference_number": "EMA/587147/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0398-2024-ema-decision-17-december-2024-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-olorofim-emea-003564-pip01-23_en.pdf"}, {"id": "71580", "name": "P/0389/2024: EMA decision of 5 Dec 2024 on the agreement of a PIP and on granting of a deferral and a waiver for 6'-([(1S,3S)-3-([5-(difluoromethoxy)-2- pyrimidinyl]amino)cyclopentyl] amino)-2H- [1,3'-bipyridin]-2-one (AZD0780) (EMEA-003580-PIP01-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T11:12:58Z", "last_update_date": "2025-12-09T11:12:58Z", "reference_number": "EMA/552707/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0389-2024-ema-decision-5-dec-2024-agreement-pip-granting-deferral-waiver-6-1s3s-3-5-difluoromethoxy-2-pyrimidinylaminocyclopentyl-amino-2h-13-bipyridin-2-one-azd0780-emea-003580-pip01-24_en.pdf"}, {"id": "71569", "name": "P/0396/2024: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral for gorilla adenovirus vector expressing HPV6 and HPV11 antigens (PRGN-2012), (EMEA-003592-PIP01-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T10:51:27Z", "last_update_date": "2025-12-09T10:51:27Z", "reference_number": "EMA/534088/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0396-2024-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-deferral-gorilla-adenovirus-vector-expressing-hpv6-hpv11-antigens-prgn-2012-emea-003592-pip01-24_en.pdf"}, {"id": "71570", "name": "P/0402/2024: EMA decision of 18 December 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for diazoxide choline, (EMEA-003614-PIP01-24)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T10:52:17Z", "last_update_date": "2025-12-09T10:52:17Z", "reference_number": "EMA/591389/2024", "url": "https://www.ema.europa.eu/en/documents/pip-decision/p-0402-2024-ema-decision-18-december-2024-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-diazoxide-choline-emea-003614-pip01-24_en.pdf"}, {"id": "66997", "name": "Kostaive: EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-26T14:54:51Z", "last_update_date": "2025-12-09T09:01:50Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/kostaive-epar-product-information_en.pdf"}, {"id": "68427", "name": "Kostaive : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-23T15:56:52Z", "last_update_date": "2025-12-09T09:50:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/kostaive-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "52272", "name": "Abecma : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-08-25T15:50:00Z", "last_update_date": "2025-12-09T14:51:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/abecma-epar-product-information_en.pdf"}, {"id": "52810", "name": "Abecma : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2021-10-12T11:49:00Z", "last_update_date": "2025-12-09T14:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/abecma-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "69679", "name": "Abecma : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-06T15:33:13Z", "last_update_date": "2025-12-09T16:07:49Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/abecma-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "52274", "name": "Abecma : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2021-08-25T15:55:00Z", "last_update_date": "2025-12-09T11:41:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/abecma-epar-risk-management-plan_en.pdf"}, {"id": "4925", "name": "Eviplera : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2012-11-16T16:00:00Z", "last_update_date": "2025-12-09T11:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/eviplera-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71599", "name": "Eviplera : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T10:06:06Z", "last_update_date": "2025-12-09T10:06:06Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/eviplera-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "32543", "name": "Aubagio : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2014-03-26T01:00:00Z", "last_update_date": "2025-12-09T14:39:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/aubagio-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "41583", "name": "Aubagio : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-09-06T02:00:00Z", "last_update_date": "2025-12-09T14:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/aubagio-epar-product-information_en.pdf"}, {"id": "71600", "name": "Aubagio : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T10:15:07Z", "last_update_date": "2025-12-09T10:15:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/aubagio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71601", "name": "Aubagio : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T10:17:51Z", "last_update_date": "2025-12-09T10:17:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/aubagio-epar-product-information-tracked-changes_en.docx"}, {"id": "48173", "name": "Eviplera : EPAR - Risk-management-plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-06-26T15:30:00Z", "last_update_date": "2025-12-09T10:28:08Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/eviplera-epar-risk-management-plan_en.pdf"}, {"id": "24137", "name": "Dacogen : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2012-10-16T02:00:00Z", "last_update_date": "2025-12-09T12:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/dacogen-epar-product-information_en.pdf"}, {"id": "4105", "name": "Levetiracetam Accord : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-10-14T02:00:00Z", "last_update_date": "2025-12-09T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/levetiracetam-accord-epar-product-information_en.pdf"}, {"id": "66283", "name": "Levetiracetam Accord : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-01-09T16:22:56Z", "last_update_date": "2025-12-09T14:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/levetiracetam-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71000", "name": "Agenda - 15th Industry stakeholder platform on research and development support", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-04T17:18:07Z", "last_update_date": "2025-12-09T11:11:11Z", "reference_number": "EMA/293578/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-15th-industry-stakeholder-platform-research-development-support_en.pdf"}, {"id": "71602", "name": "Presentation - Focus Group on agility in scientific advice (I.Gravanis, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:13:35Z", "last_update_date": "2025-12-09T11:13:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-focus-group-agility-scientific-advice-igravanis-ema_en.pdf"}, {"id": "71604", "name": "Presentation - Streamlining product-specific bioequivalence guidance (C.Versantvoort, D.van den Haak, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:15:07Z", "last_update_date": "2025-12-09T11:15:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-streamlining-product-specific-bioequivalence-guidance-cversantvoort-dvan-den-haak-ema_en.pdf"}, {"id": "71606", "name": "Presentation - Mechanism of action based PIPs in paediatric oncology (M.Sheean, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:19:17Z", "last_update_date": "2025-12-09T11:19:17Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-mechanism-action-based-pips-paediatric-oncology-msheean-ema_en.pdf"}, {"id": "71607", "name": "Presentation - Implementation of pilot initiatives based on first 5 years’ experience of PRIME: Analysis (K.Cunningham, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:19:51Z", "last_update_date": "2025-12-09T11:19:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-implementation-pilot-initiatives-based-first-5-years-experience-prime-analysis-kcunningham-ema_en.pdf"}, {"id": "71608", "name": "Presentation - Updates from EMA on scientific advice (I.Gravanis, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:20:32Z", "last_update_date": "2025-12-09T11:20:32Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-updates-ema-scientific-advice-igravanis-ema_en.pdf"}, {"id": "71609", "name": "Presentation - Reframing the voluntary data submission to foster regulatory acceptance of NAMs (S.Ponzano, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:21:05Z", "last_update_date": "2025-12-09T11:21:05Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-reframing-voluntary-data-submission-foster-regulatory-acceptance-nams-sponzano-ema_en.pdf"}, {"id": "71610", "name": "EMA/PE/0000182440 : EMA decision of 6 December 2024 on the granting of a product specific waiver for resiniferatoxin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T11:24:11Z", "last_update_date": "2025-12-09T11:24:11Z", "reference_number": "EMADOC-1700519818-1790103", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182440-ema-decision-6-december-2024-granting-product-specific-waiver-resiniferatoxin_en.pdf"}, {"id": "71611", "name": "Guideline on the development and manufacture of synthetic peptides", "type": "scientific-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T11:27:01Z", "last_update_date": "2025-12-09T11:27:01Z", "reference_number": "EMA/CHMP/CVMP/QWP/367182/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-development-manufacture-synthetic-peptides_en.pdf"}, {"id": "71612", "name": "EMA/PE/0000182447 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for amlitelimab", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T11:34:09Z", "last_update_date": "2025-12-09T11:34:09Z", "reference_number": "EMADOC-1700519818-1788084", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182447-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-amlitelimab_en.pdf"}, {"id": "17170", "name": "Opdivo : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-16T02:00:00Z", "last_update_date": "2025-12-09T11:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/opdivo-epar-risk-management-plan_en.pdf"}, {"id": "65870", "name": "Alzheimer’s disease EU-IN Horizon Scanning Report", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2024-11-28T15:10:00Z", "last_update_date": "2025-12-09T11:41:36Z", "reference_number": "EMA/540805/2024 Rev.1", "url": "https://www.ema.europa.eu/en/documents/report/alzheimers-disease-eu-horizon-scanning-report_en.pdf"}, {"id": "66931", "name": "New Approach Methodologies EU-IN Horizon Scanning Report", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-24T15:21:27Z", "last_update_date": "2025-12-09T11:43:50Z", "reference_number": "EMA/56850/2025 Rev.1", "url": "https://www.ema.europa.eu/en/documents/report/new-approach-methodologies-eu-horizon-scanning-report_en.pdf"}, {"id": "54799", "name": "Kimmtrak : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-22T11:03:00Z", "last_update_date": "2025-12-09T12:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/kimmtrak-epar-product-information_en.pdf"}, {"id": "67139", "name": "Kimmtrak : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-07T12:32:53Z", "last_update_date": "2025-12-09T11:44:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/kimmtrak-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71613", "name": "EMA/PE/0000182462 : EMA decision of 6 December 2024 on the granting of a product specific waiver for bizalimogene ralaplasmid / mavilimogene ralaplasmid / rocakinogene sifuplasmid", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T11:54:52Z", "last_update_date": "2025-12-09T11:54:52Z", "reference_number": "EMADOC-1700519818-1789264", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182462-ema-decision-6-december-2024-granting-product-specific-waiver-bizalimogene-ralaplasmid-mavilimogene-ralaplasmid-rocakinogene-sifuplasmid_en.pdf"}, {"id": "66587", "name": "Consolidated 3-year rolling work plan for the Non-clinical domain 2026-2028", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T12:06:06Z", "last_update_date": "2025-12-09T12:06:06Z", "reference_number": "EMA/372540/2025", "url": "https://www.ema.europa.eu/en/documents/other/consolidated-3-year-rolling-work-plan-non-clinical-domain-2026-2028_en.pdf"}, {"id": "66593", "name": "Consolidated 3-year rolling work plan for the Methodology Working Party 2026-2028", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T13:16:25Z", "last_update_date": "2025-12-09T13:16:25Z", "reference_number": "EMA/370294/2025", "url": "https://www.ema.europa.eu/en/documents/other/consolidated-3-year-rolling-work-plan-methodology-working-party-2026-2028_en.pdf"}, {"id": "66588", "name": "3-year work plan for the joint CHMP/CVMP Quality Working Party 2026-2028", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T12:13:30Z", "last_update_date": "2025-12-09T12:13:30Z", "reference_number": "EMA/160693/2025", "url": "https://www.ema.europa.eu/en/documents/other/3-year-work-plan-joint-chmp-cvmp-quality-working-party-2026-2028_en.pdf"}, {"id": "66581", "name": "3-year work plan for the Biologics Working Party (BWP) 2026-2028", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:36:16Z", "last_update_date": "2025-12-09T11:36:16Z", "reference_number": "EMADOC-628903358-21653", "url": "https://www.ema.europa.eu/en/documents/other/3-year-work-plan-biologics-working-party-bwp-2026-2028_en.pdf"}, {"id": "66582", "name": "3-year rolling work plan for the Biosimilar Medicinal Products Working Party 2026-2028", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:41:41Z", "last_update_date": "2025-12-09T11:41:41Z", "reference_number": "EMA/CHMP/BMWP/156161/2025", "url": "https://www.ema.europa.eu/en/documents/other/3-year-rolling-work-plan-biosimilar-medicinal-products-working-party-2026-2028_en.pdf"}, {"id": "71614", "name": "Agenda - Medicine Shortages SPOC Working Party meeting on 9 December 2025", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T12:05:31Z", "last_update_date": "2025-12-09T12:05:31Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-medicine-shortages-spoc-working-party-meeting-9-december-2025_en.pdf"}, {"id": "66570", "name": "Gohibic : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-03T12:10:27Z", "last_update_date": "2025-12-09T15:48:44Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/gohibic-epar-product-information_en.pdf"}, {"id": "71615", "name": "Gohibic : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T12:21:01Z", "last_update_date": "2025-12-09T12:21:01Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/gohibic-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf-0"}, {"id": "66569", "name": "Gohibic : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-03T12:08:20Z", "last_update_date": "2025-12-09T12:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/gohibic-epar-risk-management-plan_en.pdf"}, {"id": "71616", "name": "EMA/PE/0000182525 : EMA decision of 6 December 2024 on the granting of a product specific waiver for modified messenger ribonucleic acid encoding individual patient-specific tumour neoantigens (V940/mRNA-4157)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T12:28:37Z", "last_update_date": "2025-12-09T12:28:37Z", "reference_number": "EMADOC-1700519818-1784306", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182525-ema-decision-6-december-2024-granting-product-specific-waiver-modified-messenger-ribonucleic-acid-encoding-individual-patient-specific-tumour-neoantigens-v940-mrna-4157_en.pdf"}, {"id": "71617", "name": "EMA/PE/0000183083 : EMA decision of 6 December 2024 on the granting of a product specific waiver for (S)-(4-amino-1,3-dihydrofuro[3,4-c][1,7]naphthyridin-8-yl)(3-(4-(trifluoromethyl)phenyl)morpholino)methanone", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T12:45:57Z", "last_update_date": "2025-12-09T12:45:57Z", "reference_number": "EMADOC-1700519818-1784096", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183083-ema-decision-6-december-2024-granting-product-specific-waiver-s-4-amino-13-dihydrofuro34-c17naphthyridin-8-yl3-4-trifluoromethylphenylmorpholinomethanone_en.pdf"}, {"id": "71584", "name": "European sales and use of antimicrobials for veterinary medicine: Annual surveillance report for 2024", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T12:57:00Z", "last_update_date": "2025-12-09T12:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/report/european-sales-use-antimicrobials-veterinary-medicine-annual-surveillance-report-2024_en.pdf"}, {"id": "71618", "name": "EMA/PE/0000182808 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for zoliflodacin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T13:10:55Z", "last_update_date": "2025-12-09T13:10:55Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182808-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-zoliflodacin_en.pdf"}, {"id": "45537", "name": "Inbrija : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2020-10-12T14:58:00Z", "last_update_date": "2025-12-09T16:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/inbrija-epar-product-information_en.pdf"}, {"id": "48995", "name": "Inbrija : EPAR - Procedural steps taken and scientific information after the authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2020-10-12T12:29:00Z", "last_update_date": "2025-12-09T16:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/inbrija-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71619", "name": "Inbrija : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T13:16:41Z", "last_update_date": "2025-12-09T13:16:41Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/inbrija-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "68806", "name": "Anzupgo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-18T11:22:27Z", "last_update_date": "2025-12-08T15:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/anzupgo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71620", "name": "Anzupgo : EPAR - Procedural steps taken and scientific information (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T14:07:59Z", "last_update_date": "2025-12-09T14:07:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/anzupgo-epar-procedural-steps-taken-scientific-information-archive_en.pdf"}, {"id": "71603", "name": "Presentation - HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic modelsfor regulatory assessment - Summary report from the meeting and follow-up activities (E.Manolis, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:14:26Z", "last_update_date": "2025-12-09T11:14:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-hma-ema-multi-stakeholder-workshop-reporting-qualification-mechanistic-modelsfor-regulatory-assessment-summary-report-meeting-follow-activities-emanolis-ema_en.pdf"}, {"id": "71605", "name": "Presentation - Future-proofing Qualification of Novel Methodologies (QoNM) - Update on delivery of the action plan  (I.Gravanis, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T11:16:02Z", "last_update_date": "2025-12-09T11:16:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-future-proofing-qualification-novel-methodologies-qonm-update-delivery-action-plan-igravanis-ema_en.pdf"}, {"id": "71621", "name": "EMA/PE/0000183137 : EMA decision of 6 December 2025 on the acceptance of a modification of an agreed paediatric investigation plan for encaleret", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T14:25:15Z", "last_update_date": "2025-12-09T14:25:15Z", "reference_number": "EMADOC-1700519818-1759915", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183137-ema-decision-6-december-2025-acceptance-modification-agreed-paediatric-investigation-plan-encaleret_en.pdf"}, {"id": "71622", "name": "EMA/PE/0000183329 : EMA decision of 6 December 2024 on the of a modification of an agreed paediatric investigation plan for interleukin-23 receptor antagonist peptide (JNJ-77242113)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T14:38:09Z", "last_update_date": "2025-12-09T14:38:09Z", "reference_number": "EMADOC-1700519818-1793192", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183329-ema-decision-6-december-2024-modification-agreed-paediatric-investigation-plan-interleukin-23-receptor-antagonist-peptide-jnj-77242113_en.pdf"}, {"id": "61608", "name": "Loargys: EPAR - Risk Management Plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-12-22T16:35:24Z", "last_update_date": "2025-12-09T10:43:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/loargys-epar-risk-management-plan_en.pdf"}, {"id": "71008", "name": "Loargys : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-05T12:32:00Z", "last_update_date": "2025-12-09T13:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/loargys-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71623", "name": "Combination Products Operational Group (COMBO) - Terms of reference", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T15:01:06Z", "last_update_date": "2025-12-09T15:01:06Z", "reference_number": "EMA/219064/2025", "url": "https://www.ema.europa.eu/en/documents/other/combination-products-operational-group-combo-terms-reference_en.pdf"}, {"id": "71556", "name": "Enzalutamide Viatris : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2024-10-09T15:41:45Z", "last_update_date": "2025-12-09T15:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/enzalutamide-viatris-epar-all-authorised-presentations_en.pdf"}, {"id": "71626", "name": "EMA/PE/0000183373 : EMA decision of 6 December 2024 on the granting of a product specific waiver for tadalafil, tamsulosin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T15:47:21Z", "last_update_date": "2025-12-09T15:47:21Z", "reference_number": "EMADOC-1700519818-1775261", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183373-ema-decision-6-december-2024-granting-product-specific-waiver-tadalafil-tamsulosin_en.pdf"}, {"id": "71627", "name": "Meeting summary - PCWP/HCPWP and all eligible organisations meeting 18 November 2025", "type": "minutes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T15:50:10Z", "last_update_date": "2025-12-09T15:50:10Z", "reference_number": "EMA/364256/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/meeting-summary-pcwp-hcpwp-all-eligible-organisations-meeting-18-november-2025_en.pdf"}, {"id": "71628", "name": "Bimervax: Periodic safety update report assessment 30 September 2024 - 29 March 2025", "type": "covid-19-vaccine-safety-update", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T16:09:58Z", "last_update_date": "2025-12-09T16:09:58Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/bimervax-periodic-safety-update-report-assessment-30-september-2024-29-march-2025_en.pdf"}, {"id": "11806", "name": "Carbaglu : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-21T02:09:00Z", "last_update_date": "2025-12-09T12:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/carbaglu-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "21453", "name": "Carbaglu : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-21T02:09:00Z", "last_update_date": "2025-12-09T12:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/carbaglu-epar-product-information_en.pdf"}, {"id": "71629", "name": "Carbaglu : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T16:14:35Z", "last_update_date": "2025-12-09T16:14:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/carbaglu-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71631", "name": "Mandate, objectives and rules of procedure for the Cancer Medicines Forum", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T16:15:59Z", "last_update_date": "2025-12-09T16:15:59Z", "reference_number": "EMA/CHMP/58471/2024", "url": "https://www.ema.europa.eu/en/documents/other/mandate-objectives-rules-procedure-cancer-medicines-forum_en.pdf"}, {"id": "71630", "name": "Carbaglu : EPAR – Product information – tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T16:16:32Z", "last_update_date": "2025-12-09T16:16:32Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/carbaglu-epar-product-information-tracked-changes_en.doc"}, {"id": "4263", "name": "List of substances and products subject to worksharing for signal management", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2012-10-05T02:00:00Z", "last_update_date": "2025-12-09T15:22:00Z", "reference_number": "EMA/563056/2014 Rev. 14", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/list-substances-products-subject-worksharing-signal-management_en.xlsx"}, {"id": "71563", "name": "Concept paper on the guideline revision on good pharmacogenomic practice", "type": "scientific-guideline", "status": "Draft: consultation open", "consultation_date": "2025-12-09 - 2026-03-31", "publish_date": "2025-12-08T09:44:23Z", "last_update_date": "2025-12-09T15:57:00Z", "reference_number": "EMA/282050/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-guideline-revision-good-pharmacogenomic-practice_en.pdf"}, {"id": "71624", "name": "Information for the package leaflet regarding dextrans used as excipients in medicinal products for human use", "type": "scientific-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-09T15:07:33Z", "last_update_date": "2025-12-09T15:07:33Z", "reference_number": "EMA/CHMP/187129/2016", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/information-package-leaflet-regarding-dextrans-used-excipients-medicinal-products-human-use_en.pdf"}, {"id": "71625", "name": "Overview of comments received on 'Information for the package leaflet regarding dextrans used as excipients in medicinal products for human use' (EMA/CHMP/187129/2016)", "type": "comments", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-09T15:09:42Z", "last_update_date": "2025-12-09T15:09:42Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/comments/overview-comments-received-information-package-leaflet-regarding-dextrans-used-excipients-medicinal-products-human-use-ema-chmp-187129-2016_en.pdf"}, {"id": "42472", "name": "List of medicinal products under additional monitoring", "type": "additional-monitoring", "status": "unknown", "consultation_date": "", "publish_date": "2013-04-25T12:13:00Z", "last_update_date": "2025-12-10T09:00:00Z", "reference_number": "EMA/245297/2013 Rev. 139", "url": "https://www.ema.europa.eu/en/documents/additional-monitoring/list-medicinal-products-under-additional-monitoring_en.xlsx"}, {"id": "42471", "name": "List of medicinal products under additional monitoring", "type": "additional-monitoring", "status": "unknown", "consultation_date": "", "publish_date": "2013-06-23T14:11:00Z", "last_update_date": "2025-12-10T09:01:00Z", "reference_number": "EMA/245297/2013 Rev. 139", "url": "https://www.ema.europa.eu/en/documents/additional-monitoring/list-medicinal-products-under-additional-monitoring_en.pdf"}, {"id": "65538", "name": "Cejemly : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2024-11-05T09:18:32Z", "last_update_date": "2025-12-10T08:55:00Z", "reference_number": "EMADOC-1829012207-35850", "url": "https://www.ema.europa.eu/en/documents/overview/cejemly-epar-medicine-overview_en.pdf"}, {"id": "71632", "name": "Lumicitabine : Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision", "type": "pip-discontinuation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T09:20:26Z", "last_update_date": "2025-12-10T09:20:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/pip-discontinuation/lumicitabine-notification-discontinuation-paediatric-development-which-covered-agreed-pip-decision_en.pdf"}, {"id": "71633", "name": "Tezepelumab : Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision", "type": "pip-discontinuation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T09:22:51Z", "last_update_date": "2025-12-10T09:22:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/pip-discontinuation/tezepelumab-notification-discontinuation-paediatric-development-which-covered-agreed-pip-decision_en.pdf"}, {"id": "71634", "name": "Pamrevlumab : Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision", "type": "pip-discontinuation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T09:24:41Z", "last_update_date": "2025-12-10T09:24:41Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/pip-discontinuation/pamrevlumab-notification-discontinuation-paediatric-development-which-covered-agreed-pip-decision_en.pdf"}, {"id": "71635", "name": "Favezelimab / pembrolizumab : Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision", "type": "pip-discontinuation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T09:26:09Z", "last_update_date": "2025-12-10T09:26:09Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/pip-discontinuation/favezelimab-pembrolizumab-notification-discontinuation-paediatric-development-which-covered-agreed-pip-decision_en.pdf"}, {"id": "71636", "name": "Danuglipron : Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision", "type": "pip-discontinuation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T09:27:50Z", "last_update_date": "2025-12-10T09:27:50Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/pip-discontinuation/danuglipron-notification-discontinuation-paediatric-development-which-covered-agreed-pip-decision_en.pdf-0"}, {"id": "71637", "name": "Iclepertin : Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision", "type": "pip-discontinuation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T09:30:56Z", "last_update_date": "2025-12-10T09:30:56Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/pip-discontinuation/iclepertin-notification-discontinuation-paediatric-development-which-covered-agreed-pip-decision_en.pdf"}, {"id": "30898", "name": "Zavicefta : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2016-07-14T02:00:00Z", "last_update_date": "2025-12-10T12:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/zavicefta-epar-product-information_en.pdf"}, {"id": "16900", "name": "Esbriet : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-03-11T01:00:00Z", "last_update_date": "2025-12-10T17:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/esbriet-epar-product-information_en.pdf"}, {"id": "39382", "name": "Esbriet : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2011-03-11T01:00:00Z", "last_update_date": "2025-12-10T13:44:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/esbriet-epar-all-authorised-presentations_en.pdf"}, {"id": "67714", "name": "Esbriet : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-09T14:21:53Z", "last_update_date": "2025-12-10T09:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/esbriet-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71638", "name": "EMA/PE/0000183430 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for tralokinumab (Adtralza)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T10:02:36Z", "last_update_date": "2025-12-10T10:02:36Z", "reference_number": "EMADOC-1700519818-1789468", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183430-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-tralokinumab-adtralza_en.pdf"}, {"id": "71639", "name": "EMA/PE/0000183758 : EMA decision of 6 December 2024 on the granting of a product specific waiver for zimislecel", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T10:12:31Z", "last_update_date": "2025-12-10T10:12:31Z", "reference_number": "EMADOC-1700519818-1793563", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183758-ema-decision-6-december-2024-granting-product-specific-waiver-zimislecel_en.pdf"}, {"id": "71640", "name": "EMA/PE/0000183866 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for brexpiprazole (Rxulti)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T10:24:32Z", "last_update_date": "2025-12-10T10:24:32Z", "reference_number": "EMADOC-1700519818-1791709", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000183866-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-brexpiprazole-rxulti_en.pdf"}, {"id": "71641", "name": "EMA/PE/0000184400 : EMA decision of 5 December 2024 on the granting of a product specific waiver for dapagliflozin / eplerenone", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T10:30:02Z", "last_update_date": "2025-12-10T10:30:02Z", "reference_number": "EMADOC-1700519818-1791938", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000184400-ema-decision-5-december-2024-granting-product-specific-waiver-dapagliflozin-eplerenone_en.pdf"}, {"id": "44998", "name": "Libtayo : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2019-07-05T14:42:00Z", "last_update_date": "2025-12-10T01:24:00Z", "reference_number": "EMA/101482/2023", "url": "https://www.ema.europa.eu/en/documents/overview/libtayo-epar-medicine-overview_en.pdf"}, {"id": "45002", "name": "Libtayo : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2019-07-05T14:54:00Z", "last_update_date": "2025-12-10T09:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/libtayo-epar-risk-management-plan_en.pdf"}, {"id": "45856", "name": "Libtayo : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2019-10-30T13:52:00Z", "last_update_date": "2025-12-10T10:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/libtayo-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "65525", "name": "Libtayo : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2019-07-05T09:42:40Z", "last_update_date": "2025-12-10T09:43:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/libtayo-epar-product-information_en.pdf"}, {"id": "71642", "name": "Libtayo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T11:54:41Z", "last_update_date": "2025-12-10T11:54:41Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/libtayo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71643", "name": "Libtayo-VR-0000264999 : Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T11:56:17Z", "last_update_date": "2025-12-10T11:56:17Z", "reference_number": "EMADOC-1700519818-2492896", "url": "https://www.ema.europa.eu/en/documents/variation-report/libtayo-vr-0000264999-assessment-report-variation_en.pdf"}, {"id": "43970", "name": "Rizmoic : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2019-03-01T17:27:00Z", "last_update_date": "2025-12-10T08:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/rizmoic-epar-product-information_en.pdf"}, {"id": "68845", "name": "Rizmoic : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-19T17:31:51Z", "last_update_date": "2025-12-10T14:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/rizmoic-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "36131", "name": "Pandemic influenza vaccine H5N1 AstraZeneca : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2016-06-02T02:00:00Z", "last_update_date": "2025-12-10T16:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pandemic-influenza-vaccine-h5n1-astrazeneca-epar-product-information_en.pdf"}, {"id": "71644", "name": "Pandemic influenza vaccine H5N1 AstraZeneca : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T14:13:37Z", "last_update_date": "2025-12-10T14:13:37Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pandemic-influenza-vaccine-h5n1-astrazeneca-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf-0"}, {"id": "24430", "name": "Pandemic influenza vaccine H5N1 AstraZeneca : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2017-02-10T01:00:00Z", "last_update_date": "2025-12-10T16:33:03Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pandemic-influenza-vaccine-h5n1-astrazeneca-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71646", "name": "Minutes of the CAT meeting 10-12 September 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T14:43:46Z", "last_update_date": "2025-12-10T14:43:46Z", "reference_number": "EMA/CAT/387156/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-cat-meeting-10-12-september-2025_en.pdf"}, {"id": "71647", "name": "Minutes of the CAT meeting 8-9 October 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T14:47:06Z", "last_update_date": "2025-12-10T14:47:06Z", "reference_number": "EMA/CAT/383728/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-cat-meeting-8-9-october-2025_en.pdf"}, {"id": "71648", "name": "Withdrawal assessment report for Sirolimus TriviumVet", "type": "withdrawal-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T14:51:53Z", "last_update_date": "2025-12-10T14:51:53Z", "reference_number": "EMA/108424/2025", "url": "https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-sirolimus-triviumvet_en.pdf"}, {"id": "71649", "name": "Withdrawal letter : Sirolimus TriviumVet", "type": "withdrawal-letter", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T14:53:55Z", "last_update_date": "2025-12-10T14:53:55Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/withdrawal-letter/withdrawal-letter-sirolimus-triviumvet_en.pdf"}, {"id": "67495", "name": "Eydenzelt : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-27T13:36:34Z", "last_update_date": "2025-12-10T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/eydenzelt-epar-product-information_en.pdf"}, {"id": "68333", "name": "Eydenzelt : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-16T15:03:08Z", "last_update_date": "2025-12-10T09:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/eydenzelt-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "4306", "name": "EMA procedural advice for medicinal products intended exclusively for markets outside the European Union in the context of co-operation with the World Health Organisation (WHO)", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2009-04-01T02:00:00Z", "last_update_date": "2025-12-10T15:00:00Z", "reference_number": "EMA/534107/2008 Rev.5", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ema-procedural-advice-medicinal-products-intended-exclusively-markets-outside-european-union-context-co-operation-world-health-organisation-who_en.pdf"}, {"id": "49677", "name": "Libmeldy : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-12-22T11:10:00Z", "last_update_date": "2025-12-10T16:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/libmeldy-epar-risk-management-plan_en.pdf"}, {"id": "71652", "name": "Presentation - Enpr-EMA Annual Report 2024-2025 (P. Lepola, I. Sanchez)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:10:11Z", "last_update_date": "2025-12-10T15:10:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-enpr-ema-annual-report-2024-2025-p-lepola-i-sanchez_en.pdf"}, {"id": "71653", "name": "Presentation - Case study: Leveraging external data for efficient pediatric study design in multiple sclerosis (D. Hearing, M. Thomas)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:10:47Z", "last_update_date": "2025-12-10T15:10:47Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-case-study-leveraging-external-data-efficient-pediatric-study-design-multiple-sclerosis-d-hearing-m-thomas_en.pdf"}, {"id": "71654", "name": "Kovaltry-PAM-0000281517 : EPAR - Assessment report ", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-10T15:10:49Z", "last_update_date": "2025-12-10T15:10:49Z", "reference_number": "EMADOC-1700519818-2630630", "url": "https://www.ema.europa.eu/en/documents/variation-report/kovaltry-pam-0000281517-epar-assessment-report_en.pdf"}, {"id": "71655", "name": "Presentation - Case Study: Novel Pediatric Trial Design - A study to evaluate the efficacy, safety, and tolerability of Brivaracetam (G. Calarco Smith)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:11:27Z", "last_update_date": "2025-12-10T15:11:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-case-study-novel-pediatric-trial-design-study-evaluate-efficacy-safety-tolerability-brivaracetam-g-calarco-smith_en.pdf"}, {"id": "71656", "name": "Presentation - Translation research from lab to patients - Latest innovations by EPTRI (D. Bonifazi)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:12:36Z", "last_update_date": "2025-12-10T15:12:36Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-translation-research-lab-patients-latest-innovations-eptri-d-bonifazi_en.pdf"}, {"id": "71657", "name": "Presentation - Restoring agility - AI and the future of the paediatric research in Europe (J. Isla)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:13:12Z", "last_update_date": "2025-12-10T15:13:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-restoring-agility-ai-future-paediatric-research-europe-j-isla_en.pdf"}, {"id": "71658", "name": "Presentation - European Health Data Space (D. Morales)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:13:51Z", "last_update_date": "2025-12-10T15:13:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-european-health-data-space-d-morales_en.pdf"}, {"id": "71661", "name": "Presentation - Overview of ICH E6 R3 renovation (P.Twomey)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:15:30Z", "last_update_date": "2025-12-10T15:15:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-overview-ich-e6-r3-renovation-ptwomey_en.pdf"}, {"id": "71662", "name": "Agenda - 2025 annual internal meeting of the European network of paediatric research at the EMA (Enpr-EMA)", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:00:16Z", "last_update_date": "2025-12-10T15:00:16Z", "reference_number": "EMA/156669/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-2025-annual-internal-meeting-european-network-paediatric-research-ema-enpr-ema_en.pdf"}, {"id": "71663", "name": "Presentation - Quality criteria for paediatric clinical trial sites - an Enpr-EMA initiative (R. Fernandez, P. Skovby)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:01:39Z", "last_update_date": "2025-12-10T15:01:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-quality-criteria-paediatric-clinical-trial-sites-enpr-ema-initiative-r-fernandez-p-skovby_en.pdf"}, {"id": "71664", "name": "Presentation - Paediatric cross-border clinical trials: Enpr-EMA Working Group (B. Nafria)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:02:46Z", "last_update_date": "2025-12-10T15:02:46Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-paediatric-cross-border-clinical-trials-enpr-ema-working-group-b-nafria_en.pdf"}, {"id": "71665", "name": "Presentation - Enpr-EMA Paediatric research nurse working group (P. Dicks)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:04:23Z", "last_update_date": "2025-12-10T15:04:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-enpr-ema-paediatric-research-nurse-working-group-p-dicks_en.pdf"}, {"id": "71666", "name": "Presentation - Patient and public involvement (PPI) working group (S. Gaillard)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:05:43Z", "last_update_date": "2025-12-10T15:05:43Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-patient-public-involvement-ppi-working-group-s-gaillard_en.pdf"}, {"id": "71667", "name": "Presentation - ACT EU: Collaboration with Enpr-EMA (L. Pioppo, M. Al)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:06:45Z", "last_update_date": "2025-12-10T15:06:45Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-act-eu-collaboration-enpr-ema-l-pioppo-m-al_en.pdf"}, {"id": "71668", "name": "Presentation - The Lancet Child & Adolescent Health Commission on the future of neonatology (M. Turner)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:08:20Z", "last_update_date": "2025-12-10T15:08:20Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-lancet-child-adolescent-health-commission-future-neonatology-m-turner_en.pdf"}, {"id": "71669", "name": "Presentation - Paediatric clinical research: Overcoming challenges and hurdles to foster innovation with Enpr-EMA (A. Siapkara)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:09:01Z", "last_update_date": "2025-12-10T15:09:01Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-paediatric-clinical-research-overcoming-challenges-hurdles-foster-innovation-enpr-ema-siapkara_en.pdf"}, {"id": "71670", "name": "Presentation - Non-oncological MoA based PIP – Initial deliberations from the PDCO working group discussions (S. Scherer)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:10:21Z", "last_update_date": "2025-12-10T15:10:21Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-non-oncological-moa-based-pip-initial-deliberations-pdco-working-group-discussions-s-scherer_en.pdf-0"}, {"id": "71671", "name": "Presentation - Mechanism of action based PIPs in paediatric oncology (M. Sheean)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:11:25Z", "last_update_date": "2025-12-10T15:11:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-mechanism-action-based-pips-paediatric-oncology-m-sheean_en.pdf"}, {"id": "71672", "name": "Presentation - Strategic aims of Enpr-EMA 2025-2027 (P. Lepola)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:12:06Z", "last_update_date": "2025-12-10T15:12:06Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-strategic-aims-enpr-ema-2025-2027-p-lepola_en.pdf"}, {"id": "71673", "name": "Presentation - Enpr-EMA: Modernisation (N. Rodriguez Barcons)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:12:52Z", "last_update_date": "2025-12-10T15:12:52Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-enpr-ema-modernisation-n-rodriguez-barcons_en.pdf"}, {"id": "69755", "name": "Programme of the 2025 annual open meeting of the European network of paediatric research at EMA (Enpr-EMA)", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-18T14:43:38Z", "last_update_date": "2025-12-10T11:43:35Z", "reference_number": "EMA/156670/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/programme-2025-annual-open-meeting-european-network-paediatric-research-ema-enpr-ema_en.pdf"}, {"id": "71650", "name": "Presentation - Introducing the Principle of Responsible Inclusion of Children in the Declaration of Helsinki (2024) (D.Sprumont)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:07:47Z", "last_update_date": "2025-12-10T15:07:47Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-introducing-principle-responsible-inclusion-children-declaration-helsinki-2024-dsprumont_en.pdf"}, {"id": "71674", "name": "Presentation - Compiance monitoring based on reporting timelines (T. Paternoster-Howe)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:22:54Z", "last_update_date": "2025-12-10T15:22:54Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-compiance-monitoring-based-reporting-timelines-t-paternoster-howe_en.pdf"}, {"id": "71675", "name": "Livogiva : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:23:50Z", "last_update_date": "2025-12-10T15:23:50Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/livogiva-epar-product-information-tracked-changes_en.docx"}, {"id": "49732", "name": "Livogiva : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2021-01-06T12:43:00Z", "last_update_date": "2025-12-10T15:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/livogiva-epar-risk-management-plan_en.pdf"}, {"id": "71676", "name": "Draft guideline on quality of radiopharmaceuticals - Revision 2", "type": "scientific-guideline", "status": "Draft: consultation open", "consultation_date": "2025-12-10 - 2026-04-30", "publish_date": "2025-12-10T15:26:32Z", "last_update_date": "2025-12-10T15:26:32Z", "reference_number": "EMA/CHMP/QWP/363827/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-radiopharmaceuticals-revision-2_en.pdf"}, {"id": "32525", "name": "Aimovig : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2018-08-08T02:00:00Z", "last_update_date": "2025-12-10T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/aimovig-epar-risk-management-plan_en.pdf"}, {"id": "71415", "name": "Aimovig : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-01T10:59:05Z", "last_update_date": "2025-12-10T15:42:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/aimovig-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71677", "name": "Draft user manual for the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) user interface (XEVMPDweb)", "type": "other", "status": "Draft", "consultation_date": "", "publish_date": "2025-12-10T16:31:57Z", "last_update_date": "2025-12-10T16:31:57Z", "reference_number": "EMA/389113/2025", "url": "https://www.ema.europa.eu/en/documents/other/draft-user-manual-extended-eudravigilance-medicinal-product-dictionary-xevmpd-user-interface-xevmpdweb_en.pdf"}, {"id": "56193", "name": "Article 57 product data", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2018-07-30T09:49:00Z", "last_update_date": "2025-12-10T12:00:00Z", "reference_number": "EMA/518502/2018 Rev. 81", "url": "https://www.ema.europa.eu/en/documents/other/article-57-product-data_en.xlsx"}, {"id": "71651", "name": "Presentation - Quality criteria for paediatric clinical trial sites - an Enpr-EMA initiative (P. Skovby, R. Fernandes)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:09:13Z", "last_update_date": "2025-12-10T15:09:13Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-quality-criteria-paediatric-clinical-trial-sites-enpr-ema-initiative-p-skovby-r-fernandes_en.pdf"}, {"id": "71660", "name": "Presentation - Paediatric clinical trial assessments under the new CTR - from PIP to CTA (L. Fankhauser)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:15:00Z", "last_update_date": "2025-12-10T15:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-paediatric-clinical-trial-assessments-under-new-ctr-pip-cta-l-fankhauser_en.pdf"}, {"id": "71659", "name": "Presentation - Putting E11A into practice - Extrapolation from guideline to application (D. Karres)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T15:14:19Z", "last_update_date": "2025-12-10T15:14:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-putting-e11a-practice-extrapolation-guideline-application-d-karres_en.pdf"}, {"id": "71679", "name": "Presentation - ACT EU Paediatrics Trials in EU EEA Workshop on the assessment of clinical trials (A. Solli Karlsen)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T16:59:19Z", "last_update_date": "2025-12-10T16:59:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-act-eu-paediatrics-trials-eu-eea-workshop-assessment-clinical-trials-solli-karlsen_en.pdf"}, {"id": "71678", "name": "Presentation - European Rare Diseases Research Alliance ERDERA (D. Julkowska)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-10T16:58:36Z", "last_update_date": "2025-12-10T16:58:36Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-european-rare-diseases-research-alliance-erdera-d-julkowska_en.pdf"}, {"id": "71680", "name": "Agenda - Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting inthe EU: Hands-on Training Course using the EudraVigilance System - 2026", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T08:40:54Z", "last_update_date": "2025-12-11T08:40:54Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-mandatory-use-iso-ich-e2br3-individual-case-safety-reporting-inthe-eu-hands-training-course-using-eudravigilance-system-2026_en.pdf"}, {"id": "71682", "name": "Questions and answers on post approval change management protocols (PACMP) - Revision 1", "type": "scientific-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-11T08:57:14Z", "last_update_date": "2025-12-11T08:57:14Z", "reference_number": "EMA/CHMP/QWP/586330/2010 Rev 1", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-post-approval-change-management-protocols-pacmp-revision-1_en.pdf"}, {"id": "71681", "name": "Direct healthcare professional communication (DHPC): Tranexamic acid intravenous formulations – Serious including fatal adverse reactions due to inadvertent intrathecal administration", "type": "dhpc", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T08:44:40Z", "last_update_date": "2025-12-11T08:44:40Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/dhpc/direct-healthcare-professional-communication-dhpc-tranexamic-acid-intravenous-formulations-serious-including-fatal-adverse-reactions-due-inadvertent-intrathecal-administration_en.pdf"}, {"id": "59500", "name": "Consolidated 3-year work plan for the Emergency Task Force (ETF)", "type": "work-programme", "status": "unknown", "consultation_date": "", "publish_date": "2023-07-27T10:10:00Z", "last_update_date": "2025-12-11T09:05:00Z", "reference_number": "EMA/388410/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/consolidated-3-year-work-plan-emergency-task-force-etf_en.pdf"}, {"id": "71419", "name": "Presentation - ICH E2D and ICH E2B updates (A.van Haren, Medicines Evaluation Board; G.Touraille, EMA; T.Paternoster-Howe, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-01T11:53:08Z", "last_update_date": "2025-12-11T09:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-ich-e2d-ich-e2b-updates-avan-haren-medicines-evaluation-board-gtouraille-ema-tpaternoster-howe-ema_en.pdf"}, {"id": "71420", "name": "Presentation - Impact of the EudraVigilance Signal Detection Pilot termination by MAHs: IR.(EU)2025/1466, amendment of IR (EU)520/2012 (E. Savvaidou, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-01T11:54:16Z", "last_update_date": "2025-12-11T09:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-impact-eudravigilance-signal-detection-pilot-termination-mahs-ireu2025-1466-amendment-ir-eu520-2012-e-savvaidou-ema_en.pdf"}, {"id": "71422", "name": "Presentation - Best practice for signal assessment - NCA perspective (B.Mulder, Medicines Evaluation Board)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-01T11:57:01Z", "last_update_date": "2025-12-11T09:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-best-practice-signal-assessment-nca-perspective-bmulder-medicines-evaluation-board_en.pdf"}, {"id": "71424", "name": "Presentation - Automated compliance monitoring based on reporting timelines (R.Nic An Ri, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-01T12:01:42Z", "last_update_date": "2025-12-11T09:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-automated-compliance-monitoring-based-reporting-timelines-rnic-ri-ema_en.pdf"}, {"id": "71436", "name": "Presentation - Medicinal product reporting - EU implementation of ISO IDMP: from XEVMPD to PMS (A.van Haren, Medicines Evaluation Board; A.Cochino, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-01T13:27:01Z", "last_update_date": "2025-12-11T09:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-medicinal-product-reporting-eu-implementation-iso-idmp-xevmpd-pms-avan-haren-medicines-evaluation-board-acochino-ema_en.pdf"}, {"id": "71683", "name": "Methodology Working Party (MWP) interested parties meeting report, September 2025", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T10:47:15Z", "last_update_date": "2025-12-11T10:47:15Z", "reference_number": "EMA/389090/2025", "url": "https://www.ema.europa.eu/en/documents/report/methodology-working-party-mwp-interested-parties-meeting-report-september-2025_en.pdf"}, {"id": "71684", "name": "Amlodipine / atorvastatin : List of nationally authorised medicinal products - PSUSA/00000177/202501", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T12:01:45Z", "last_update_date": "2025-12-11T12:01:45Z", "reference_number": "EMADOC-1700519818-2658372", "url": "https://www.ema.europa.eu/en/documents/psusa/amlodipine-atorvastatin-list-nationally-authorised-medicinal-products-psusa-00000177-202501_en.pdf"}, {"id": "71685", "name": "Amlodipine / atorvastatin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000177/202501", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T12:04:17Z", "last_update_date": "2025-12-11T12:04:17Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/amlodipine-atorvastatin-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00000177-202501_en.pdf"}, {"id": "71028", "name": "From laboratory to patients: How the safety of medicines is ensured in the European Union", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-06T12:00:00Z", "last_update_date": "2025-12-11T12:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/laboratory-patients-how-safety-medicines-ensured-european-union_en.pdf"}, {"id": "71686", "name": "Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (17 December 2025)", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T12:35:00Z", "last_update_date": "2025-12-11T12:35:00Z", "reference_number": "EMA/367190/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-executive-steering-group-shortages-safety-medicinal-products-mssg-17-december-2025_en.pdf"}, {"id": "21998", "name": "Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2012-11-30T01:00:00Z", "last_update_date": "2025-12-11T12:45:00Z", "reference_number": "EMA/257906/2011 Rev.4", "url": "https://www.ema.europa.eu/en/documents/other/members-coordinating-group-european-network-paediatric-research-european-medicines-agency-enpr-ema_en.pdf"}, {"id": "67859", "name": "Mounjaro : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-15T15:52:06Z", "last_update_date": "2025-12-11T17:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/mounjaro-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71029", "name": "Mounjaro : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-06T09:56:25Z", "last_update_date": "2025-12-11T12:58:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/mounjaro-epar-product-information-tracked-changes_en.docx"}, {"id": "62352", "name": "Methodology European Specialised Expert Community (ESEC): Members", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2024-02-29T10:20:00Z", "last_update_date": "2025-12-11T12:25:00Z", "reference_number": "EMA/389254/2025", "url": "https://www.ema.europa.eu/en/documents/other/methodology-european-specialised-expert-community-esec-members_en.pdf"}, {"id": "26389", "name": "Hefiya : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2018-08-06T16:44:00Z", "last_update_date": "2025-12-11T16:44:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/hefiya-epar-risk-management-plan_en.pdf"}, {"id": "68027", "name": "Hefiya : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-29T14:46:22Z", "last_update_date": "2025-12-11T15:33:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/hefiya-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "41739", "name": "Hyrimoz : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2018-08-02T02:00:00Z", "last_update_date": "2025-12-11T10:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/hyrimoz-epar-risk-management-plan_en.pdf"}, {"id": "68033", "name": "Hyrimoz : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-29T17:35:13Z", "last_update_date": "2025-12-11T15:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/hyrimoz-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "47175", "name": "Veyvondi : EPAR - Procedural steps taken and scientific information after the authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2020-03-27T08:37:00Z", "last_update_date": "2025-12-11T16:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/veyvondi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71692", "name": "Veyvondi-PAM-0000291090 : EPAR - Assessment report", "type": "variation-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T15:20:24Z", "last_update_date": "2025-12-11T15:20:24Z", "reference_number": "EMADOC-1700519818-2679383", "url": "https://www.ema.europa.eu/en/documents/variation-report/veyvondi-pam-0000291090-epar-assessment-report_en.pdf"}, {"id": "43271", "name": "Pifeltro : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2019-01-10T12:16:00Z", "last_update_date": "2025-12-11T08:41:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pifeltro-epar-product-information_en.pdf"}, {"id": "44595", "name": "Pifeltro : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2019-05-27T15:43:00Z", "last_update_date": "2025-12-11T08:41:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pifeltro-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71695", "name": "Pifeltro : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T15:25:17Z", "last_update_date": "2025-12-11T15:25:17Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pifeltro-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "10410", "name": "Afstyla : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2017-05-10T02:00:00Z", "last_update_date": "2025-12-11T16:42:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/afstyla-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71696", "name": "Afstyla-PAM-0000282137 : EPAR - Assessment report", "type": "variation-report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T15:28:51Z", "last_update_date": "2025-12-11T15:28:51Z", "reference_number": "EMADOC-1700519818-2569488", "url": "https://www.ema.europa.eu/en/documents/variation-report/afstyla-pam-0000282137-epar-assessment-report_en.pdf"}, {"id": "12293", "name": "Tobi Podhaler : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-08-25T02:00:00Z", "last_update_date": "2025-12-11T16:59:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tobi-podhaler-epar-product-information_en.pdf"}, {"id": "18098", "name": "Tobi Podhaler : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2012-05-03T02:00:00Z", "last_update_date": "2025-12-11T17:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tobi-podhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71697", "name": "Tobi Podhaler : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T15:53:06Z", "last_update_date": "2025-12-11T15:53:06Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tobi-podhaler-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "22088", "name": "Darunavir Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-02-03T01:00:00Z", "last_update_date": "2025-12-11T12:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/darunavir-viatris-epar-product-information_en.pdf"}, {"id": "63317", "name": "Darunavir Viatris (previously Darunavir Mylan) : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-24T11:57:00Z", "last_update_date": "2025-12-11T11:11:01Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/darunavir-viatris-previously-darunavir-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71698", "name": "Agenda - Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system (February, May 2026)", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T16:09:06Z", "last_update_date": "2025-12-11T16:09:06Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-virtual-live-hands-training-course-clinical-trials-sponsors-using-eudravigilance-system-february-may-2026_en.pdf"}, {"id": "56736", "name": "Teriflunomide Viatris : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-11-22T10:55:00Z", "last_update_date": "2025-12-11T12:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/teriflunomide-viatris-epar-product-information_en.pdf"}, {"id": "57295", "name": "Teriflunomide Viatris : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2023-01-16T12:09:00Z", "last_update_date": "2025-12-11T10:42:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/teriflunomide-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71702", "name": "Teriflunomide Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T16:39:59Z", "last_update_date": "2025-12-11T16:39:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/teriflunomide-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71703", "name": "Highlights - 20th EMA Industry Platform meeting on the operation of EU pharmacovigilance legislation meeting", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-11T16:43:43Z", "last_update_date": "2025-12-11T16:43:43Z", "reference_number": "EMA/370879/2025", "url": "https://www.ema.europa.eu/en/documents/report/highlights-20th-ema-industry-platform-meeting-operation-eu-pharmacovigilance-legislation-meeting_en.pdf"}, {"id": "71705", "name": "Guideline on stability testing for applications for variations to a marketing authorisation - Revision 3", "type": "scientific-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T09:17:37Z", "last_update_date": "2025-12-12T09:17:37Z", "reference_number": "EMA/CHMP/QWP/441071/2011- Rev.3", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-stability-testing-applications-variations-marketing-authorisation-revision-3_en.pdf"}, {"id": "57073", "name": "Work plan for the Committee for Veterinary Medicinal Products (CVMP) Scientific Advice Working Party (SAWP-V) for 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T09:24:00Z", "last_update_date": "2025-12-12T09:24:00Z", "reference_number": "EMA/CVMP/SAWP/302107/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-committee-veterinary-medicinal-products-cvmp-scientific-advice-working-party-sawp-v-2026_en.pdf"}, {"id": "57426", "name": "Work plan for the Committee for Veterinary Medicinal Products (CVMP) Immunologicals Working Party (IWP) 2026", "type": "work-programme", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T09:27:00Z", "last_update_date": "2025-12-12T09:27:00Z", "reference_number": "EMA/CVMP/IWP/298213/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-committee-veterinary-medicinal-products-cvmp-immunologicals-working-party-iwp-2026_en.pdf"}, {"id": "66117", "name": "Work plan for the Committee for Veterinary Medicinal  Products (CVMP) Safety Working Party (SWP-V) 2025", "type": "work-programme", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T09:30:00Z", "last_update_date": "2025-12-12T09:30:00Z", "reference_number": "EMA/CVMP/SWP/192449/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-committee-veterinary-medicinal-products-cvmp-safety-working-party-swp-v-2025_en.pdf"}, {"id": "59447", "name": "Work plan for the European Sales and Use of Antimicrobials in veterinary medicine Working Group (ESUAvet WG) 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T09:32:00Z", "last_update_date": "2025-12-12T09:32:00Z", "reference_number": "EMA/CVMP/ESUAVET/290391/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-european-sales-use-antimicrobials-veterinary-medicine-working-group-esuavet-wg-2026_en.pdf"}, {"id": "59831", "name": "Work plan for the Committee for Veterinary Medicinal Products (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T09:34:00Z", "last_update_date": "2025-12-12T09:34:00Z", "reference_number": "EMA/CVMP/PhVWP/189306/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-committee-veterinary-medicinal-products-cvmp-pharmacovigilance-working-party-phvwp-v-2026_en.pdf"}, {"id": "57090", "name": "Work plan for the CVMP Novel Therapies & Technologies Working Party (NTWP) 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T09:36:00Z", "last_update_date": "2025-12-12T09:36:00Z", "reference_number": "EMA/CVMP/NTWP/228977/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-cvmp-novel-therapies-technologies-working-party-ntwp-2026_en.pdf"}, {"id": "54013", "name": "Work plan for the Committee for Veterinary Medicinal Products (CVMP) Environmental Risk Assessment Working Party (ERAWP) 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T09:38:00Z", "last_update_date": "2025-12-12T09:38:00Z", "reference_number": "EMA/CVMP/ERA/291857/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-committee-veterinary-medicinal-products-cvmp-environmental-risk-assessment-working-party-erawp-2026_en.pdf"}, {"id": "54015", "name": "Work plan for the Committee for Veterinary Medicinal Products (CVMP) Efficacy Working Party (EWP-V) 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T09:40:00Z", "last_update_date": "2025-12-12T09:40:00Z", "reference_number": "EMA/CVMP/EWP/230324/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-committee-veterinary-medicinal-products-cvmp-efficacy-working-party-ewp-v-2026_en.pdf"}, {"id": "35163", "name": "Prevymis : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-01-17T01:00:00Z", "last_update_date": "2025-12-12T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/prevymis-epar-product-information_en.pdf"}, {"id": "67878", "name": "Prevymis : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-16T13:40:14Z", "last_update_date": "2025-12-12T10:16:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/prevymis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71715", "name": "CVMP work plan 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T10:30:35Z", "last_update_date": "2025-12-12T10:30:35Z", "reference_number": "EMA/CVMP/210842/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/cvmp-work-plan-2026_en.pdf"}, {"id": "53792", "name": "Libmyris : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-01-18T09:42:00Z", "last_update_date": "2025-12-12T09:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/libmyris-epar-product-information_en.pdf"}, {"id": "69595", "name": "Libmyris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-31T11:18:45Z", "last_update_date": "2025-12-12T11:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/libmyris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "66071", "name": "Union list of critical medicines", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T11:05:00Z", "last_update_date": "2025-12-12T11:05:00Z", "reference_number": "EMA/361872/2025", "url": "https://www.ema.europa.eu/en/documents/other/union-list-critical-medicines-en.xlsx"}, {"id": "47345", "name": "Azacitidine Mylan : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2020-04-06T09:33:00Z", "last_update_date": "2025-12-12T15:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/azacitidine-mylan-epar-product-information_en.pdf"}, {"id": "67698", "name": "Azacitidine Mylan : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-08T14:13:01Z", "last_update_date": "2025-12-12T16:40:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/azacitidine-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "61369", "name": "Questions and answers on the Union list of critical medicines", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2023-12-12T11:51:24Z", "last_update_date": "2025-12-12T11:08:00Z", "reference_number": "EMA/363146/2025", "url": "https://www.ema.europa.eu/en/documents/other/questions-answers-union-list-critical-medicines_en.pdf"}, {"id": "71720", "name": "ICH E22 Guideline on general considerations for patient preference studies - Step 2b", "type": "scientific-guideline", "status": "Draft: consultation open", "consultation_date": "2025-12-12 - 2026-04-12", "publish_date": "2025-12-12T11:00:00Z", "last_update_date": "2025-12-12T11:00:00Z", "reference_number": "EMA/CHMP/ICH/371537/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e22-guideline-general-considerations-patient-preference-studies-step-2b_en.pdf"}, {"id": "58109", "name": "Synagis : EPAR - Risk Management Plan", "type": "rmp-summary", "status": "unknown", "consultation_date": "", "publish_date": "2023-03-22T10:06:00Z", "last_update_date": "2025-12-12T11:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp-summary/synagis-epar-risk-management-plan_en.pdf"}, {"id": "71713", "name": "HMPC meeting report on European Union herbal monographs, guidelines and other activities - 17-19 November 2025", "type": "committee-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T12:02:00Z", "last_update_date": "2025-12-12T12:02:00Z", "reference_number": "EMA/HMPC/371247/2025", "url": "https://www.ema.europa.eu/en/documents/committee-report/hmpc-meeting-report-european-union-herbal-monographs-guidelines-other-activities-17-19-november-2025_en.pdf"}, {"id": "71725", "name": "Guideline on the clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome - Revision 2", "type": "scientific-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T13:06:10Z", "last_update_date": "2025-12-12T13:06:10Z", "reference_number": "EMA/58320/2025 rev. 2", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-patients-acute-respiratory-distress-syndrome-revision-2_en.pdf"}, {"id": "71726", "name": "Highlights - Fourth European Medicines Agency - MedTech Europe bilateral meeting", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T13:25:42Z", "last_update_date": "2025-12-12T13:25:42Z", "reference_number": "EMA/369789/2025", "url": "https://www.ema.europa.eu/en/documents/report/highlights-fourth-european-medicines-agency-medtech-europe-bilateral-meeting_en.pdf"}, {"id": "30162", "name": "Prialt : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-05-08T02:00:00Z", "last_update_date": "2025-12-12T13:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/prialt-epar-product-information_en.pdf"}, {"id": "35884", "name": "Prialt : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-05-08T02:00:00Z", "last_update_date": "2025-12-12T13:33:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/prialt-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71727", "name": "Prialt : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T13:32:22Z", "last_update_date": "2025-12-12T13:32:22Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/prialt-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71728", "name": "Imaavy : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T13:49:15Z", "last_update_date": "2025-12-12T13:49:15Z", "reference_number": "EMA/322549/2025", "url": "https://www.ema.europa.eu/en/documents/overview/imaavy-epar-medicine-overview_en.pdf"}, {"id": "71729", "name": "Imaavy : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T13:50:24Z", "last_update_date": "2025-12-12T13:50:24Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/imaavy-epar-risk-management-plan_en.pdf"}, {"id": "71730", "name": "Imaavy : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T13:51:22Z", "last_update_date": "2025-12-12T13:51:22Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/imaavy-epar-product-information_en.pdf"}, {"id": "71731", "name": "Imaavy : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T13:52:15Z", "last_update_date": "2025-12-12T13:52:15Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/imaavy-epar-all-authorised-presentations_en.pdf"}, {"id": "71732", "name": "Imaavy : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T13:53:05Z", "last_update_date": "2025-12-12T13:53:05Z", "reference_number": "EMA/CHMP/290491/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/imaavy-epar-public-assessment-report_en.pdf"}, {"id": "50647", "name": "Checklist for the submission of Day 215 product information annexes for a post-opinion linguistic review (Word file)", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2021-03-19T09:10:00Z", "last_update_date": "2025-12-12T09:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/checklist-submission-day-215-product-information-annexes-post-opinion-linguistic-review-word-file_en.docx"}, {"id": "71706", "name": "CHMP post-authorisation summary of positive opinion for Dovprela (EMAVR0000258124)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1700519818-2699355", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-dovprela-emavr0000258124_en.pdf"}, {"id": "71704", "name": "Melatomed Article 29(4) referral - EMA recommends authorisation of Melatomed (melatonin, prolonged-release tablets) in the EU", "type": "referral", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T08:56:21Z", "last_update_date": "2025-12-12T08:56:21Z", "reference_number": "EMA/386502/2025", "url": "https://www.ema.europa.eu/en/documents/referral/melatomed-article-294-referral-ema-recommends-authorisation-melatomed-melatonin-prolonged-release-tablets-eu_en.pdf"}, {"id": "71708", "name": "CHMP summary of positive opinion for Ranluspec", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1829012207-37184", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-ranluspec_en.pdf"}, {"id": "71712", "name": "CHMP summary of positive opinion for Gotenfia", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1829012207-36858", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-gotenfia_en.pdf"}, {"id": "71714", "name": "CHMP summary of positive opinion for Anktiva", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1829012207-35903", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-anktiva_en.pdf"}, {"id": "71709", "name": "CHMP post-authorisation summary of positive opinion for Elucirem (EMAVR0000249008)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1700519818-2671019", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-elucirem-emavr0000249008_en.pdf"}, {"id": "71710", "name": "CHMP post-authorisation summary of positive opinion for Vueway (EMAVR0000249008)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1700519818-2707211", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-vueway-emavr0000249008_en.pdf"}, {"id": "71719", "name": "CHMP summary of positive opinion for Exdensur", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1829012207-35814", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-exdensur_en.pdf"}, {"id": "71718", "name": "CHMP post-authorisation summary of positive opinion for Nucala (EMAVR0000257645)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1700519818-2707697", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-nucala-emavr0000257645_en.pdf"}, {"id": "71716", "name": "Questions and answers on the withdrawal of application for the marketing authorisation of Jelrix (cartilage-forming cells, autologous)", "type": "medicine-qa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T10:34:35Z", "last_update_date": "2025-12-12T10:34:35Z", "reference_number": "EMEA/H/C/004594", "url": "https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-withdrawal-application-marketing-authorisation-jelrix-cartilage-forming-cells-autologous_en.pdf"}, {"id": "71722", "name": "CHMP summary of positive opinion for Aumseqa", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMA/CHMP/369595/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-aumseqa_en.pdf"}, {"id": "71724", "name": "CHMP post-authorisation summary of positive opinion for Uplizna (EMAVR0000257358)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1700519818-2662446", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-uplizna-emavr0000257358_en.pdf"}, {"id": "71711", "name": "CHMP summary of positive opinion for mNexspike", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMA/CHMP/381880/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-mnexspike_en.pdf"}, {"id": "71723", "name": "CHMP post-authorisation summary of positive opinion for Mounjaro (EMAVR0000281937)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-12T14:00:00Z", "reference_number": "EMADOC-1700519818-2705294", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-mounjaro-emavr0000281937_en.pdf"}, {"id": "71707", "name": "CHMP post-authorisation summary of positive opinion for Eylea (EMA/VR/0000264981)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T10:02:36Z", "last_update_date": "2025-12-12T10:02:36Z", "reference_number": "EMADOC-1700519818-2706651", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-eylea-ema-vr-0000264981_en.pdf"}, {"id": "71694", "name": "CHMP post-authorisation summary of positive opinion for Winrevair (EMA/VR/0000278021)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T15:25:04Z", "last_update_date": "2025-12-12T15:25:04Z", "reference_number": "EMADOC-1700519818-2692693", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-winrevair-ema-vr-0000278021_en.pdf"}, {"id": "71691", "name": "CHMP post-authorisation summary of positive opinion for Arexvy (EMA/VR/0000276225)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-11T15:07:39Z", "last_update_date": "2025-12-11T15:07:39Z", "reference_number": "EMADOC-1700519818-2676032", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-arexvy-ema-vr-0000276225_en.pdf"}, {"id": "71689", "name": "CHMP post-authorisation summary of positive opinion for Vfend (EMA/VR/0000284468)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:07:02Z", "last_update_date": "2025-12-12T14:07:02Z", "reference_number": "EMADOC-1700519818-2658010", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-vfend-ema-vr-0000284468_en.pdf"}, {"id": "71699", "name": "CHMP summary of positive opinion for Myqorzo", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T16:15:02Z", "last_update_date": "2025-12-12T16:15:02Z", "reference_number": "EMA/376438/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-myqorzo_en.pdf"}, {"id": "71688", "name": "CHMP post-authorisation summary of positive opinion for Simponi (II-121)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T13:49:58Z", "last_update_date": "2025-12-12T13:49:58Z", "reference_number": "EMA/CHMP/378614/2025", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-simponi-ii-121_en.pdf"}, {"id": "71645", "name": "CHMP post-authorisation summary of positive opinion for Recarbrio (EMA/VR/0000265089)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:30:09Z", "last_update_date": "2025-12-12T14:30:09Z", "reference_number": "EMADOC-1700519818-2608675", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-recarbrio-ema-vr-0000265089_en.pdf"}, {"id": "71687", "name": "CHMP post-authorisation summary of positive opinion for Aspaveli (EMA/VR/0000248937)", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T13:46:14Z", "last_update_date": "2025-12-12T13:46:14Z", "reference_number": "EMADOC-1700519818-2607912", "url": "https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-aspaveli-ema-vr-0000248937_en.pdf"}, {"id": "59896", "name": "Checklist for the submission of day +5 translations for a post-opinion linguistic review - veterinary", "type": "template-form", "status": "unknown", "consultation_date": "", "publish_date": "2023-09-05T11:20:00Z", "last_update_date": "2025-12-12T13:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/template-form/checklist-submission-day-5-translations-post-opinion-linguistic-review-veterinary_en.docx"}, {"id": "71734", "name": "Presentation - Actions arising from previous meeting and other updates (M. Filancia, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:35:22Z", "last_update_date": "2025-12-12T14:35:22Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-actions-arising-previous-meeting-other-updates-m-filancia-ema_en.pdf-1"}, {"id": "71735", "name": "Presentation - New pharmaceutical legislation update : engagement with industry during implementation (M. Carr, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:38:15Z", "last_update_date": "2025-12-12T14:38:15Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-new-pharmaceutical-legislation-update-engagement-industry-during-implementation-m-carr-ema_en.pdf"}, {"id": "71736", "name": "Presentation - Regulatory / HTA interface under the HTAR – update on implementation activities (N. Manent & D. Karres, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:41:16Z", "last_update_date": "2025-12-12T14:41:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-regulatory-hta-interface-under-htar-update-implementation-activities-n-manent-d-karres-ema_en.pdf"}, {"id": "71737", "name": "Presentation - HTA Regulation (V. Barbuto, EC)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:43:26Z", "last_update_date": "2025-12-12T14:43:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-hta-regulation-v-barbuto-ec_en.pdf"}, {"id": "71738", "name": "Presentation - Publication of information in CVMP agenda and minutes (S. Ribeiro & T. Ferreira, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:44:45Z", "last_update_date": "2025-12-12T14:44:45Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-publication-information-cvmp-agenda-minutes-s-ribeiro-t-ferreira-ema_en.pdf"}, {"id": "71739", "name": "Presentation - OPEN framework (N. Perombelon, H. Cuenca & R. Cherif, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:46:04Z", "last_update_date": "2025-12-12T14:46:04Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-open-framework-n-perombelon-h-cuenca-r-cherif-ema_en.pdf"}, {"id": "71740", "name": "Presentation - Update on Product Management Service (PMS) (H. Hamann & I. Chicharo, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:48:35Z", "last_update_date": "2025-12-12T14:48:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-update-product-management-service-pms-h-hamann-i-chicharo-ema_en.pdf"}, {"id": "71741", "name": "Presentation - Industry stakeholders feedback on engagement and communication activities (M. Filancia, EMA)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T14:49:53Z", "last_update_date": "2025-12-12T14:49:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-industry-stakeholders-feedback-engagement-communication-activities-m-filancia-ema_en.pdf"}, {"id": "13922", "name": "Clopidogrel Viatris : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2010-03-10T01:00:00Z", "last_update_date": "2025-12-12T14:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/clopidogrel-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "38319", "name": "Clopidogrel Viatris : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-11-09T01:00:00Z", "last_update_date": "2025-12-12T14:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/clopidogrel-viatris-epar-product-information_en.pdf"}, {"id": "71742", "name": "Clopidogrel Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T15:22:27Z", "last_update_date": "2025-12-12T15:22:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/clopidogrel-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "56779", "name": "Mounjaro : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-17T09:01:00Z", "last_update_date": "2025-12-11T13:40:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mounjaro-epar-product-information_en.pdf"}, {"id": "71743", "name": "Biomarkers in oncology indications approved in the EU: key facts", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-12T16:30:00Z", "last_update_date": "2025-12-12T16:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/biomarkers-oncology-indications-approved-eu-key-facts_en.pdf"}, {"id": "71746", "name": "Work plan for the Committee for Veterinary Medicinal Products (CVMP) Antimicrobials Working Party (AWP) 2026", "type": "work-programme", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T16:43:30Z", "last_update_date": "2025-12-12T16:43:30Z", "reference_number": "EMA/CVMP/AWP/289168/2025", "url": "https://www.ema.europa.eu/en/documents/work-programme/work-plan-committee-veterinary-medicinal-products-cvmp-antimicrobials-working-party-awp-2026_en.pdf"}, {"id": "71747", "name": "Minutes of the CVMP meeting 4-6 November 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T16:53:48Z", "last_update_date": "2025-12-12T16:53:48Z", "reference_number": "EMA/380332/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-cvmp-meeting-4-6-november-2025_en.pdf"}, {"id": "68019", "name": "CTIS Simplification Task Force: topics for analysis", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-29T16:04:59Z", "last_update_date": "2025-12-12T16:40:46Z", "reference_number": "EMA/121136/2025", "url": "https://www.ema.europa.eu/en/documents/other/ctis-simplification-task-force-topics-analysis_en.pdf"}, {"id": "32163", "name": "Levetiracetam Hospira : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2014-01-20T01:00:00Z", "last_update_date": "2025-12-15T14:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/levetiracetam-hospira-epar-product-information_en.pdf"}, {"id": "68230", "name": "Levetiracetam Hospira : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-12T15:00:08Z", "last_update_date": "2025-12-15T10:17:56Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/levetiracetam-hospira-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "16524", "name": "Repatha : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2016-07-08T02:00:00Z", "last_update_date": "2025-12-15T12:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/repatha-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "34269", "name": "Repatha : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-08-03T02:00:00Z", "last_update_date": "2025-12-15T12:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/repatha-epar-product-information_en.pdf"}, {"id": "71752", "name": "Repatha : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-15T09:29:14Z", "last_update_date": "2025-12-15T09:29:14Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/repatha-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "7390", "name": "European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2017-02-07T12:30:00Z", "last_update_date": "2025-12-15T10:50:00Z", "reference_number": "EMA/821278/2015", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-pre-authorisation-procedural-advice-users-centralised-procedure-document-tracked-changes_en.pdf"}, {"id": "2846", "name": "European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-31T02:00:00Z", "last_update_date": "2025-12-15T10:50:00Z", "reference_number": "EMA/821278/2015", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-pre-authorisation-procedural-advice-users-centralised-procedure_en.pdf"}, {"id": "25112", "name": "European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2013-12-09T10:30:00Z", "last_update_date": "2025-12-15T12:05:00Z", "reference_number": "EMEA-H-19984/03 Rev. 115", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure-document-tracked-changes_en.pdf"}, {"id": "35439", "name": "European Medicines Agency post-authorisation procedural advice for users of the centralised procedure", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-01T02:00:00Z", "last_update_date": "2025-12-15T12:05:00Z", "reference_number": "EMEA-H-19984/03 Rev. 115", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure_en.pdf"}, {"id": "11617", "name": "Remicade : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-11-24T01:00:00Z", "last_update_date": "2025-12-15T13:59:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/remicade-epar-product-information_en.pdf"}, {"id": "64652", "name": "Remicade : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-08-29T17:00:26Z", "last_update_date": "2025-12-15T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/remicade-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "68565", "name": "Remicade : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-04T10:43:52Z", "last_update_date": "2025-12-15T12:48:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/remicade-epar-product-information-tracked-changes_en.docx"}, {"id": "18233", "name": "Coagadex : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2016-04-04T02:00:00Z", "last_update_date": "2025-12-15T16:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/coagadex-epar-product-information_en.pdf"}, {"id": "67102", "name": "Coagadex : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-04T14:44:05Z", "last_update_date": "2025-12-15T14:20:32Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/coagadex-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "50970", "name": "Retsevmo : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-23T16:01:00Z", "last_update_date": "2025-12-15T11:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/retsevmo-epar-product-information_en.pdf"}, {"id": "68442", "name": "Retsevmo : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-23T19:34:56Z", "last_update_date": "2025-12-15T15:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/retsevmo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "50973", "name": "Retsevmo : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-23T16:08:00Z", "last_update_date": "2025-12-15T11:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/retsevmo-epar-risk-management-plan_en.pdf"}, {"id": "61627", "name": "Agamree : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-01-04T14:26:31Z", "last_update_date": "2025-12-16T16:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/agamree-epar-product-information_en.pdf"}, {"id": "63205", "name": "Agamree : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-13T16:29:00Z", "last_update_date": "2025-12-16T12:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/agamree-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71762", "name": "Agamree : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:19:07Z", "last_update_date": "2025-12-16T08:19:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/agamree-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "67446", "name": "Agamree : EPAR - Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-25T16:52:21Z", "last_update_date": "2025-12-16T08:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/agamree-epar-product-information-tracked-changes_en.docx"}, {"id": "49673", "name": "Libmeldy : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2020-12-22T11:01:00Z", "last_update_date": "2025-12-16T16:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/libmeldy-epar-product-information_en.pdf"}, {"id": "69535", "name": "Libmeldy : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-28T14:19:29Z", "last_update_date": "2025-12-16T15:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/libmeldy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "8689", "name": "Cholib : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-09-18T02:00:00Z", "last_update_date": "2025-12-16T10:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/cholib-epar-product-information_en.pdf"}, {"id": "21306", "name": "Cholib : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2014-04-09T02:00:00Z", "last_update_date": "2025-12-16T10:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cholib-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71763", "name": "Cholib : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:30:30Z", "last_update_date": "2025-12-16T08:30:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cholib-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "45055", "name": "Ambrisentan Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2019-07-15T10:03:00Z", "last_update_date": "2025-12-16T10:38:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ambrisentan-viatris-epar-product-information_en.pdf"}, {"id": "47092", "name": "Ambrisentan Viatris : EPAR - Procedural steps taken and scientific information after the authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2020-03-20T17:26:00Z", "last_update_date": "2025-12-16T10:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ambrisentan-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71764", "name": "Ambrisentan Viatris : EPAR - Procedural steps taken and scientific information after the authorisation ", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:35:23Z", "last_update_date": "2025-12-16T08:35:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ambrisentan-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "17262", "name": "Trisenox : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-10-08T02:09:00Z", "last_update_date": "2025-12-16T01:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/trisenox-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "15027", "name": "Trisenox : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-10-08T02:09:00Z", "last_update_date": "2025-12-16T01:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/trisenox-epar-product-information_en.pdf"}, {"id": "71765", "name": "Trisenox : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:41:07Z", "last_update_date": "2025-12-16T08:41:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/trisenox-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71766", "name": "Trisenox : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T08:42:55Z", "last_update_date": "2025-12-16T08:42:55Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/trisenox-epar-product-information-tracked-changes_en.docx"}, {"id": "41149", "name": "Protopic : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-06T02:00:00Z", "last_update_date": "2025-12-16T12:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/protopic-epar-product-information_en.pdf"}, {"id": "20642", "name": "Opsumit : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2014-02-07T12:47:00Z", "last_update_date": "2025-12-16T14:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/opsumit-epar-product-information_en.pdf"}, {"id": "67633", "name": "\tOpsumit : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-04T13:01:04Z", "last_update_date": "2025-12-16T09:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/opsumit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "10278", "name": "Cyanokit : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-04-20T02:00:00Z", "last_update_date": "2025-12-16T14:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cyanokit-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "14307", "name": "Cyanokit : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-04-20T02:00:00Z", "last_update_date": "2025-12-16T14:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/cyanokit-epar-product-information_en.pdf"}, {"id": "71767", "name": "Cyanokit : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:29:35Z", "last_update_date": "2025-12-16T09:29:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/cyanokit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "60989", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 23-26 October PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2023-11-20T13:42:36Z", "last_update_date": "2025-12-16T09:35:12Z", "reference_number": "EMA/PRAC/477437/2023", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-23-26-october-prac_en.pdf"}, {"id": "23101", "name": "Pramipexole Teva : EPAR - Summary for the public", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2009-03-10T01:00:00Z", "last_update_date": "2025-12-16T09:34:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/overview/pramipexole-teva-epar-summary-public_en.pdf"}, {"id": "62004", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 8-11 January 2024 PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2024-02-05T16:13:47Z", "last_update_date": "2025-12-16T09:45:12Z", "reference_number": "EMA/PRAC/2749/2024", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-8-11-january-2024-prac_en.pdf"}, {"id": "71768", "name": "Opsumit : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:46:55Z", "last_update_date": "2025-12-16T09:46:55Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/opsumit-epar-product-information-tracked-changes_en.docx"}, {"id": "61643", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 27-30 November 2023 PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2024-01-05T15:12:46Z", "last_update_date": "2025-12-16T09:45:10Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-27-30-november-2023-prac_en.pdf"}, {"id": "62773", "name": "New product information wording – Extracts from PRAC recommendations on signals adopted at the 4-7 March 2024 PRAC", "type": "prac-recommendation", "status": "unknown", "consultation_date": "", "publish_date": "2024-04-02T11:15:27Z", "last_update_date": "2025-12-16T09:48:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/prac-recommendation/new-product-information-wording-extracts-prac-recommendations-signals-adopted-4-7-march-2024-prac_en.pdf"}, {"id": "71769", "name": "Ventavis : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:51:58Z", "last_update_date": "2025-12-16T09:51:58Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ventavis-epar-risk-management-plan_en.pdf"}, {"id": "41137", "name": "Ventavis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-03T03:00:00Z", "last_update_date": "2025-12-16T14:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ventavis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71770", "name": "Ventavis : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T09:57:21Z", "last_update_date": "2025-12-16T09:57:21Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ventavis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "10180", "name": "Quality Review of Documents (QRD) working group plenary meeting dates", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2023-12-05T16:18:00Z", "last_update_date": "2025-12-16T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/quality-review-documents-qrd-working-group-plenary-meeting-dates_en.pdf"}, {"id": "55873", "name": "Sunlenca : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-08-25T14:42:00Z", "last_update_date": "2025-12-16T15:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/sunlenca-epar-product-information_en.pdf"}, {"id": "59097", "name": "Sunlenca : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2023-06-27T08:40:00Z", "last_update_date": "2025-12-16T15:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/sunlenca-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71771", "name": "Sunlenca : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T10:33:24Z", "last_update_date": "2025-12-16T10:33:24Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/sunlenca-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71772", "name": "Start of procedure: Extension of marketing authorisation (14 November - 11 December 2025)", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T10:33:58Z", "last_update_date": "2025-12-16T10:33:58Z", "reference_number": "EMA/392654/2025", "url": "https://www.ema.europa.eu/en/documents/report/start-procedure-extension-marketing-authorisation-14-november-11-december-2025_en.xlsx"}, {"id": "71773", "name": "Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (14 November - 11 December 2025)", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T10:36:46Z", "last_update_date": "2025-12-16T10:36:46Z", "reference_number": "EMA/392653/2025", "url": "https://www.ema.europa.eu/en/documents/report/start-procedure-type-ii-variation-extension-indication-under-evaluation-chmp-14-november-11-december-2025_en.xlsx"}, {"id": "50889", "name": "Kesimpta : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-16T15:26:00Z", "last_update_date": "2025-12-16T09:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/kesimpta-epar-product-information_en.pdf"}, {"id": "51347", "name": "Kesimpta : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2021-06-02T16:08:00Z", "last_update_date": "2025-12-16T09:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/kesimpta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71774", "name": "Kesimpta : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T11:46:39Z", "last_update_date": "2025-12-16T11:46:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/kesimpta-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "3041", "name": "Erelzi : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-06-29T02:00:00Z", "last_update_date": "2025-12-16T16:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/erelzi-epar-product-information_en.pdf"}, {"id": "71324", "name": "Erelzi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-25T09:29:03Z", "last_update_date": "2025-12-16T12:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/erelzi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "45861", "name": "Erelzi : EPAR - Risk-management-plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2019-10-30T16:50:00Z", "last_update_date": "2025-12-16T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/erelzi-epar-risk-management-plan_en.pdf"}, {"id": "70177", "name": "Questions and answers on the withdrawal of application for the marketing authorisation of Omforro (midazolam)", "type": "medicine-qa", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-19T08:47:25Z", "last_update_date": "2025-12-16T12:38:08Z", "reference_number": "EMA/300796/2025", "url": "https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-withdrawal-application-marketing-authorisation-omforro-midazolam_en.pdf"}, {"id": "71776", "name": "Withdrawal assessment report for Omforro", "type": "withdrawal-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T12:37:32Z", "last_update_date": "2025-12-16T12:37:32Z", "reference_number": "EMADOC-1829012207-24322", "url": "https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-omforro_en.pdf"}, {"id": "50813", "name": "Seffalair Spiromax : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-04-13T16:39:00Z", "last_update_date": "2025-12-16T11:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/seffalair-spiromax-epar-product-information_en.pdf"}, {"id": "67621", "name": "Seffalair Spiromax : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-03T13:31:19Z", "last_update_date": "2025-12-16T13:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/seffalair-spiromax-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71777", "name": "Seffalair Spiromax : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T12:58:12Z", "last_update_date": "2025-12-16T12:58:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/seffalair-spiromax-epar-product-information-tracked-changes_en.docx"}, {"id": "71779", "name": "EMA/PE/0000221500 : EMA decision of 5 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for Phleum pratense pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:17:09Z", "last_update_date": "2025-12-16T13:17:09Z", "reference_number": "EMADOC-1700519818-1792191", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221500-ema-decision-5-december-2024-refusal-paediatric-investigation-plan-granting-waiver-phleum-pratense-pollen-extract_en.pdf"}, {"id": "71780", "name": "EMA/PE/0000221511 : EMA decision of 6 December 2024 on the granting of a product specific waiver for recombinant human apolipoprotein A-I", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:34:48Z", "last_update_date": "2025-12-16T13:34:48Z", "reference_number": "EMADOC-1700519818-1793267", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221511-ema-decision-6-december-2024-granting-product-specific-waiver-recombinant-human-apolipoprotein-i_en.pdf"}, {"id": "71781", "name": "EMA/PE/0000221664 : EMA decision of 6 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for parietaria judaica pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:45:06Z", "last_update_date": "2025-12-16T13:45:06Z", "reference_number": "EMADOC-1700519818-1793193", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221664-ema-decision-6-december-2024-refusal-paediatric-investigation-plan-granting-waiver-parietaria-judaica-pollen-extract_en.pdf"}, {"id": "71782", "name": "EMA/PE/0000221674 : EMA decision of 6 December 2024 on the granting of a product specific waiver for xaluritamig", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:54:35Z", "last_update_date": "2025-12-16T13:54:35Z", "reference_number": "EMADOC-1700519818-1793219", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221674-ema-decision-6-december-2024-granting-product-specific-waiver-xaluritamig_en.pdf"}, {"id": "71783", "name": "EMA/PE/0000221695 : EMA decision of 5 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for Cupressus arizonica pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T14:07:28Z", "last_update_date": "2025-12-16T14:07:28Z", "reference_number": "EMADOC-1700519818-1792235", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221695-ema-decision-5-december-2024-refusal-paediatric-investigation-plan-granting-waiver-cupressus-arizonica-pollen-extract_en.pdf"}, {"id": "71784", "name": "EMA/PE/0000221772 : EMA decision of 6 December 2024 on the refusal of a paediatric investigation plan and on the granting of a waiver for Olea europaea pollen extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T14:10:37Z", "last_update_date": "2025-12-16T14:10:37Z", "reference_number": "EMADOC-1700519818-1790725", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221772-ema-decision-6-december-2024-refusal-paediatric-investigation-plan-granting-waiver-olea-europaea-pollen-extract_en.pdf"}, {"id": "71785", "name": "EMA/PE/0000221419 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for Pneumococcal Polysaccharide Serotype 3 – Diphtheria CRM197 Conjugate...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T14:39:47Z", "last_update_date": "2025-12-16T14:39:47Z", "reference_number": "EMADOC-1700519818-1793577", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221419-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-pneumococcal-polysaccharide-serotype-3-diphtheria-crm197-conjugate_en.pdf"}, {"id": "68471", "name": "Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025", "type": "regulatory-procedural-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-05-27T14:36:42Z", "last_update_date": "2025-12-16T09:52:00Z", "reference_number": "EMA/CVMP/PhVWP/101663/2025", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/pharmacovigilance-related-regulatory-recommendations-centrally-authorised-veterinary-medicinal-products-during-2025_en.pdf"}, {"id": "20750", "name": "Matever : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-10-14T02:00:00Z", "last_update_date": "2025-12-16T17:09:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/matever-epar-product-information_en.pdf"}, {"id": "68326", "name": "Matever : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-16T14:40:34Z", "last_update_date": "2025-12-16T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/matever-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "54337", "name": "Ngenla : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-03-02T17:13:00Z", "last_update_date": "2025-12-16T10:29:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ngenla-epar-product-information_en.pdf"}, {"id": "67939", "name": "Ngenla : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-23T14:53:36Z", "last_update_date": "2025-12-16T15:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ngenla-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "60698", "name": "Pradaxa : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-03-22T14:24:00Z", "last_update_date": "2025-12-16T14:02:24Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/pradaxa-epar-risk-management-plan_en.pdf"}, {"id": "71786", "name": "EMA/PE/0000221485 : EMA decision of 6 December 2024 on the refusal of a modification of an agreed paediatric investigation plan for cangrelor tetrasodium (Kengrexal)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T15:18:03Z", "last_update_date": "2025-12-16T15:18:03Z", "reference_number": "EMADOC-1700519818-1792970", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221485-ema-decision-6-december-2024-refusal-modification-agreed-paediatric-investigation-plan-cangrelor-tetrasodium-kengrexal_en.pdf"}, {"id": "71778", "name": "EMA/PE/0000221424 : EMA decision of 6 December 2024 on the refusal of a paediatric investigation plan and on the granting of a product-specific waiver for dermatophagoides pteronyssinus extract", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T13:01:14Z", "last_update_date": "2025-12-16T13:01:14Z", "reference_number": "EMADOC-1700519818-1793274", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221424-ema-decision-6-december-2024-refusal-paediatric-investigation-plan-granting-product-specific-waiver-dermatophagoides-pteronyssinus-extract_en.pdf"}, {"id": "71787", "name": "EMA/PE/0000221199 : EMA decision of 6 December 2024 on the granting of a product specific waiver for bemcentinib", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-16T15:25:05Z", "last_update_date": "2025-12-16T15:25:05Z", "reference_number": "EMADOC-1700519818-1793576", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221199-ema-decision-6-december-2024-granting-product-specific-waiver-bemcentinib_en.pdf"}, {"id": "71757", "name": "Overview of comments received on ICH M11 guideline", "type": "comments", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-15T17:17:52Z", "last_update_date": "2025-12-15T17:17:52Z", "reference_number": "EMA/CHMP/ICH/116369/2023", "url": "https://www.ema.europa.eu/en/documents/comments/overview-comments-received-ich-m11-guideline_en.pdf-0"}, {"id": "71759", "name": "Overview of comments received on ICH M11 technical specification", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-15T17:22:34Z", "last_update_date": "2025-12-15T17:22:34Z", "reference_number": "EMA/CHMP/ICH/118288/2023", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/overview-comments-received-ich-m11-technical-specification_en.pdf"}, {"id": "71761", "name": "Overview of comments received on ICH M11 template", "type": "comments", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-15T17:33:34Z", "last_update_date": "2025-12-15T17:33:34Z", "reference_number": "EMA/CHMP/ICH/118289/2023", "url": "https://www.ema.europa.eu/en/documents/comments/overview-comments-received-ich-m11-template_en.pdf-0"}, {"id": "71788", "name": "eCTD v4.0 and EURSnext roadmap", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:46:04Z", "last_update_date": "2025-12-16T15:46:04Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/ectd-v40-eursnext-roadmap_en.pdf"}, {"id": "71750", "name": "Factsheet - Network reporting via the European Shortages Monitoring Platform (ESMP) during an MSSG-led preparedness action", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:57:00Z", "last_update_date": "2025-12-16T15:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-network-reporting-european-shortages-monitoring-platform-esmp-during-mssg-led-preparedness-action_en.pdf"}, {"id": "71749", "name": "Factsheet - Network reporting via the European Shortages Monitoring Platform (ESMP) during a crisis", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:58:00Z", "last_update_date": "2025-12-16T15:58:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-network-reporting-european-shortages-monitoring-platform-esmp-during-crisis_en.pdf"}, {"id": "71748", "name": "Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) during a crisis or MSSG-led preparedness action", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T19:57:07Z", "last_update_date": "2025-12-16T19:57:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-industry-reporting-european-shortages-monitoring-platform-esmp-during-crisis-or-mssg-led-preparedness-action_en.pdf"}, {"id": "63569", "name": "European Shortages Monitoring Platform (ESMP) Informational brief", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-11T13:48:32Z", "last_update_date": "2025-12-16T16:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/european-shortages-monitoring-platform-esmp-informational-brief_en.pdf"}, {"id": "64375", "name": "Frequently asked questions on the European Shortages Monitoring Platform (ESMP)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2024-07-31T16:55:00Z", "last_update_date": "2025-12-16T18:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/frequently-asked-questions-european-shortages-monitoring-platform-esmp_en.pdf"}, {"id": "71789", "name": "Rivaroxaban Koanaa : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:32:56Z", "last_update_date": "2025-12-17T08:32:56Z", "reference_number": "EMA/319706/2025", "url": "https://www.ema.europa.eu/en/documents/overview/rivaroxaban-koanaa-epar-medicine-overview_en.pdf"}, {"id": "71790", "name": "Rivaroxaban Koanaa : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:34:11Z", "last_update_date": "2025-12-17T08:34:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/rivaroxaban-koanaa-epar-risk-management-plan_en.pdf"}, {"id": "71791", "name": "Rivaroxaban Koanaa : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:35:16Z", "last_update_date": "2025-12-17T08:35:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/rivaroxaban-koanaa-epar-product-information_en.pdf"}, {"id": "71792", "name": "Rivaroxaban Koanaa : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T08:36:21Z", "last_update_date": "2025-12-17T08:36:21Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/rivaroxaban-koanaa-epar-all-authorised-presentations_en.pdf"}, {"id": "71793", "name": "Rivaroxaban Koanaa : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T08:37:16Z", "last_update_date": "2025-12-17T08:37:16Z", "reference_number": "EMA/335639/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/rivaroxaban-koanaa-epar-public-assessment-report_en.pdf"}, {"id": "68248", "name": "Datroway : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-13T10:01:05Z", "last_update_date": "2025-12-17T15:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/datroway-epar-product-information_en.pdf"}, {"id": "68928", "name": "Datroway : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-24T15:20:38Z", "last_update_date": "2025-12-17T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/datroway-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71794", "name": "Rapiscan : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T09:25:16Z", "last_update_date": "2025-12-17T09:25:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/rapiscan-epar-risk-management-plan_en.pdf"}, {"id": "69946", "name": "Rapiscan : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-03T15:39:46Z", "last_update_date": "2025-12-17T09:26:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/rapiscan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "15182", "name": "Tasigna : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-29T02:09:00Z", "last_update_date": "2025-12-17T17:21:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tasigna-epar-product-information_en.pdf"}, {"id": "19599", "name": "Tasigna : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-10-08T02:09:00Z", "last_update_date": "2025-12-17T17:13:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tasigna-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71795", "name": "Tasigna : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T09:58:40Z", "last_update_date": "2025-12-17T09:58:40Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tasigna-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71796", "name": "Programme - eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course 2026", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T10:08:23Z", "last_update_date": "2025-12-17T10:08:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/programme-extended-eudravigilance-medicinal-product-dictionary-xevmpd-training-course-2026_en.pdf"}, {"id": "71797", "name": "Programme - eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course for sponsors 2026", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T10:19:52Z", "last_update_date": "2025-12-17T10:19:52Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/agenda/programme-extended-eudravigilance-medicinal-product-dictionary-xevmpd-training-course-sponsors-2026_en.pdf"}, {"id": "71798", "name": "EMA/PE/0000181219: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for bedaquiline (fumarate) (Sirturo)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T11:30:47Z", "last_update_date": "2025-12-17T11:30:47Z", "reference_number": "EMADOC-1700519818-1775423", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181219-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-bedaquiline-fumarate-sirturo_en.pdf"}, {"id": "71799", "name": "EMA/PE/0000181236: EMA decision of 5 December 2024 on the granting of a product specific waiver for telisotuzumab conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g] ...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T11:48:05Z", "last_update_date": "2025-12-17T11:48:05Z", "reference_number": "EMADOC-1700519818-1791510", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181236-ema-decision-5-december-2024-granting-product-specific-waiver-telisotuzumab-conjugated-2s-2-2-bromoacetamido-n-2s-1-3-7s-7-ethyl-7-hydroxy-811-dioxo-781113-tetrahydro-2h10h_en.pdf"}, {"id": "11377", "name": "Adjupanrix : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-12-17T01:00:00Z", "last_update_date": "2025-12-17T01:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/adjupanrix-epar-product-information_en.pdf"}, {"id": "14742", "name": "Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-12-21T01:00:00Z", "last_update_date": "2025-12-17T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/adjupanrix-previously-pandemic-influenza-vaccine-h5n1-split-virion-inactivated-adjuvanted-glaxosmithkline-biologicals-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71800", "name": "Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T12:04:29Z", "last_update_date": "2025-12-17T12:04:29Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/adjupanrix-previously-pandemic-influenza-vaccine-h5n1-split-virion-inactivated-adjuvanted-glaxosmithkline-biologicals-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71801", "name": "EMA/PE/0000181238: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a waiver for resiquimod", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:07:40Z", "last_update_date": "2025-12-17T12:07:40Z", "reference_number": "EMADOC-1700519818-1775491", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181238-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-waiver-resiquimod_en.pdf"}, {"id": "71802", "name": "EMA/PE/0000181294: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for tolebrutinib", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:23:45Z", "last_update_date": "2025-12-17T12:23:45Z", "reference_number": "EMADOC-1700519818-1766802", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181294-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-tolebrutinib_en.pdf"}, {"id": "71803", "name": "EMA/PE/0000181300: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for avalglucosidase alfa (Nexviadyme)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:31:22Z", "last_update_date": "2025-12-17T12:31:22Z", "reference_number": "EMADOC-1700519818-1793517", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181300-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-avalglucosidase-alfa-nexviadyme_en.pdf"}, {"id": "71751", "name": "Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) in normal circumstances", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-16T15:54:00Z", "last_update_date": "2025-12-16T15:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/factsheet-industry-reporting-european-shortages-monitoring-platform-esmp-normal-circumstances_en.pdf"}, {"id": "71804", "name": "EMA/PE/0000221175 : EMA decision of 16 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for vibegron", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:57:00Z", "last_update_date": "2025-12-17T12:57:00Z", "reference_number": "EMADOC-1700519818-1807888", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221175-ema-decision-16-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-vibegron_en.pdf"}, {"id": "19866", "name": "QRD Appendix V - Adverse-drug-reaction reporting details", "type": "template-form", "status": "unknown", "consultation_date": "", "publish_date": "2013-03-15T17:00:00Z", "last_update_date": "2025-12-17T13:20:00Z", "reference_number": "EMA/67830/2013 Version 34", "url": "https://www.ema.europa.eu/en/documents/template-form/qrd-appendix-v-adverse-drug-reaction-reporting-details_en.docx"}, {"id": "56226", "name": "Agenda - ACT EU multi-stakeholder meeting on decentralised clinical trials", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-28T10:58:00Z", "last_update_date": "2025-12-17T15:50:00Z", "reference_number": "EMA/789028/2022", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-act-eu-multi-stakeholder-meeting-decentralised-clinical-trials_en.pdf"}, {"id": "71806", "name": "Oxbryta Article-20 procedure - Assessment report", "type": "referral", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:01:49Z", "last_update_date": "2025-12-17T14:01:49Z", "reference_number": "EMA/354175/2025", "url": "https://www.ema.europa.eu/en/documents/referral/oxbryta-article-20-procedure-assessment-report_en.pdf"}, {"id": "71807", "name": "EMA/PE/0000220986 : EMA decision of 6 December 2024 on the granting of a product specific waiver for tenapanor", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:15:21Z", "last_update_date": "2025-12-17T14:15:21Z", "reference_number": "EMADOC-1700519818-1793255 Corr", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000220986-ema-decision-6-december-2024-granting-product-specific-waiver-tenapanor_en.pdf"}, {"id": "71808", "name": "EMA/PE/0000221021 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for atazanavir (sulphate) / cobicistat (EVOTAZ)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:19:52Z", "last_update_date": "2025-12-17T14:19:52Z", "reference_number": "EMADOC-1700519818-1793575", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221021-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-atazanavir-sulphate-cobicistat-evotaz_en.pdf"}, {"id": "71809", "name": "EMA/PE/0000181335: EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for budesonide / glycopyrronium bromide / formoterol (fumarate) (Trixeo Aerosphere)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:21:24Z", "last_update_date": "2025-12-17T14:21:24Z", "reference_number": "EMADOC-1700519818-1791535", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181335-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-budesonide-glycopyrronium-bromide-formoterol-fumarate-trixeo-aerosphere_en.pdf"}, {"id": "71810", "name": "EMA/PE/0000181441: EMA decision of 6 December 2024 on the granting of a product specific waiver for telisotuzumab conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g] ...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:27:14Z", "last_update_date": "2025-12-17T14:27:14Z", "reference_number": "EMADOC-1700519818-1793529", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181441-ema-decision-6-december-2024-granting-product-specific-waiver-telisotuzumab-conjugated-2s-2-2-bromoacetamido-n-2s-1-3-7s-7-ethyl-7-hydroxy-811-dioxo-781113-tetrahydro-2h10h_en.pdf"}, {"id": "71811", "name": "EMA/PE/0000221101 : EMA decision of 5 December 2024 on the granting of a product specific waiver for esepapogene zalarnarepvec", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:29:02Z", "last_update_date": "2025-12-17T14:29:02Z", "reference_number": "EMADOC-1700519818-1791979", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221101-ema-decision-5-december-2024-granting-product-specific-waiver-esepapogene-zalarnarepvec_en.pdf"}, {"id": "71812", "name": "EMA/PE/0000181518: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for lerodalcibep", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:34:07Z", "last_update_date": "2025-12-17T14:34:07Z", "reference_number": "EMADOC-1700519818-1766926", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181518-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-lerodalcibep_en.pdf"}, {"id": "71813", "name": "EMA/PE/0000221751 : EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for ascorbic acid, macrogol 3350, potassium chloride, sodium ascorbate, sodium chloride, sodium sulphate (Plenvu)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:41:20Z", "last_update_date": "2025-12-17T14:41:20Z", "reference_number": "EMADOC-1700519818-1792265", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221751-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-ascorbic-acid-macrogol-3350-potassium-chloride-sodium-ascorbate-sodium-chloride-sodium_en.pdf"}, {"id": "43389", "name": "Ocrevus : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-11-10T15:51:00Z", "last_update_date": "2025-12-17T16:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ocrevus-epar-risk-management-plan_en.pdf"}, {"id": "68135", "name": "Ocrevus : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-06T18:32:15Z", "last_update_date": "2025-12-17T15:18:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ocrevus-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71814", "name": "EMA/PE/0000181778: EMA decision of 6 December 2024 on the granting of a product specific waiver for rilvegostomig", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:50:39Z", "last_update_date": "2025-12-17T14:50:39Z", "reference_number": "EMADOC-1700519818-1793273", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181778-ema-decision-6-december-2024-granting-product-specific-waiver-rilvegostomig_en.pdf"}, {"id": "10225", "name": "Entyvio : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2014-06-16T02:00:00Z", "last_update_date": "2025-12-17T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/entyvio-epar-all-authorised-presentations_en.pdf"}, {"id": "36026", "name": "Entyvio : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2014-06-16T12:00:00Z", "last_update_date": "2025-12-17T09:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/entyvio-epar-product-information_en.pdf"}, {"id": "67249", "name": "Entyvio : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-13T12:16:27Z", "last_update_date": "2025-12-17T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/entyvio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71815", "name": "EMA/PE/0000182170: EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for regorafenib (Stivarga)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:09:08Z", "last_update_date": "2025-12-17T15:09:08Z", "reference_number": "EMADOC-1700519818-1791595", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182170-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-regorafenib-stivarga_en.pdf"}, {"id": "71816", "name": "EMA/PE/0000182217: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for cedazuridine / decitabine (Inaqovi)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:15:58Z", "last_update_date": "2025-12-17T15:15:58Z", "reference_number": "EMADOC-1700519818-1789714", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182217-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-cedazuridine-decitabine-inaqovi_en.pdf"}, {"id": "71817", "name": "EMA/PE/0000182239: EMA decision of 19 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for setmelanotide (Imcivree) ", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:21:52Z", "last_update_date": "2025-12-17T15:21:52Z", "reference_number": "EMADOC-1700519818-1796893", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182239-ema-decision-19-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-setmelanotide-imcivree_en.pdf"}, {"id": "71818", "name": "EMA/PE/0000182297: EMA decision of 6 December 2024 on the granting of a product specific waiver for oxybutynin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:26:23Z", "last_update_date": "2025-12-17T15:26:23Z", "reference_number": "EMADOC-1700519818-1790205", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182297-ema-decision-6-december-2024-granting-product-specific-waiver-oxybutynin_en.pdf"}, {"id": "71819", "name": "EMA/PE/0000182333: EMA decision of 6 December 2024 on the granting of a product specific waiver for precemtabart tocentecan", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:32:37Z", "last_update_date": "2025-12-17T15:32:37Z", "reference_number": "EMADOC-1700519818-1789267", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182333-ema-decision-6-december-2024-granting-product-specific-waiver-precemtabart-tocentecan_en.pdf"}, {"id": "9718", "name": "Trumenba : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-06-06T02:00:00Z", "last_update_date": "2025-12-17T15:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/trumenba-epar-product-information_en.pdf"}, {"id": "67770", "name": "Trumenba : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-14T10:47:33Z", "last_update_date": "2025-12-17T16:29:38Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/trumenba-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71820", "name": "EMA/PE/0000182345: EMA decision of 6 December 2024 on the granting of a product specific waiver for inbakicept, nogapendekin alfa", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:40:57Z", "last_update_date": "2025-12-17T15:40:57Z", "reference_number": "EMADOC-1700519818-1790021", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182345-ema-decision-6-december-2024-granting-product-specific-waiver-inbakicept-nogapendekin-alfa_en.pdf"}, {"id": "71756", "name": "ICH M11 Guideline on clinical electronic structured harmonised protocol (CeSHarP) step 5", "type": "regulatory-procedural-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-15T17:16:04Z", "last_update_date": "2025-12-15T17:16:04Z", "reference_number": "EMA/CHMP/ICH/778799/2022", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ich-m11-guideline-clinical-electronic-structured-harmonised-protocol-cesharp-step-5_en.pdf"}, {"id": "71758", "name": "ICH M11 Clinical electronic structured harmonised protocol (CeSHarP) - Technical specification step 5", "type": "regulatory-procedural-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-15T17:20:28Z", "last_update_date": "2025-12-15T17:20:28Z", "reference_number": "EMA/CHMP/ICH/778800/2022", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ich-m11-clinical-electronic-structured-harmonised-protocol-cesharp-technical-specification-step-5_en.pdf"}, {"id": "71760", "name": "ICH M11 Clinical electronic structured harmonised protocol (CeSHarP) – Template step 5", "type": "template-form", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-15T17:32:15Z", "last_update_date": "2025-12-15T17:32:15Z", "reference_number": "EMA/CHMP/ICH/778801/2022", "url": "https://www.ema.europa.eu/en/documents/template-form/ich-m11-clinical-electronic-structured-harmonised-protocol-cesharp-template-step-5_en.pdf"}, {"id": "71821", "name": "Overview of (invented) names reviewed in November 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 11 December 2025", "type": "chmp-annex", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:58:28Z", "last_update_date": "2025-12-17T15:58:28Z", "reference_number": "EMA/394227/2025", "url": "https://www.ema.europa.eu/en/documents/chmp-annex/overview-invented-names-reviewed-november-2025-name-review-group-nrg-adopted-chmp-meeting-11-december-2025_en.pdf"}, {"id": "69085", "name": "Ziihera : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-03T10:50:07Z", "last_update_date": "2025-12-17T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ziihera-epar-product-information_en.pdf"}, {"id": "71822", "name": "Ziihera : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:10:11Z", "last_update_date": "2025-12-17T16:10:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ziihera-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71823", "name": "Presentation - System Demo Q4 2025", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:09:39Z", "last_update_date": "2025-12-17T16:09:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-system-demo-q4-2025_en.pdf"}, {"id": "71824", "name": "Q&A - System Demo Q4 2025", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:11:23Z", "last_update_date": "2025-12-17T16:11:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/qa-system-demo-q4-2025_en.pdf"}, {"id": "71755", "name": "Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals", "type": "scientific-guideline", "status": "Draft: consultation open", "consultation_date": "2025-12-15 - 2026-02-15", "publish_date": "2025-12-15T11:41:06Z", "last_update_date": "2025-12-17T16:16:23Z", "reference_number": "EMA/INS/GMP/389655/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-annex-3-guidelines-good-manufacturing-practice-radiopharmaceuticals_en.pdf"}, {"id": "71825", "name": "Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:19:26Z", "last_update_date": "2025-12-17T16:19:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/shortage-prevention-plan-spp-shortage-mitigation-plan-smp-pilot-report_en.pdf"}, {"id": "57218", "name": "Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2023-01-11T14:13:00Z", "last_update_date": "2025-12-17T13:22:00Z", "reference_number": "EMA/934543/2022 Rev.7", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/table-decisions-labelling-exemption-requests-falling-under-article-63-directive-2001-83-ec-examined-quality-review-documents-qrd-group_en.pdf"}, {"id": "71561", "name": "Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)", "type": "other", "status": "Draft: consultation open", "consultation_date": "2025-12-08 - 2026-01-12", "publish_date": "2025-12-08T09:32:29Z", "last_update_date": "2025-12-17T16:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/call-user-acceptance-testers-read-functionality-public-product-management-service-pms-application-programming-interface-api_en.pdf"}, {"id": "29593", "name": "List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2012-10-01T14:08:00Z", "last_update_date": "2025-12-17T16:30:00Z", "reference_number": "EMA/630645/2012 Rev. 155", "url": "https://www.ema.europa.eu/en/documents/other/list-european-union-reference-dates-eurd-frequency-submission-periodic-safety-update-reports-psurs_en.xlsx"}, {"id": "7374", "name": "Lucentis : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2007-03-14T01:00:00Z", "last_update_date": "2025-12-17T10:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/lucentis-epar-all-authorised-presentations_en.pdf"}, {"id": "27249", "name": "Lucentis : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T02:00:00Z", "last_update_date": "2025-12-17T12:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/lucentis-epar-product-information_en.pdf"}, {"id": "27264", "name": "Lucentis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T02:00:00Z", "last_update_date": "2025-12-17T12:53:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lucentis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71827", "name": "Lucentis : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:35:49Z", "last_update_date": "2025-12-17T16:35:49Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lucentis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71828", "name": "Lucentis : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:37:39Z", "last_update_date": "2025-12-17T16:37:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lucentis-epar-product-information-tracked-changes_en.docx"}, {"id": "71826", "name": "Mozobil : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T16:21:21Z", "last_update_date": "2025-12-17T16:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mozobil-epar-product-information_en.pdf"}, {"id": "26168", "name": "Abilify Maintena : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-28T01:00:00Z", "last_update_date": "2025-12-18T15:16:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/abilify-maintena-epar-product-information_en.pdf"}, {"id": "70883", "name": "Abilify Maintena : EPAR – Product information – tracked changes ", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-28T14:07:56Z", "last_update_date": "2025-12-18T08:33:03Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_en.docx"}, {"id": "42179", "name": "Invokana : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2018-10-03T11:48:00Z", "last_update_date": "2025-12-18T11:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/invokana-epar-risk-management-plan_en.pdf"}, {"id": "9353", "name": "Invokana : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-29T01:00:00Z", "last_update_date": "2025-12-18T14:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/invokana-epar-product-information_en.pdf"}, {"id": "20433", "name": "Invokana : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2014-09-04T02:00:00Z", "last_update_date": "2025-12-18T11:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/invokana-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "31621", "name": "Invokana : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-29T01:00:00Z", "last_update_date": "2025-12-18T01:00:00Z", "reference_number": "EMA/277052/2025", "url": "https://www.ema.europa.eu/en/documents/overview/invokana-epar-medicine-overview_en.pdf"}, {"id": "71829", "name": "Invokana-H-C-002649-II-0069 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T08:49:34Z", "last_update_date": "2025-12-18T08:49:34Z", "reference_number": "EMA/273696/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/invokana-h-c-002649-ii-0069-epar-assessment-report-variation_en.pdf"}, {"id": "71830", "name": "Invokana : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T09:02:25Z", "last_update_date": "2025-12-18T09:02:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/invokana-epar-product-information-tracked-changes_en.docx"}, {"id": "70228", "name": "Alyftrek : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-23T13:54:19Z", "last_update_date": "2025-12-18T11:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/alyftrek-epar-product-information_en.pdf"}, {"id": "54706", "name": "Breyanzi : EPAR - Medicine Overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:22:00Z", "last_update_date": "2025-12-18T16:16:00Z", "reference_number": "EMADOC-1829012207-33599", "url": "https://www.ema.europa.eu/en/documents/overview/breyanzi-epar-medicine-overview_en.pdf"}, {"id": "54709", "name": "Breyanzi : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:31:00Z", "last_update_date": "2025-12-18T17:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/breyanzi-epar-risk-management-plan_en.pdf"}, {"id": "54707", "name": "Breyanzi : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:26:00Z", "last_update_date": "2025-12-18T12:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/breyanzi-epar-product-information_en.pdf"}, {"id": "67743", "name": "Breyanzi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-11T08:28:20Z", "last_update_date": "2025-12-18T12:19:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/breyanzi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71831", "name": "Breyanzi-VR-0000265024 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T09:20:07Z", "last_update_date": "2025-12-18T09:20:07Z", "reference_number": "EMADOC-1700519818-2456442", "url": "https://www.ema.europa.eu/en/documents/variation-report/breyanzi-vr-0000265024-epar-assessment-report-variation_en.pdf"}, {"id": "71832", "name": "Breyanzi-H-C-004731-P46-023 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T09:22:37Z", "last_update_date": "2025-12-18T09:22:37Z", "reference_number": "EMA/500721/2024", "url": "https://www.ema.europa.eu/en/documents/variation-report/breyanzi-h-c-004731-p46-023-epar-assessment-report_en.pdf"}, {"id": "62259", "name": "Azacitidine Kabi: EPAR - Product Information ", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-02-22T14:51:44Z", "last_update_date": "2025-12-18T11:11:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/azacitidine-kabi-epar-product-information_en.pdf"}, {"id": "71833", "name": "Azacitidine Kabi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T09:44:14Z", "last_update_date": "2025-12-18T09:44:14Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/azacitidine-kabi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "8802", "name": "Caelyx pegylated liposomal : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-03-09T01:00:00Z", "last_update_date": "2025-12-18T17:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/caelyx-pegylated-liposomal-epar-product-information_en.pdf"}, {"id": "69918", "name": "Caelyx pegylated liposomal : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-02T08:48:49Z", "last_update_date": "2025-12-18T09:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/caelyx-pegylated-liposomal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "33324", "name": "Mepact : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-05-06T02:00:00Z", "last_update_date": "2025-12-18T14:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mepact-epar-product-information_en.pdf"}, {"id": "69345", "name": "Mepact : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-17T11:49:56Z", "last_update_date": "2025-12-18T09:55:05Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/mepact-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71174", "name": "Alyftrek : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-14T11:10:29Z", "last_update_date": "2025-12-18T10:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/alyftrek-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "21436", "name": "Leflunomide ratiopharm : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-01-17T01:00:00Z", "last_update_date": "2025-12-18T13:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/leflunomide-ratiopharm-epar-product-information_en.pdf"}, {"id": "39696", "name": "Leflunomide ratiopharm : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-03-21T01:00:00Z", "last_update_date": "2025-12-18T13:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/leflunomide-ratiopharm-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71834", "name": "EMA/PE/0000232894 : EMA decision of 14 April 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral for adeno-associated viral vector serotype 9 containing the human MECP2 gene", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:12:49Z", "last_update_date": "2025-12-18T10:12:49Z", "reference_number": "EMADOC-1700519818-2039246", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000232894-ema-decision-14-april-2025-agreement-paediatric-investigation-plan-granting-deferral-adeno-associated-viral-vector-serotype-9-containing-human-mecp2-gene_en.pdf"}, {"id": "71836", "name": "Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 20 November 2025", "type": "minutes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T10:19:17Z", "last_update_date": "2025-12-18T10:19:17Z", "reference_number": "EMA/367781/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-executive-steering-group-shortages-safety-medicinal-products-mssg-20-november-2025_en.pdf"}, {"id": "71837", "name": "EMA/PE/0000232896 : EMA decision of 21 February 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for antisense oligonucleotide against patatin like phospholipase....sodium salt", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:19:18Z", "last_update_date": "2025-12-18T10:19:18Z", "reference_number": "EMADOC-1700519818-1911730", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000232896-ema-decision-21-february-2025-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-antisense-oligonucleotide-against-patatin-phospholipasesodium-salt_en.pdf"}, {"id": "71838", "name": "Cosentyx-PAM-0000301644 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:26:26Z", "last_update_date": "2025-12-18T10:26:26Z", "reference_number": "EMADOC-1700519818-2769286", "url": "https://www.ema.europa.eu/en/documents/variation-report/cosentyx-pam-0000301644-epar-assessment-report_en.pdf"}, {"id": "59548", "name": "Ebymect : EPAR - Risk-management-plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2015-11-23T14:19:00Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ebymect-epar-risk-management-plan_en.pdf"}, {"id": "45348", "name": "Xigduo : EPAR - Risk Management Plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-05-26T14:19:00Z", "last_update_date": "2025-12-18T10:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/xigduo-epar-risk-management-plan_en.pdf"}, {"id": "47119", "name": "Qtern : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-03-25T14:46:00Z", "last_update_date": "2025-12-18T10:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/qtern-epar-risk-management-plan_en.pdf"}, {"id": "23191", "name": "Strimvelis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2017-08-17T16:44:00Z", "last_update_date": "2025-12-18T16:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/strimvelis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71839", "name": "Overview of comments received on \"Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations\"", "type": "comments", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T11:05:35Z", "last_update_date": "2025-12-18T11:05:35Z", "reference_number": "(EMA/CHMP/72790/2024)", "url": "https://www.ema.europa.eu/en/documents/comments/overview-comments-received-guideline-allergen-products-development-immunotherapy-allergy-diagnosis-moderate-low-sized-study-populations_en.pdf"}, {"id": "54235", "name": "Saphnelo : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:15:00Z", "last_update_date": "2025-12-18T15:16:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/saphnelo-epar-product-information_en.pdf"}, {"id": "54236", "name": "Saphnelo : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:17:00Z", "last_update_date": "2025-12-18T11:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/saphnelo-epar-all-authorised-presentations_en.pdf"}, {"id": "56429", "name": "Saphnelo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2022-10-18T13:38:00Z", "last_update_date": "2025-12-18T15:17:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/saphnelo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "54237", "name": "Saphnelo : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:20:00Z", "last_update_date": "2025-12-18T13:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/saphnelo-epar-risk-management-plan_en.pdf"}, {"id": "71840", "name": "Saphnelo-H-C-004975-X-0023 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T11:56:09Z", "last_update_date": "2025-12-18T11:56:09Z", "reference_number": "EMA/348230/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/saphnelo-h-c-004975-x-0023-epar-assessment-report-variation_en.pdf"}, {"id": "66198", "name": "Absimky : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:14:51Z", "last_update_date": "2025-12-18T15:50:00Z", "reference_number": "EMA/536423/2024", "url": "https://www.ema.europa.eu/en/documents/overview/absimky-epar-medicine-overview_en.pdf"}, {"id": "66202", "name": "Absimky : EPAR - Risk Management Plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:23:35Z", "last_update_date": "2025-12-18T12:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/absimky-epar-risk-management-plan_en.pdf"}, {"id": "65325", "name": "CHMP summary of positive opinion for Absimky", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2024-10-18T12:00:00Z", "last_update_date": "2025-12-18T12:06:00Z", "reference_number": "EMA/CHMP/448121/2024 ", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-absimky_en.pdf"}, {"id": "66201", "name": "Absimky : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2024-12-18T13:21:48Z", "last_update_date": "2025-12-18T12:06:00Z", "reference_number": "EMA/511029/2024", "url": "https://www.ema.europa.eu/en/documents/assessment-report/absimky-epar-public-assessment-report_en.pdf"}, {"id": "66200", "name": "Absimky : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:20:05Z", "last_update_date": "2025-12-18T19:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/absimky-epar-product-information_en.pdf"}, {"id": "66199", "name": "Absimky : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:18:45Z", "last_update_date": "2025-12-18T12:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_en.pdf"}, {"id": "68505", "name": "Absimky : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-28T19:26:20Z", "last_update_date": "2025-12-18T11:00:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/absimky-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71841", "name": "Minutes of the PRAC meeting 27 - 30 October 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T12:16:18Z", "last_update_date": "2025-12-18T12:16:18Z", "reference_number": "EMA/PRAC/375420/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-27-30-october-2025_en.pdf"}, {"id": "71805", "name": "Agenda - Management Board meeting: 17-18 December 2025", "type": "agenda", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T13:40:00Z", "last_update_date": "2025-12-18T12:20:29Z", "reference_number": "EMA/MB/331769/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-management-board-meeting-17-18-december-2025_en.pdf"}, {"id": "22425", "name": "Name Review Group form - questions and answers", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2013-01-24T12:10:00Z", "last_update_date": "2025-12-18T12:10:00Z", "reference_number": "EMA/741768/2012 Rev.1", "url": "https://www.ema.europa.eu/en/documents/other/name-review-group-form-questions-answers_en.pdf"}, {"id": "30832", "name": "Jentadueto : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2012-08-16T02:00:00Z", "last_update_date": "2025-12-18T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/jentadueto-epar-product-information_en.pdf"}, {"id": "68165", "name": "Jentadueto : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T11:50:56Z", "last_update_date": "2025-12-18T12:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/jentadueto-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "22982", "name": "Orgalutran : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-02-29T01:00:00Z", "last_update_date": "2025-12-18T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/orgalutran-epar-product-information_en.pdf"}, {"id": "32215", "name": "Orgalutran : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2008-02-29T01:00:00Z", "last_update_date": "2025-12-18T17:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/orgalutran-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71842", "name": "Orgalutran : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:28:12Z", "last_update_date": "2025-12-18T12:28:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/orgalutran-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71843", "name": "Orgalutran : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:30:12Z", "last_update_date": "2025-12-18T12:30:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/orgalutran-epar-product-information-tracked-changes_en.docx"}, {"id": "71844", "name": "Cetrotide : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:34:25Z", "last_update_date": "2025-12-18T12:34:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cetrotide-epar-product-information-tracked-changes_en.docx"}, {"id": "17698", "name": "RotaTeq : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-12-04T00:09:00Z", "last_update_date": "2025-12-18T17:41:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf"}, {"id": "67995", "name": "RotaTeq : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-25T16:26:37Z", "last_update_date": "2025-12-18T12:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/rotateq-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71845", "name": "Prazepam : List of nationally authorised medicinal products - PSUSA/00002502/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:57:21Z", "last_update_date": "2025-12-18T12:57:21Z", "reference_number": "EMADOC-1700519818-2770702", "url": "https://www.ema.europa.eu/en/documents/psusa/prazepam-list-nationally-authorised-medicinal-products-psusa-00002502-202503_en.pdf"}, {"id": "71846", "name": "Prazepam : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002502/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:58:59Z", "last_update_date": "2025-12-18T12:58:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/prazepam-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002502-202503_en.pdf"}, {"id": "71733", "name": "Questions and answers on the refusal of the marketing authorisation for Blarcamesine Anavex", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-18T13:25:00Z", "reference_number": "EMA/385732/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/questions-answers-refusal-marketing-authorisation-blarcamesine-anavex_en.pdf"}, {"id": "71850", "name": "Fetcroja-PAM-0000303390 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T14:12:48Z", "last_update_date": "2025-12-18T14:12:48Z", "reference_number": "EMADOC-1700519818-2517542", "url": "https://www.ema.europa.eu/en/documents/variation-report/fetcroja-pam-0000303390-epar-assessment-report_en.pdf"}, {"id": "59513", "name": "List of medicines currently in PRIME scheme", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2016-10-17T17:41:00Z", "last_update_date": "2025-12-18T14:30:00Z", "reference_number": "EMA/521657/2016", "url": "https://www.ema.europa.eu/en/documents/other/list-medicines-currently-prime-scheme_en.xlsx"}, {"id": "71851", "name": "Recommendations on eligibility to PRIME scheme Adopted at the CHMP meeting of 8-11 December 2025", "type": "chmp-annex", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T14:27:07Z", "last_update_date": "2025-12-18T14:27:07Z", "reference_number": "EMA/371701/2025", "url": "https://www.ema.europa.eu/en/documents/chmp-annex/recommendations-eligibility-prime-scheme-adopted-chmp-meeting-8-11-december-2025_en.pdf"}, {"id": "71852", "name": "Summary of bilateral meeting: European Medicines Agency and the European Consumer Organisation (BEUC)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T15:16:51Z", "last_update_date": "2025-12-18T15:16:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/summary-bilateral-meeting-european-medicines-agency-european-consumer-organisation-beuc_en.pdf"}, {"id": "71853", "name": "Agenda - EMA/BEUC Bilateral", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T15:18:11Z", "last_update_date": "2025-12-18T15:18:11Z", "reference_number": "EMA/230706/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-ema-beuc-bilateral_en.pdf"}, {"id": "27303", "name": "Puregon : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-31T02:00:00Z", "last_update_date": "2025-12-18T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/puregon-epar-product-information_en.pdf"}, {"id": "70953", "name": "Puregon : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-30T17:19:06Z", "last_update_date": "2025-12-18T15:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/puregon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "36387", "name": "Puregon : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2008-08-31T02:00:00Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/puregon-epar-all-authorised-presentations_en.pdf"}, {"id": "66197", "name": "Afqlir : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-01-20T11:54:28Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/afqlir-epar-product-information_en.pdf"}, {"id": "67963", "name": "Afqlir : EPAR -Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-24T16:52:28Z", "last_update_date": "2025-12-18T16:01:47Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/afqlir-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "57312", "name": "Pirfenidone Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2023-01-17T17:03:00Z", "last_update_date": "2025-12-19T18:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pirfenidone-viatris-epar-product-information_en.pdf"}, {"id": "63476", "name": "Pirfenidone Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-04T14:00:00Z", "last_update_date": "2025-12-19T12:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pirfenidone-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "64073", "name": "Altuvoct : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-07-12T11:11:01Z", "last_update_date": "2025-12-19T10:39:56Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/altuvoct-epar-product-information_en.pdf"}, {"id": "66065", "name": "Altuvoct : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-11T10:45:05Z", "last_update_date": "2025-12-19T08:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/altuvoct-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71854", "name": "Altuvoct : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:22:53Z", "last_update_date": "2025-12-19T08:22:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/altuvoct-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71855", "name": "Altuvoct-PSUSA-00011062-202502 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:23:31Z", "last_update_date": "2025-12-19T08:23:31Z", "reference_number": "EMADOC-1700519818-2767181", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/altuvoct-psusa-00011062-202502-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "71856", "name": "Macitentan Accord : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:38:28Z", "last_update_date": "2025-12-19T08:38:28Z", "reference_number": "EMA/251911/2025", "url": "https://www.ema.europa.eu/en/documents/overview/macitentan-accord-epar-medicine-overview_en.pdf"}, {"id": "71857", "name": "Macitentan Accord : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:39:28Z", "last_update_date": "2025-12-19T08:39:28Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/macitentan-accord-epar-risk-management-plan_en.pdf"}, {"id": "71858", "name": "Macitentan Accord : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:40:31Z", "last_update_date": "2025-12-19T08:40:31Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/macitentan-accord-epar-product-information_en.pdf"}, {"id": "71859", "name": "Macitentan Accord : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:41:26Z", "last_update_date": "2025-12-19T08:41:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/macitentan-accord-epar-all-authorised-presentations_en.pdf"}, {"id": "71860", "name": "Macitentan Accord : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T08:42:29Z", "last_update_date": "2025-12-19T08:42:29Z", "reference_number": "EMA/CHMP/216790/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/macitentan-accord-epar-public-assessment-report_en.pdf"}, {"id": "56060", "name": "Vyvgart : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-12T10:34:00Z", "last_update_date": "2025-12-19T12:38:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/vyvgart-epar-product-information_en.pdf"}, {"id": "71862", "name": "Varicella vaccine (live) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:06:11Z", "last_update_date": "2025-12-19T09:06:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00010473-202503_en.pdf"}, {"id": "71861", "name": "Varicella vaccine (live) : List of nationally authorised medicinal products - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:04:47Z", "last_update_date": "2025-12-19T09:04:47Z", "reference_number": "EMADOC-1700519818-2588438", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-list-nationally-authorised-medicinal-products-psusa-00010473-202503_en.pdf"}, {"id": "71863", "name": "Varicella vaccine (live) : List of nationally authorised medicinal products - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:12:47Z", "last_update_date": "2025-12-19T09:12:47Z", "reference_number": "EMADOC-1700519818-2588438", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-list-nationally-authorised-medicinal-products-psusa-00010473-202503_en.pdf-0"}, {"id": "47660", "name": "Ruconest : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-05-18T09:20:00Z", "last_update_date": "2025-12-19T13:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ruconest-epar-risk-management-plan_en.pdf"}, {"id": "31810", "name": "Ruconest : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-10-14T02:00:00Z", "last_update_date": "2025-12-19T12:49:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ruconest-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71864", "name": "Ruconest : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:24:35Z", "last_update_date": "2025-12-19T09:24:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ruconest-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "69781", "name": "Comirnaty : 3.2.P drug product", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-20T10:25:15Z", "last_update_date": "2025-12-19T11:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/comirnaty-32p-drug-product_en.zip"}, {"id": "71721", "name": "Questions and answers on the refusal of the marketing authorisation for Hetlioz X-39", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-19T11:30:00Z", "reference_number": "EMEA/H/C/003870/X/0039", "url": "https://www.ema.europa.eu/en/documents/smop/questions-answers-refusal-marketing-authorisation-hetlioz-x-39_en.pdf"}, {"id": "69922", "name": "Comirnaty : 3.2.S Drug substance", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-02T09:31:43Z", "last_update_date": "2025-12-19T11:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/comirnaty-32s-drug-substance_en.zip"}, {"id": "71866", "name": "Methylthioninium chloride Proveblue : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T11:32:51Z", "last_update_date": "2025-12-19T11:32:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/methylthioninium-chloride-proveblue-epar-risk-management-plan_en.pdf"}, {"id": "20098", "name": "Methylthioninium chloride Proveblue : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2012-02-28T01:00:00Z", "last_update_date": "2025-12-19T17:21:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/methylthioninium-chloride-proveblue-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71867", "name": "Methylthioninium chloride Proveblue : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T11:36:13Z", "last_update_date": "2025-12-19T11:36:13Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/methylthioninium-chloride-proveblue-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "16662", "name": "Methylthioninium chloride Proveblue : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-06-06T02:00:00Z", "last_update_date": "2025-12-19T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/methylthioninium-chloride-proveblue-epar-product-information_en.pdf"}, {"id": "26375", "name": "Simulect : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-10-31T01:00:00Z", "last_update_date": "2025-12-19T11:51:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/simulect-epar-product-information_en.pdf"}, {"id": "35844", "name": "Simulect : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2008-10-31T01:00:00Z", "last_update_date": "2025-12-19T11:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/simulect-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71868", "name": "Simulect : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:03:14Z", "last_update_date": "2025-12-19T12:03:14Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/simulect-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "25860", "name": "Yargesa : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-04-10T18:57:00Z", "last_update_date": "2025-12-19T09:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/yargesa-epar-product-information_en.pdf"}, {"id": "68766", "name": "Yargesa : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-16T12:12:21Z", "last_update_date": "2025-12-19T12:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/yargesa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "35861", "name": "Leflunomide medac : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2010-08-05T02:00:00Z", "last_update_date": "2025-12-19T13:43:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/leflunomide-medac-epar-product-information_en.pdf"}, {"id": "69102", "name": "Leflunomide medac : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-04T11:58:20Z", "last_update_date": "2025-12-19T12:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/leflunomide-medac-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "68206", "name": "Tuzulby : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T16:49:55Z", "last_update_date": "2025-12-19T11:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tuzulby-epar-product-information_en.pdf"}, {"id": "70993", "name": "Tuzulby : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-04T11:11:00Z", "last_update_date": "2025-12-19T12:17:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tuzulby-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "27102", "name": "Pregabalin Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-31T02:00:00Z", "last_update_date": "2025-12-19T12:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pregabalin-viatris-epar-product-information_en.pdf"}, {"id": "63218", "name": "Pregabalin Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-16T11:00:00Z", "last_update_date": "2025-12-19T08:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pregabalin-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "19027", "name": "Replagal : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-11-03T01:00:00Z", "last_update_date": "2025-12-19T11:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/replagal-epar-product-information_en.pdf"}, {"id": "70140", "name": "Replagal : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-18T11:54:07Z", "last_update_date": "2025-12-19T12:33:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/replagal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "10369", "name": "Shingrix : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2018-03-28T02:00:00Z", "last_update_date": "2025-12-19T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/shingrix-epar-all-authorised-presentations_en.pdf"}, {"id": "25698", "name": "Shingrix : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-03-28T02:00:00Z", "last_update_date": "2025-12-19T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_en.pdf"}, {"id": "69347", "name": "Shingrix : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-17T12:36:03Z", "last_update_date": "2025-12-19T13:50:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/shingrix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "48900", "name": "Shingrix : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-09-28T14:21:00Z", "last_update_date": "2025-12-19T11:47:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/shingrix-epar-risk-management-plan_en.pdf"}, {"id": "71869", "name": "Shingrix-X-0000243671 : EPAR - Assessment report - Extension", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T12:41:11Z", "last_update_date": "2025-12-19T12:41:11Z", "reference_number": "EMADOC-1700519818-2471078", "url": "https://www.ema.europa.eu/en/documents/variation-report/shingrix-x-0000243671-epar-assessment-report-extension_en.pdf"}, {"id": "52379", "name": "Minjuvi : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-09-08T15:00:00Z", "last_update_date": "2025-12-19T10:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/minjuvi-epar-product-information_en.pdf"}, {"id": "70461", "name": "Minjuvi : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-06T17:18:59Z", "last_update_date": "2025-12-19T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/minjuvi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "16444", "name": "Olumiant : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-03-16T01:00:00Z", "last_update_date": "2025-12-19T16:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/olumiant-epar-product-information_en.pdf"}, {"id": "71870", "name": "Olumiant : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:53:04Z", "last_update_date": "2025-12-19T12:53:04Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/olumiant-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf-0"}, {"id": "71871", "name": "Metoprolol : List of nationally authorised medicinal products - PSUSA/00002039/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:47:09Z", "last_update_date": "2025-12-19T12:47:09Z", "reference_number": "EMADOC-1700519818-2771118", "url": "https://www.ema.europa.eu/en/documents/psusa/metoprolol-list-nationally-authorised-medicinal-products-psusa-00002039-202503_en.pdf"}, {"id": "71872", "name": "Metoprolol : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002039/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:49:53Z", "last_update_date": "2025-12-19T12:49:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/metoprolol-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002039-202503_en.pdf"}, {"id": "71875", "name": "Macitentan AccordPharma : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:08:09Z", "last_update_date": "2025-12-19T13:08:09Z", "reference_number": "EMA/251923/2025", "url": "https://www.ema.europa.eu/en/documents/overview/macitentan-accordpharma-epar-medicine-overview_en.pdf"}, {"id": "71876", "name": "Macitentan AccordPharma : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:09:15Z", "last_update_date": "2025-12-19T13:09:15Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/macitentan-accordpharma-epar-risk-management-plan_en.pdf"}, {"id": "71877", "name": "Macitentan AccordPharma : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:11:10Z", "last_update_date": "2025-12-19T13:11:10Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/macitentan-accordpharma-epar-product-information_en.pdf"}, {"id": "71878", "name": "Macitentan AccordPharma : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:12:19Z", "last_update_date": "2025-12-19T13:12:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/macitentan-accordpharma-epar-all-authorised-presentations_en.pdf"}, {"id": "71879", "name": "Macitentan AccordPharma : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T13:13:14Z", "last_update_date": "2025-12-19T13:13:14Z", "reference_number": "EMA/CHMP/216792/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/macitentan-accordpharma-epar-public-assessment-report_en.pdf"}, {"id": "60975", "name": "Product information URLs for member states", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-09-27T11:05:53Z", "last_update_date": "2025-12-19T13:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/product-information-urls-member-states_en.xls"}, {"id": "68207", "name": "Tuzulby : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T16:52:13Z", "last_update_date": "2025-12-19T13:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/tuzulby-epar-all-authorised-presentations_en.pdf"}, {"id": "45256", "name": "Rotarix : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2019-08-14T14:58:00Z", "last_update_date": "2025-12-19T15:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/rotarix-epar-risk-management-plan_en.pdf"}, {"id": "71880", "name": "Rifampicin : List of nationally authorised medicinal products - PSUSA/00002640/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:27:19Z", "last_update_date": "2025-12-19T13:27:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rifampicin-list-nationally-authorised-medicinal-products-psusa-00002640-202503_en.pdf"}, {"id": "71881", "name": "Rifampicin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002640/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:32:53Z", "last_update_date": "2025-12-19T13:32:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rifampicin-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002640-202503_en.pdf"}, {"id": "71882", "name": "Olumiant : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:48:16Z", "last_update_date": "2025-12-19T14:48:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olumiant-epar-product-information-tracked-changes_en.docx"}, {"id": "71883", "name": "Rocuronium : List of nationally authorised medicinal products - PSUSA/00002656/202502", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:48:22Z", "last_update_date": "2025-12-19T14:48:22Z", "reference_number": "EMADOC-1700519818-2775133", "url": "https://www.ema.europa.eu/en/documents/psusa/rocuronium-list-nationally-authorised-medicinal-products-psusa-00002656-202502_en.pdf"}, {"id": "71884", "name": "Rocuronium : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002656/202502", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:50:51Z", "last_update_date": "2025-12-19T14:50:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rocuronium-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002656-202502_en.pdf"}, {"id": "11519", "name": "Tremfya : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T11:59:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/overview/tremfya-epar-medicine-overview_en.pdf"}, {"id": "49890", "name": "Tremfya : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2021-01-22T10:29:00Z", "last_update_date": "2025-12-19T11:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/tremfya-epar-risk-management-plan_en.pdf"}, {"id": "17468", "name": "Tremfya : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T16:31:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tremfya-epar-product-information_en.pdf"}, {"id": "41843", "name": "Tremfya : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T13:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/tremfya-epar-all-authorised-presentations_en.pdf"}, {"id": "69993", "name": "Tremfya : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-08T13:53:43Z", "last_update_date": "2025-12-19T16:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tremfya-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71885", "name": "Tremfya-X-0000248626 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T15:07:42Z", "last_update_date": "2025-12-19T15:07:42Z", "reference_number": "EMADOC-1700519818-2583818", "url": "https://www.ema.europa.eu/en/documents/variation-report/tremfya-x-0000248626-epar-assessment-report-variation_en.pdf"}, {"id": "71886", "name": "Tremfya : EPAR - Statement indicating compliance with the agreed completed paediatric investigation plan", "type": "pip-compliance", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:12:46Z", "last_update_date": "2025-12-19T15:12:46Z", "reference_number": "EMADOC-1700519818-2494684", "url": "https://www.ema.europa.eu/en/documents/pip-compliance/tremfya-epar-statement-indicating-compliance-agreed-completed-paediatric-investigation-plan_en.pdf"}, {"id": "71887", "name": "Selegiline : List of nationally authorised medicinal products - PSUSA/00002688/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:18:31Z", "last_update_date": "2025-12-19T15:18:31Z", "reference_number": "EMADOC-1700519818-2775121", "url": "https://www.ema.europa.eu/en/documents/psusa/selegiline-list-nationally-authorised-medicinal-products-psusa-00002688-202503_en.pdf"}, {"id": "71888", "name": "Selegiline : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002688/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:20:02Z", "last_update_date": "2025-12-19T15:20:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/selegiline-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002688-202503_en.pdf"}, {"id": "69897", "name": "Attrogy : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-28T16:29:07Z", "last_update_date": "2025-12-19T15:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/attrogy-epar-product-information_en.pdf"}, {"id": "71889", "name": "Attrogy : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:28:27Z", "last_update_date": "2025-12-19T15:28:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/attrogy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "55558", "name": "Technology Capability Investment Plan to 2028 - Becoming a digital hub for the European medicines regulator network", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T10:45:00Z", "last_update_date": "2025-12-19T10:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/report/technology-capability-investment-plan-2028-becoming-digital-hub-european-medicines-regulator-network_en.pdf"}, {"id": "63601", "name": "Fabhalta : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-14T11:11:01Z", "last_update_date": "2025-12-19T13:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/fabhalta-epar-product-information_en.pdf"}, {"id": "66907", "name": "Fabhalta : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-20T16:24:17Z", "last_update_date": "2025-12-19T16:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/fabhalta-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "36422", "name": "Avastin : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-17T15:08:00Z", "last_update_date": "2025-12-19T17:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/avastin-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "5223", "name": "Avastin : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-17T02:00:00Z", "last_update_date": "2025-12-19T12:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/avastin-epar-product-information_en.pdf"}, {"id": "66920", "name": "Avastin : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-24T10:35:59Z", "last_update_date": "2025-12-19T12:03:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/avastin-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71891", "name": "Avastin-PSUSA-00000403-202502 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T16:39:48Z", "last_update_date": "2025-12-19T16:39:48Z", "reference_number": "EMADOC-1700519818-2470418", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/avastin-psusa-00000403-202502-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "67978", "name": "Avastin : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-25T12:05:23Z", "last_update_date": "2025-12-19T16:42:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/avastin-epar-product-information-tracked-changes_en.docx"}, {"id": "71892", "name": "Summary - Joint HMA/EMA multi-stakeholder workshop on Patient Registries for Alzheimer's disease December 2025", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:38:32Z", "last_update_date": "2025-12-22T09:38:32Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/report/summary-joint-hma-ema-multi-stakeholder-workshop-patient-registries-alzheimers-disease-december-2025_en.pdf"}, {"id": "71893", "name": "Presentation - Opening remarks from the European Commission: HMA/EMA multi-stakeholder workshop on Patient Registries for Alzheimer's disease (T. Raemaekers)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:40:20Z", "last_update_date": "2025-12-22T09:40:20Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-opening-remarks-european-commission-hma-ema-multi-stakeholder-workshop-patient-registries-alzheimers-disease-t-raemaekers_en.pdf"}, {"id": "71895", "name": "Presentation - Introduction on Alzheimer’s Disease and current therapies (M. Haberkamp)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:42:52Z", "last_update_date": "2025-12-22T09:42:52Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-introduction-alzheimers-disease-current-therapies-m-haberkamp_en.pdf"}, {"id": "71896", "name": "Presentation - Industry perspective on real-world evidence generation: Shaping fit-for-purpose Alzheimer’s Disease registries (E. Grace and P. Dobay)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:43:50Z", "last_update_date": "2025-12-22T09:43:50Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-industry-perspective-real-world-evidence-generation-shaping-fit-purpose-alzheimers-disease-registries-e-grace-p-dobay_en.pdf"}, {"id": "71897", "name": "Presentation - EU Regulator's view on RWD in Alzheimer's disease (P. Mol)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:46:37Z", "last_update_date": "2025-12-22T09:46:37Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-eu-regulators-view-rwd-alzheimers-disease-p-mol_en.pdf"}, {"id": "71898", "name": "Presentation - FDA: Real-world data in Alzheimer's disease (T. Buracchio)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:49:28Z", "last_update_date": "2025-12-22T09:49:28Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-fda-real-world-data-alzheimers-disease-t-buracchio_en.pdf"}, {"id": "71899", "name": "Presentation - HTA perspective on real-world evidence generation (N. Hedberg)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:53:40Z", "last_update_date": "2025-12-22T09:53:40Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-hta-perspective-real-world-evidence-generation-n-hedberg_en.pdf"}, {"id": "71900", "name": "Presentation - Payer's perspective: Current evidence gaps and potential of real-world data (C. Hernandez)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:55:05Z", "last_update_date": "2025-12-22T09:55:05Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-payers-perspective-current-evidence-gaps-potential-real-world-data-c-hernandez_en.pdf"}, {"id": "71901", "name": "Presentation - Healthcare professional perspective on real-world evidence generation (K. Frederiksen)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:57:11Z", "last_update_date": "2025-12-22T09:57:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-healthcare-professional-perspective-real-world-evidence-generation-k-frederiksen_en.pdf"}, {"id": "71903", "name": "Presentation - Big MS Network: Multiple sclerosis lessons for Alzheimer’s Disease registries (J. Hillert)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T10:03:09Z", "last_update_date": "2025-12-22T10:03:09Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-big-ms-network-multiple-sclerosis-lessons-alzheimers-disease-registries-j-hillert_en.pdf"}, {"id": "71904", "name": "Presentation - Swedish registry for cognitive and dementia disorders (SveDem): Registry holder's perspectives on real-world evidence generation (D. Religa)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T10:04:54Z", "last_update_date": "2025-12-22T10:04:54Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-swedish-registry-cognitive-dementia-disorders-svedem-registry-holders-perspectives-real-world-evidence-generation-d-religa_en.pdf"}, {"id": "71905", "name": "Presentation - International Registry for Alzheimer's Disease and Other Dementias (InRAD): Driving international collaboration for real-world evidence in Alzheimer's disease (R. Perneczky and R. Hyde)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T10:06:41Z", "last_update_date": "2025-12-22T10:06:41Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-international-registry-alzheimers-disease-other-dementias-inrad-driving-international-collaboration-real-world-evidence-alzheimers-disease-r-perneczky-r-hyde_en.pdf"}, {"id": "71894", "name": "Presentation - Lived experience of Alzheimer’s Disease (European Working Group of People with Dementia) (S. Dougall)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T09:41:58Z", "last_update_date": "2025-12-22T09:41:58Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-lived-experience-alzheimers-disease-european-working-group-people-dementia-s-dougall_en.pdf"}, {"id": "71902", "name": "Presentation - Patient representative perspective: Understanding European perspectives on data sharing (L. Duffner)", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T10:01:07Z", "last_update_date": "2025-12-22T10:01:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-patient-representative-perspective-understanding-european-perspectives-data-sharing-l-duffner_en.pdf"}, {"id": "71906", "name": "Report - EMA roundtable with stakeholders on the 20th anniversary of the SME regulation", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T10:27:18Z", "last_update_date": "2025-12-22T10:27:18Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/report/report-ema-roundtable-stakeholders-20th-anniversary-sme-regulation_en.pdf"}, {"id": "71907", "name": "Role description: Financial Officer - Corporate Functions & Administration - FGIV", "type": "recruitment", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T10:32:31Z", "last_update_date": "2025-12-22T10:32:31Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/recruitment/role-description-financial-officer-corporate-functions-administration-fgiv_en.pdf"}, {"id": "33600", "name": "List of centrally authorised products with safety-related changes to the product information", "type": "regulatory-procedural-guideline", "status": "Adopted", "consultation_date": "", "publish_date": "2016-09-19T16:40:00Z", "last_update_date": "2025-12-22T11:00:00Z", "reference_number": "EMA/376138/2025", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/list-centrally-authorised-products-safety-related-changes-product-information_en.xlsx"}, {"id": "71908", "name": "HMA-EMA joint Network Data Steering Group meeting - 6 November 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-22T11:43:05Z", "last_update_date": "2025-12-22T11:43:05Z", "reference_number": "EMA/323786/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/hma-ema-joint-network-data-steering-group-meeting-6-november-2025_en.pdf"}, {"id": "69972", "name": "Zemcelpro : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-05T15:07:32Z", "last_update_date": "2025-12-22T14:58:57Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/zemcelpro-epar-product-information_en.pdf"}, {"id": "71909", "name": "Zemcelpro : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T14:59:13Z", "last_update_date": "2025-12-22T14:59:13Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/zemcelpro-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "48742", "name": "Aybintio : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2020-09-02T17:26:00Z", "last_update_date": "2025-12-22T11:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/aybintio-epar-product-information_en.pdf"}, {"id": "69547", "name": "Osvyrti : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-28T15:27:34Z", "last_update_date": "2025-12-22T15:18:41Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/osvyrti-epar-product-information_en.pdf"}, {"id": "71910", "name": "Osvyrti : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-22T15:18:48Z", "last_update_date": "2025-12-22T15:18:48Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/osvyrti-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}]}